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Abstract 
Two studies were perfonned to detect aetiology of acute diarrhoea in hospitalized 
children aged under five years in Tripoli, Libya. In the first study, two hundred and 
thirty-six stool samples were obtained. Of these, 118 were from patients admitted for 
acute diarrhoeal disease, and 118 age and sex-matched concurrent controls were 
admitted for other reasons. In the second study, eight hundred and ten stool specimens 
were collected 405 from patients and the same number from controls. All were 
admitted to the AIjala Children, s Hospital, Tripoli, Libya. The first study was 
conducted between August I't 1997 and 31" October 1997 and the second study was 
conducted between January 1" 2003 and 3l't December 2003. One or more enteric 
pathogens were isolated from 55.9% of patients and 13.6% of controls in the first study 
and 68.1 % of patients and 12.6% of controls in the second study. 
In the first study, the organisms were identified from stool of patients; Escherichia coli 
22.9%, rotavirus 15.3%, Campylobacter 7.6%, Proteus 7.6%, Klebsiella 4.2%, 
Entamoeba histolytica 4.2%, Cryptosporidium 2.5% and Giardia lamblia 1.7%, 
Salmonella was not isolated in both studies, because not growth on ordinary media 
were used (MacConkey agar and Blood agar) but usually growth on Salmonella- 
Shigella medium where not used. 
In the second study, enteropathogens identified were: rotavirus 30.4%, Escherichia coli 
16.5%, Entamoeba histolytica 12.5%, Campylobacter 6.7%, Giardia lamblia 3.7%, 
Cryptosporidium 3.2%, Klebsiella 2.9%, Proteus 2.2%. 
Libyan children under six months of age were the most susceptible to acute diarrhoea 
requiring admission to the hospital. This was remarked in 46.6% of patients in the first 
study and 43.2% in the second. Exclusive breast feeding in Libyan children was 
of a very low percentage. In the first study it was 19.5% and in the second 29.1%. 
ix 
Children use dummies were about 3 times more at risk of diarrhoea than the non users 
in the first study (OD: 5.95,95%, Cl: 1.120-2.37, p<0.001) and RR: 3.1 and (0: 
: 2.986ý 95%. Cl: 2.13-4.16, P<0.001) and RR: 23 in the second, this fell to children 
being twice as much at risk of contracting diarrhoea. 
Watery stool was the most common stool consistency of patients in both studies. Fever 
was the most common clinical feature associated with acute diarrhoea in the two 
studies (72.9% and 71.6% respectively). Vomiting was present in 51.7% of patients 
among the first study and 58.3% among the second. Moderate and isotonic dehydration 
were the most common degree and type of dehydration across both studies. In the 
second study, Rotavirus peaked during the winter (cold season) while bacteria and 
parasites peaked during the summer and autumn seasons. 
API 20E and API Campy were used to identify bacterial isolated by cultures and the 
number of confirmed cases decreased from 142 to 112 samples. 
Polymerase Chain Reaction was adopted in the second study to confirm detection of 
Campylobacter spp. these were identified by API Campy technique, where all 
Campylobacter spp. were identified as the saine as detected by API Campy and for 24 
samples. 
Chapter I 
CHAPTERI 
INTRODUCTION 
1.1 General introduction 
Diarrhoeal diseases are a major cause of childhood morbidity and mortality, especially 
in developing countries. According to World Health Organization (WHO) figures, 
acute diarrhoea due to gastroenteritis (GE) causes about 750 million episodes of 
diarrhoea a year. From this, there are 4-5 million deaths in children under the age of 5 
years in developing countries (Anon. 1982). In 1992, it was estimated that 2.9 million 
deaths worldwide could be attributed to diarrhoeal disease, with most of the deaths 
occurring in developing countries (Murry and Lopez 1997). In 1998, it was estimated 
that 2.2 million deaths, most of whom were under 5 years of age were caused by 
diarrhoea (Victoria et al. 2000). The highest rates of illness are in children under the 
age of 2 years (Dupont 1995). The prospective, community-based studies reveal that 
acute gastrointestinal illnesses are extremely common ranging from one to three 
illnesses per year in the developed countries and five to 18 illnesses per person per 
year in impoverished areas of tropical, developing countries. In the latter areas, 
diarrhoeal diseases are major causes of morbidity as well as leading causes of death 
(Guerrant et al. 1990). In these low income countries, diarrhoea accounts for as many 
as 21 percent of all deaths in children under the age of 5 years (Parashar et al. 2003b 
& Kosek et al. 2003). These figures are striking when compared with the developed 
world, where diarrhoea is associated with fever in I percent of deaths in children 
(Parashar et al. 2003b). The highest age-mortality rate (8.5 per 1000/yr) occurred in 
children younger than I year of age (Kosek et al. 2003). 
Latin American children under 5 years of age will have an average of 5 to 10 
diarrhocal episodes per year. The highest attack rate will occur during the first year of 
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life. Differences in diarrhoeal mortality are observed among individual countries; in 
Mexico, mortality rates due to diarrhoea are 6 per 1000 children, in Peru 7 in 1000, 
and in Chile 3 in 1000. Mortality associated with acute diarrhoea is highest among 
infants less than I year of age, where it averages the rate of 20 per 1000 children 
(Lanata et al. 1992). It is well known that diarrhoeal disease is one of the leading 
causes of illness and death in young children. But it is not clear how accurate the 
morbidity and mortality estimates are? (Parashar et al. 2003b). In 1976, Rohde and 
Northrup estimated that annually, diarrhoea killed up to 5 million children in 
developing countries (Rohde and Northrop 1976). Snyder and Merson (1982) analysed 
24 longitudinal, prospective, community-based studies of diarrhoea published between 
1954 and 1979. They estimated that children under 5 years old had 2.2 episodes of 
diarrhoea per year, resulting in 4.6 million deaths (Snyder and Merson 1982). In 1986, 
a committee of the US Institute of Medicine revised the diarrhoea mortality estimate to 
3.5 million deaths per year, based on published data and field experience (Anon. 1986). 
Bern et al. (1992) then updated Snyder and Merson's is analysis by using studies 
published from 1980 to 1990. They documented diarrhoea morbidity of 2.6 episodes 
per child per year, a similar finding to that reported a decade earlier, but with lower 
mortality 3.3 million deaths per year (Bern et al. 1992). Kosek et al. (2003) have 
recently made a further update by reviewing 60 studies of diarrhoea morbidity and 
mortality published between 1990 and 2000. They concluded that diarrhoea accounts 
for 21% of all deaths in children under the age of 5 and causes 2.5 million deaths per 
year, although diarrhoea morbidity remains relatively unchanged. 
In developed countries, diarrhoeal disease is an important cause of morbidity with 
significant health cost (Ferson 1996). In the United States, for example, where attack 
rates range from I to 5 episodes per child per year (Guerrant et al. 1990), it accounts 
for some 500 deaths annually and 10% of preventable post neonatal infant deaths, and 
3 
costs the health care system $ 264 million (Ho et al. 1988). Over 5% of consultations 
made by general practitioners for children under 5 years in England and Wales are for 
infectious disease (Anon. 1995a) and the age specific incidence of inpatient episodes 
for infectious intestinal disease in England is highest in children under 5 years at 6.3 in 
100,000 per year (Anon. 1995b). In Southeast Asian counties such as Malaysia, the 
mortality resulting from diarrhoeal illness is low, but continues to be a major cause of 
hospital admission in children (Lee and Ooi 1999). Infectious intestinal disease in 
children is associated with mortality, although rarely in developed countries (Crowley 
et al. 1997). In the United States, an estimated 211 to 375 million episodes of acute 
diarrhoea occur each year (1.4 episodes per person per year); such episodes are 
responsible for more than 900,000 hospitalizations and 6000 deaths annually 
(Herikstand et al. 2002). 
Despite the different methods and sources of information, each successive review of 
the diarrhoea burden over the past three decades has demonstrated declining mortality 
but relatively stable morbidity (Parashar et al. 2003b). The decline in global diarrhoea 
mortality is confirmed by detailed information from monitoring in certain countries 
over time (Victoria et al. 2000). Increased use of oral rehydration therapy, (ORT) 
improved nutrition, increased breast feeding, better supplement feeding, enhanced 
female education, measles immunization, and improvements in hygiene and sanitation 
are all believed to have contributed to this decline (Parashar et al. 2003). 
1.2 Definition of diarrhoea 
Diarrhoea can be defined as increased frequency and fluidity of the stool; that is, the 
passage of stool containing excess water and electrolytes losses. Acute diarrhoea is 
defined as the presence of three or more loose, watery stools within a 24-hour period 
(Anon. 1995c). Dysentery, often termed bloody diarrhoea, indicates visible blood and 
4 
mucous in diarrhoeal stools. Episodes of diarrhoea lasting more than 14 days are 
referred to as persistent diarrhoea. 
1.3 Clinical features 
Acute diarrhoea usually manifests as an increase in the frequency or volume of stool. 
Fever is a common symptom and is usually associated with invasive pathogens. 
Bloody stools are also present in diarrhoea caused by invasive pathogens. Vomiting is 
observed more frequently in viral diarrhoea. Abdominal cramps are present in some 
cases. Dehydration is one of the most important clinical features. Assessment of 
dehydration requires a great deal of experience. In general an onset of excessive stools 
and vomiting leads to severe dehydration. Dehydration can be classified into mild, 
moderate and severe based on the severity of body fluid loss. Patients with mild 
dehydration appear almost clinically normal, yet they may have lost considerable body 
fluid (4-5% body weight loss i. e. mild dehydration). Fluid losses in moderate 
dehydration (6-9% body weight loss) and in severe dehydration (10% or more of body 
weight loss) are greater. Symptoms and signs particularly useful in assessment of 
dehydration and monitoring of rehydration are: thirst, radial pulse, blood pressure, skin 
elasticity, anterior fontanella in infants, appearance of tongue, mucous membranes, 
eyes, eyeball tension, tears, respiration, urinary output, estimation of body weight and 
central nervous system manifestations. 
1.4 Diarrhoea and malnutrition 
In developing countries diarrhoea and malnutrition are closely related: decreased food 
intake during diarrhoeal episodes leads to weight loss and malnutrition and diarrhoea 
is more severe and more prolonged in malnourished children. Intake of food is often 
voluntarily reduced by the child's mother during illness. Marasmus (very low body 
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weight) and, less commonly, Kwashiorkor ( low body weight) results from deficiency 
of protein and energy as calories in the diet. Protein energy deficiency may develop 
during diarrhoea episodes leading to stunting of growth. In children with malnutrition, 
episodes of diarrhoea are prolonged and frequently associated with complications of 
illness (Guerrant 1994). In certain areas, micronutrient deficiencies are common. The 
micronutrients of potential critical to general infant health in these regions include iron, 
iodine, vitamin B 12, folate, vitamin A and zinc. Of these, vitamin A and zinc 
deficiencies are particularly important to diarrhoeal disease. Vitamin A deficiency is 
associated with the development of both acute and persistent diarrhoea (Usha et aL 
1991). Deficiency in tissue level of zinc is associated with diarrhoea and atrophy of 
intestinal mucosa (Hambidge 1992). However this is less consistent and generally does 
not support the use of vitamin A supplementation for reducing morbidity associated 
with acute diarrhoea (Grotto et al. 2003). Zinc deficiency, in particular, suppresses 
immune system function and is associated with an increased prevalence of persistent 
diarrhoea (Bitarakwate et al. 2003). 
1.5 Breast feeding and diarrhoea 
The neonatal period is particularly critical in this respect, because the newborn is 
immediately exposed to a large number of micro-organisms, foreign proteins and 
chemicals. Breast-feeding is therefore important, not only as a natural immunological 
4substitution therapy' or 'passive vaccine', but also because immune - modulating 
factors in breast milk may exert an important impact on the suckling s developing 
immune system (Brandtzaeg 1998 and 2002). Epidemiological data indicate that the 
risk of dying from diarrhoea could be reduced 14-24 times in breast-fed children 
(Anonymous 1994). Lactating mammary glands are part of an integrated immune 
system with local production of antibodies, mainly consisting of secretory 
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immunoglobulin A (Slg A). The main purpose of the secretory antibody system is, in 
cooperation with innate mucosal defence mechanisms, to perform immune exclusion. 
Most important to this end, Slg A inhibits colonization and invasion by pathogens, and 
carries the pathogens and their products back to the lumen, thus avoiding cytolytic 
damage to the epithelium (Norderhaug et al. 1999). In addition to antibodies and free 
glycoproteins called membrane secretory components, other components are thought 
to protect the very young children. These include innate defence factors such as 
lysozyme, lactoferrin, peroxidase, complex oligosacharides, fatty acids and mucins. 
Moreover, a variety of leukocytes occur in colostrum and later milk together with 
macrophages, neutrophilic granulocytes and cytokines (Goldman 1993). Two studies 
published in Latin American and Asia at the end of the 1980s found that exclusively 
breastfed infants had considerably reduced risks of diarrhoea (and other infections) 
compared with infants who either received other foods or liquids along with breast 
milk or were fully weaned off breast feeding (Popkin et al. 1990). Similar results have 
been published more recently from a more industrialized setting (Kramer et al. 200 1). 
1.6 Diarrhoea in children and adults 
Diarrhoea is the most common cause of death in children under 3 years of age because 
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a young child s body has not yet developed acquired immunity to infection. During an 
episode of diarrhoea, some children do not obtain enough food and drink because 
many people believe that it is dangerous to feed a child who has diarrhoea. This may 
result in starvation leading to malnutrition. Children are also not able to state that they 
are thirsty and often are not supplied with enough drink. If malnourished children get 
diarrhoea this makes the malnutrition worse. Children are more likely than adults to 
suffer the ill-affects of other infections which are often present during diarrhoea. In the 
native adult population, although acute diarrhoea occurs, it is not a major problem and 
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is not considered a major public health issue. Gastroenteritis in adults is usually not 
severe and does not require medical intervention, the exceptions to this being acute 
diarrhoea caused by Vibrio cholerae (V cholerae) (Prado and 0 Ryan 1994), Typhoid, 
Eenteropathogenic Escherichia coli (EPEC) and Enterohaemorrhagic Escherichia coli 
(EHEC e. g. 0 15 7). 
1.7 Traveller's diarrhoea 
Traveller's diarrhoea remains the most frequent infectious illness among travellers 
from industrialized countries visiting destinations in developing countries. Groups at 
particularly high risk of symptoms include infants, people with impaired gastric acid 
barrier and travellers with co-existing medical problems. Travellers diarrhoea may be 
particularly severe and long-lasting in small children (Pitzinger et aL 1991). 
Traveller's diarrhoea is usually caused by faecal contamination of food and drink. 
Bacterial agents predominate, especially Enterotoxigenic Escherichia coli (ETEC) and 
Enteroinvasive Escherichia coli (EIEC) which are responsible for up to 60% of cases. 
Salmonella, Campylobacter and other species of bacterial pathogens, as well as 
Giardia lamblia (G. lamblia) and Entamoeba histolytica (Ent. histolytica), each cause 
fewer than 5% of the cases (Gomi et al. 2001). Rotavirus and Cryptosporidium (Cr. ) 
may also be responsible for some cases. 
Despite extensive microbiological assessment, approximately 20% of all cases remain 
of undetermined aetiology. (Behrens and Steffen 2003). Indeed, the imPortance of 
Campylobacterjejuni (C. jejuni) as a cause of traveller's diarrhoea (Taylor 1992) has 
led to the observation that the spectrum of illness in travellers is similar to that 
described in their country of origin. Bacterial agents probably cause most of these 
cases because they can be prevented by use of antimicrobial agents (Ericson 2000). 
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1.8 Persistent diarrhoea 
The mortality rate from acute diarrhoea is being reduced significantly by the increased 
use of ORT. Prolonged diarrhoea (14-20 days) is emerging as an increasingly 
important cause of morbidity and mortality. Between 3% and 10% of acute diarrhoeal 
cases occurring in developing regions progress to a course of 14 days or longer 
(Guerrant 1994). Most enteroPathogens that have been isolated in acute diarrhoea have 
also been isolated in persistent episodes (Bhan 1989). However, persistent diarrhoea is 
emerging as a serious public health problem. Causes of persistent diarrhoea are 
multiple and include certain enteropathogens such as Enteroadherent E. coli (EAEC), 
Yersinia enterocolitica (Y enterocOlitica), enteric adenovirus, Isospora belli, 
Cyclospora cayelerensis, G. lamblia), Microsporidium, Cryptosporidium parvum (Cr. 
parvum), transitory lactose intolerance, and moderate to severe malnutrition (Bhan et 
al. 1989 and Fang et al. 1995). The incidence of this diarrhoea is also high, suggesting 
that both conditions may have common risk factors. Virulence factors of individual 
infectious agents besides specific host factors may influence the occurrence of both 
acute and persistent diarrhoea (Lanata, et al. 1992). 
1.9 Pathophysiology 
1.9.1 Bacterial enteropathogens 
1.9.1.1 Adherence factors. These factors include pili, glycoproteins, or other surface 
proteins that allow bacteria to colonize the intestine. The presence of one or more of 
these factors that bind to specific surface receptors in the enterocyte is critical for 
adhesion in the first phase of infection. (Prado &0 Ryan 1994). 
1.9.1.2 Toxin production. The major toxins produced by enteropathogenic bacteria 
are enterotoxins and cytotoxins. These toxins can cause diarrhoea by activation of 
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secretory mechanisms in the intestinal mucosa. ETEC produces both heat-stable (ST) 
and heat-labile (LT) toxins. These produce secretion of sodium and water through 
stimulation of the cyclic adenosine monophosphate (cAMP) or cyclic guanosine 
monophosphate (cGNT) circuits, respectively. Cytotoxins produce direct cell damage, 
mainly through inhibition of protein synthesis. The best characterized enteric 
cytotoxins are the Shiga and Shiga-like toxins (Prado &0 Ryan 1994). Some agents, 
such as V cholerae and ETEC, produce enterotoxins that cause diarrhoea by activation 
of secretory mechanisms in the intestinal mucosa. ETEC produces both heat-stable 
(STa and STb) and heat-labile (LTI and LTII) toxins. Other pathogens such as Shigella 
dysenteriae (Sh. dysenteriae) and V paraheamolyticus, produce cytotoxins that lead to 
destruction of the intestinal epithelium, hence resulting in inflammatory diarrhoea. 
Some agents, such as Staphylococcus aureus (Staph. aureus) and Bacillus cereus, 
produce neurotoxins that induce diarrhoea by acting directly on the nervous system. 
Dysentery results from either the production of toxins or from direct invasion of the 
intestinal mucosa by pathogens such as Shigella organisms and EIEC. Some enteric 
pathogen, such as Salmonella typhi (S. typhi) and Y enterocolitica, can penetrate the 
intestinal mucosa and disseminate through the regional lymphatics to enter the 
bloodstream, resulting in systemic manifestations (Podewils et al. 2004). 
1.9.1.3 Invasiveness. The capacity of Gram negative bacteria to invade and multiply 
in a cell, causing cell destruction, is determined by the lipopolysaccharide composition 
of the bacterial cell wall in combination with production and liberation of specific 
plasmids and chromosomal genes that vary from one enteropathogen to another. The 
presence of some of these factors is a prerequisite for disease (for example virulence 
plasmids in Shigella and Yersinia infections). Others factors add to pathogenesis, 
albeit not essential (enzymes and surface antigens in Shigella and EPEC infections). 
The genetic basis for these pathogenic characteristics is located in plasmids, the 
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chromosome and bacteriophages (Prado &0 Ryan 1994). Sequencing the virulence 
plasmid of the Shigellaflexneri (Sh. flexneri) 5a strain M90T has allowed investigators 
to identify the genes encoding approximately 25 proteins secreted by the type ILI 
secretion system (Buchrieser et al. 2000). This secretion system, like that in some 
other Gram-negative bacteria, translocates the Shigella effector molecules from the 
bacteria cytoplasm of the host cell (Galan & Collmer 1999). A31 -kb segment of the 
virulence plasmid, called the entry region or ipalmxi-spa locus, comprises the 
pathogenicity island, which is actually sufficient for entry of Shigella into intestinal 
epithelial cells, for apoptotic death of macrophages and for activation of polymorpho- 
nuclear leukocytes (Ingersoll et al. 2002). The island is organized into two divergently 
transcribed operons (Fernandez & Sansonetti, 2003 and Ingersoll et al. 2002). 
1.9.2 Viral entropathogens 
Information on the pathophysiology of rotavirus as well as other enteric viral 
infections has been obtained mostly from animal studies and from a few biopsy 
specimens obtained from seriously infected children. Thus, the pathophysiological 
mechanisms proposed for viral gastroenteritis, although probably correct, cannot be 
assured at this time. During the recovery phase, the enteroblastic cells will mature and 
reconstruct the villous structure. 
Diarrhoea that occurs may be a result of one or more of the following: (1) decrease in 
surface area, (2) disruption in epithelial integrity, (3) disaccharide deficiency, and/or 
(4) imbalance of counter current mechanisms with a net result of intestinal fluid 
secretion. It is not clear which of these mechanisms play a greater role in the 
pathogenesis of rotavirus or other enteric viral diarrhoea (Prado &0 Rayan 1994). 
Enteric viruses cause diarrhoea through multiple mechanisms, including interfering 
with gastrointestinal motility or destroying the intestinal epithelium and reducing 
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brush border enzymes (Moon 1997). Studies in mice indicate that a non-structural 
protein of rotavirus 4 (NSP4) acts as an enterotoxin and causes secretory diarrhoea by 
altering epithelial cell function and permeability (Morris et al. 1999 and Estes 2001). 
Recent data indicate that a specific cleavage product of NSP4 (aa 112 to 175) is 
actively secreted from infected cells and that NSP4 is released from the apical side of 
infected epithelial cells via an atypical pathway that bypasses the Golgi apparatus and 
involves lipid microdomains called rafts (Sapin et al. 2002 and Zhang et al. 2000). 
Other studies indicate that rotavirus antigen and Ribonucleic acid (RNA) are present in 
serum of children with acute rotavirus infection, suggesting that rotavirus perhaps 
escapes the intestinal tract in children, resulting in antigenaernia and possible viremia 
(Blutt et al. 2003). However, since NSP4 was detected in vivo at the basement 
membrane (BM) with antibodies against aa 114 to 135 and 120 to 147, it can be 
concluded that the released peptide sequence contains at least the enterotoxic domain. 
After basal release, NSP4 would bind to extra cellular matrix (ECM) proteins laminin- 
P3 and fibronectin (Boshuizen et al. 2004). Larninin and fibronectin are 
multifunctional proteins with diverse biological activities. They can influence cell 
adhesion, growth, morphology, differentiation, migration and agglutination as well as 
the assembly of the ECM (Colognato, and Yorchenco 2000). 
1.9.3 Parasitic enteropathogens 
Protozoa that produce diarrhoea have adherence mechanisms that allow the organism 
to attach to the intestinal epithelium. Once adhered, the organism produces 
inflammation at the submucosa, rapid cell turnover and atrophy of the intestinal villi 
(Prado &0 Rayan 1994). Specific surface structures that facilitate parasite adhesion 
include surface glycoproteins such as glycophorin A and B, complement receptors, 
adsorbed components of the complement cascade fibronectin, and N- 
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acetylglucosamine conjugates. Numerous investigators have suggested that toxic 
products elaborated by parasitic protozoa are responsible for at least some aspects of 
pathology. 
1.10 Aetiology of acute diarrhoea 
Many recent advances have allowed a more clear understanding of the role of different 
viral and bacterial agents as a cause of diarrhoeal disease worldwide, rapid 
identification of new aetiologic agents of acute diarrhoea. The discovery of new 
pathogenic mechanisms of enteric infections and the elaboration of new molecular- 
based diagnostic techniques for diarrhoeal pathogens have taken place during the past 
25-30 years. Most causes of diarrhoeal disease are due to the action of pathogenic 
organisms in the small or large bowel. Currently, the leading aetiological agents of 
diarrhoea in developed and developing countries are bacteria (Escherichia coli (E. coli) 
; ETEC, EPEC, EIEC, EHEC and Enteroaggrigative EC (EAggEC), Campylobacter 
spp., Shigella spp., Salmonella spp., cytotoxigenic Clostridium difficile (Cl. difficile), 
Clostridium perftingens (Cl. perfingens), V cholerae, Y. enterocolitica, Staph. aureus 
and Bacillus spp), viruses (rotaviruses, enteric adenoviruses, noroviruses, 
caliciviruses, astrovirus and coronavirus), and parasites (Ent. histolytica, G. lamblia, 
Cryptosporidium and Cyclosporium), which are the most common aetiological agents 
of acute diarrhoea. 
1.10.1 Bacterial Agents 
Diarrhoeal diseases caused by enteric bacterial pathogens have become less prevalent 
in industrialized countries (with the exception of Campylobacters and Salmonellas), 
but remain an important cause of morbidity and mortality in developing countries, 
especially in infants and children in tropical countries. Many bacteria can cause 
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outbreaks of diarrhoea. Identification of the pathogen causing disease in an individual 
or outbreak depends not only on a microbiology laboratory, but also on the history of 
the episode, clinical examination of patients, inspection of the stools and 
epidemiological knowledge. Children in developing countries are exposed to a wide 
range of bacterial enteric pathogens at a very early age and suffer numerous episodes 
of diarrhoeal illness as a result. The predominant bacterial pathogens vary with the age 
of the child and also with time, showing both seasonal and secular trends, as well as 
geographical variation (Podewils et al. 2004). 
1.10.1.1 Escherichia coli 
E. coli are motile Gram negative bacilli, some strains are capsulated, they are aerobic 
and facultative anaerobes and they grow on simple media. 
These are normal inhabitants of the intestine of man and animal. However, some can 
cause disease in man. E. coli is responsible for a number of diseases, including 
septicaernia, urinary tract infections, neonatal meningitis, appendicitis, peritonitis and 
gastroenteritis. E. coli is the predominant facultative anaerobe of human colonic flora 
and colonizes the infant gastrointestinal tract within hours of birth (Nataro & Kaper 
1998). Although most E. coli strains are harmless or even beneficial to their human 
host, several highly adapted clones are capable of causing diarrhoeal disease. From the 
6 classes of diarrhoeagenic E. coli, 5 classes have been defined by the presence of 
specific virulent characteristics: ETEC, EPEC, EIEC, EHEC and EAggEC. 
A sixth category is Diffuse adherent EC (DAEC). The role of this strain that attaches 
diffusely to Hela and Flep-2 cells in diarrhoeal disease has been controversial. The 
scant information currently available on pathogenic mechanisms associated with 
DAEC does not allow a clear differentiation among true pathogenic and non 
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pathogenic DAEC strains (Prado &0 Ryan 1994). All five diarrhoeagenic E. coli are a 
cause of disease in children in the developing world but, EHEC, including E. coli 
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01 57: H7, are the agents of diarrhoea more commonly identified in developed countries 
(Podewils et al. 2004). As a group, diarrhoeagenic K coli are the most common 
bacteria detected in studies from economically developing countries, causing 30 to 40 
percent of acute diarrhoeal episodes in children (Albert et al. 1999 and Torres et al. 
200 1). EAggEC, EPEC and ETEC cause endemic watery diarrhoea and have been 
reported most frequently in children younger than 2 years of age (Albert et al. 1999). 
ETEC, EAEC and EHEC are toxin producers; EPEC, EAEC and DAggEC have 
characteristic adhesion patterns. EIEC is distinguished by capacity to invade epithelial 
cells and the inability to produce toxins (Rodrigues et al. 2004). ETEC is a common 
cause of traveller's diarrhoea in economically developing countries. EIEC generally 
causes diarrhoea with fever and blood indistinuishable from Shigella infections in all 
ages. Shigatoxin-producing E. coli (STEC) has been established as the main etiologic 
agent of Haemolytic Uraemic Syndrome (HUS) (Lopez et al. 2000) and reported as a 
common cause of bloody diarrhoea among some developing countries (mainly Chile 
and Argentina), but these findings have not been universal (0 Ryan et al. 2005). 
1.10.1.1.1 Enterotoxigenie E. coli 
Epidemiology ETEC has a worldwide distribution and is a major health hazard in 
adults and children in developing countries and is spread is by the faecal-oral route 
either directly or indirectly via food or water. Infants are at particular risk during 
weaning. In community-based studies in developing countries ETEC are responsible 
for 15-20 % of cases of diarrhoea in developing countries. The infective dose is high 
in the normal host colonies forming unit (c. f. u; iol-iol). ETEC is among the most 
frequently detected enteric pathogens in the stools of children under 5 years of age in 
developing countries and in travellers to those regions who developed acute watery 
diarrhoea. In Latin American, ETEC is a common cause of diarrhoeal disease in 
children (Prado &0 Ryan 1994). 
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Pathogenesis This is the most clearly identifiable diarrhoegenic E coli associated 
with production of acute diarrhoea. The first phase of ETEC infection is adherence to 
the enterocyte mediated by adherence fimbria, denominated colonization factors that 
attach to specific ganglioside M, (GMI) ganglioside receptors on the enterocyte 
surface. The bacteria then release their toxins. The genes for these adhesions are coded 
in plasmids, and six different antigen determinants have been identified for ETEC 
fimbria (CSI to CS6). These antigens form combinations that are grouped into 
families denominated colonization factor antigen (CFAI, CFAFI, and CFAIV). After 
attachment, ETEC produce and release an enterotoxin, LT and / or ST that is 
responsible for the secretion of sodium and water into the intestinal lumen. Both toxins 
bind to receptors in intestinal epithelial cells and insert an enzymatic subunit that 
modifies aG protein associated with the adenylete cyclase complex. The increase of 
cyclic AMP and increased synthesis of prostaglandins by toxin-stimulated cells 
initiates a metabolic cascade that results in a significant increase of secretion of fluid 
and electrolytes in to the intestinal lumen. There are no specific histo-pathological 
changes to be seen in the intestinal mucosa, and no evidence of inflammation (Hart 
and Shears 2003). 
1.10.1.1.2 Enteropathogenic E. coli 
Epidemiology The first infections with EPEC were described in the UK and the 
USA in the 1940s and 1950s, in epidemics of infantile diarrhoea (Bray & Beavan 1948 
and Neter 1959). Nowadays they are a cause of sporadic disease. In developing 
countries EPEC is still a major cause of infantile diarrhoea. EPEC was initially 
identified from common-source outbreaks of diarrhoea among infants by their 
serological characters. A range of 0 serotypes of E. coli was then identified which 
became widely used to detect EPEC strains known to be previously associated with 
these outbreaks. EPEC has also been associated with Traveller's diarrhoea. 
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Transmission is by the faecal-oral route, either directly or in food or water. The 
infective dose appears to be low at less than 104 C. f . U. (Hart and Shears 2003). EPEC 
strains cause acute secretory diarrhoea, largely in children of 2 years of age and 
younger and especially in those who are 6 months or younger. EPEC strains are 
associated with chronic diarrhoea in children but rarely cause disease in adults 
(Podewils et al. 2004). 
Pathogenesis EPEC strains were the first E. coli strains associated with diarrhoea. 
There are two factors of pathogenic mechanisms, one of these is a fimbrium of 60 mD 
called adherence factor (AF). The presence of this factor alone is not sufficient to 
cause illness. The second factor is a surface protein, coded by chromosomal gene eae, 
which seems responsible for the alterations in the cytoskeleton of the intestinal cell 
and the disruption of the micro villi structure (Jerse et al. 1990). Significant toxin 
production has not been shown for EPEC strains, although the clinical characteristics 
of EPEC-associated diarrhoea suggest that secretory mechanisms may be involved 
(Prado &0 Ryan 1994). The ingested EPEC adhere to the mucous overlying the small 
intestinal enterocytes using firnbriae. On contact with enterocytes, pathogenicity island 
(PAI), (called the locus of enterocytes effacement; LEE) associated genes are activated. 
This induces the formation of a type IH secretion system (TTSS) that delivers effector 
molecules across both bacterial membranes and through a pilus-like structure into the 
enterocyte (Vallance & Finlay 2000). Secreted effectors include Tir (translocatable 
intimin receptor), which becomes inserted in the enterocyte membrane. This has 
affinity for intimin, a surface protein on the EPEC. Thus EPEC is unique in 
synthesizing, secreting and inserting its own receptor into host cell membranes. This 
then mediates the intimate attachment of EPEC to the enterocyte surface. 
Subsequently the brush border is lost by a process of vesiculation (Embaye et al. 
1989). PAI often encode both effector molecules responsible for disease and secretion 
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system that deliver these effectors to host cells. Diarrhoeageinc EPEC and EHEC are 
attaching/ effacing (A/E) bacterial pathogens that attach to host intestinal epithelium 
and efface brush border microvilli, forming A/E lesions (Frankel et al. 1998 and 
Clarke et al. 2003). The factors are often encoded by PAI present in the genomes of 
pathogenic, but absent in non-pathogenic strains (Hacker and Kaper 2000). Many key 
virulence factors shared by A/E pathogens reside in the LEE), a PAI essential for A/E 
lesion fon-nation (Deng et al 2001 and Taauschek et al. 2002 and Deng et al. 2003). 
The LEE contains 41 genes and encodes a TTSS, a common virulence mechanism for 
many human and plant pathogens (Hacker & Kaper 2000, Galan 2001 and Cornelis 
2002). TTSSs are conserved organelles that deliver bacterial effectors proteins capable 
of modulating host functions for forming such organelle (Clarke et al. 2003). Recently 
a study showed a large repertoire of non-LEE- encoded effectors indicates that 
diseases mediated by A/E pathogens may require coordinated action of effectors 
encoded by the LEE and at least three other PAIs (Deng et al. 2003). 
1.10.1.1.3 Enteroinvasive E. coli 
Epidemiology EIEC are not a common cause of diarrhoea. A recent study performed 
in Santiago, Chile, found that these organisms were associated with 2% to 3% of 
diarrhoea cases, more commonly in children older than 2 years of age. Diarrhoea 
caused by these organisms is most commonly watery, although dysentery, similar to 
that observed for Shigella enterocolitis, also occurs in EIEC infections (Prado &0 
Ryan 1994). Infection is uncommon in children under I year of age but may be a 
cause of travellers Diarrhoea (Hart and Shears 2003). EIEC strains cause bloody 
mucoid diarrhoea and share many biochemical and pathogenic properties with Shigella 
organisms. Watery diarrhoea is also observed and fever is a common finding 
(Podewils et al. 2004). 
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Pathogenicity These E. coli strains have the capacity to colonize, invade, and destroy 
colonic cells, properties that are genetically coded by chromosomal and plasmid 
Deoxy ribonucleic acid (DNA). Enteroinvasive E. coli (EIEQ harbor a 120 mD 
plasmid that shares homology with the virulence plasmid of Shigella. These organisms 
additionally elaborate an enterotoxin, which is more intensely expressed in low iron 
environments. This toxin stimulates secretion of water and electrolytes at the small 
intestine level (Fasano et aL 1990). 
1.10.1.1.4 Enterohemorrhagic E. coli 
Epidemiology Infection with EHEC was initially described in industrialized countries. 
Here they tend to cause outbreaks of infection, usually as result of the consumption of 
incompletely cooked beef (Karmali 1989). EHEC can be part of the normal enteric 
flora of cattle, sheep, goats, cats and dogs in which they cause no disease. It is 
transmitted to humans primarily through consumption of contaminated foods, such as 
raw or uncooked ground meat products and raw milk. The incidence of EHEC 
infections varies by age group, with the highest incidence of reported cases occurring 
in children aged under 15 years (0.7 cases per 100,000 in the United States). It is 
estimated that up to 10% of patients with EHEC infection may develop Haernolytic 
Uraemic Syndrome (HUS), with a case-fatality rate from 3% to 5%. E. coli 0157 is 
the most important EHEC serotype in relation to public health; other serotypes have 
frequently been involved in sporadic cases and outbreaks (Anon. 2005). The infective 
dose is low (less than 102 c. f. u. ), and person-to-person spread also occurs (Hart and 
Shears 2003). EHEC infections are more common occurrences in developed countries, 
although a large outbreak has been described in Swaziland (Effler et al. 2001). 
Pathogenesis EHEC produce attaching effacement, limited to the terminal ileum and 
colon, and have most of the genes in the LEE pathogenicity island of EPEC. 
In addition, they release one or both of the toxins, verocytotoxin (VT) I or 2. These 
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toxins are also called Shiga-like toxins (SLT)I and 2; they inhibit protein synthesis 
and are cytotoxic (Roe & Gally 2000). There are three pathogenic characteristics 
attributable to EHEC strains: (1) adherence is mediated by plasmid coded fimbria, (2) 
attachment and effacement lesions identical to that observed for classic EPEC occurs 
and is mediated by a chromosomal gene similar to the EPEC eae, and (3) these strains 
produce one and / or two phase encoded toxins, similar to the Shigella dysenteriae I 
toxin,, and called SLTI and SLT TI (formerly called verotoxins because of their 
capacity to destroy vero cells). At least 10 EHEC serogroups and 55 serotypes have 
been described, of which the most commonly found are serogroups 0157,026, and 
0111 and serotypes 0157: H7,026: HI 1,026; H32, Oll I; H8, and 0111: H30 (Levine 
et al. 1987). EHEC-associated diarrhoea can present with watery stools when infection 
is moderate or with gross bloody diarrhoea when infection is severe (Prado &0 Ryan 
1994). STEC produces either or both of two phage-encoded toxins, Stxl and StX2 
(Popoff 1998) which are thought to cause the vascular endothelial damage observed in 
haernorhagic colitis (HC) and HUS patients (Podewils 2004). 
1.10.1.1.5 EnteroAggregative E. coli 
Epidemiology EAggEC are the most recently discovered pathogenic group (Nataro et 
al. 1998). Diagnosis is by culture of K coli that produce a distinctive aggregative 
pattern on cultured cells and that contain EAggEC pathogenicity genes detectable by 
PCR (Steiner et al. 1998). EAggEC are being recognized increasingly as important 
diarrhoeal pathogens, although the mechanism by which they act remains poorly 
understood. They are associated with watery diarrhoea in young children and have 
been reported as a cause of persistent diarrhoea in children and Human 
Immunodeficiency Virus (HIV) in adults (Podewils et al. 2004). 
Pathogenicity These E. coli strains tend to autoaggregative in Hep-2 or HeLa cell 
culture system in a stacked brick pattern, which is why they have been termed 
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autoaggregative E. coli, although enteroaggregative may be more appropriate. 
Autoaggregation is determined by the presence of a 55 to 65 mD plasmid that codes 
for adherence fimbria, a smooth lipopolysacharide, and a new heat-stable enterotoxin 
named enteroaggregative stable toxin (Nataro et al. 1992). A second thermolabile 
toxin antigenically related to E. coli hemolysin has also been detected for some of 
these strains (Savarino et al. 1991). These E. coli can cause necrosis of micro-villi, and 
mononuclear infiltration of the submucosa (Prado & 0, Ryan 1994). 
1.10.1.1.6 Diffuse Adherent E. coli (DAEC) 
The role of these sixth- category E. coli strains that attach diffusely to HeLa and Hep-2 
cells in diarrhoeal disease has been controversial. Some studies have reported isolation 
of these strains more frequently in children with diarrhoea than in controls and in 
children with persistent diarrhoea (Baqui et al. 1992). In Santiago, DAEC infection 
seems to be more common in older children and has a seasonal distribution similar to 
ETEC. Other studies, including those with volunteers, did not show an association of 
this organism with diarrhoea production (Gomes et al. 1989 and Tacket et al. 1990). 
The difftise adhesion pattern of aggregation has been associated with the presence of 
firnbriae (Bilge et al. 1989). Enterotoxin production has not yet been shown for these 
E. coli strains. The scarce information currently available on pathogenic mechanisms 
associated with DAEC does not allow a clear differentiation among true pathogenic 
and non-pathogenic DAEC strains (Prado &0 Ryan 1994). 
1.10.1.2 Campylobacter spp. 
Campylobacteriosis is a collective description for infectious diseases caused by 
members of the bacterial genus Campylobacter. In 1977, Skirrow confirmed the 
findings of a Belgian team and described a simple technique for culturing 
Campaylobacter jejuni (C. jejuni) and Campylobacter coli (C. coli) from stool 
specimens, which allowed widespread isolation of these organisms (Skirrow 1977). 
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Although the species names of C jejuni and C. coli were derived from an initial 
association with enteric disease in animals (Jones et al. 1931 and Doyle 1948), they 
are the most important human pathogens in this genus, with the former usually 
responsible for the majority of enteric Campylobacter infections (80-90%; Nacharnkin 
and Blaser 2000). However, a variety of other species, including C upsaliensis, C. 
hyointestinalis and C. lari, also infect humans (Mishu et al. 1992). Campylobacteriosis 
is a zoonosis and has in recent years been recognized as a primary cause of childhood 
diarrhoea which is often accompanied by abdominal pain with bloody stool. Infection 
in young adults may be related to the popularity among that age group for consuming 
fast food and takeaway meals (Skirrow 1990). Campylobacter is one of the most 
frequently isolated bacteria from the stools of infants and children in developing 
countries (Coker et al. 2002). 
Campylobacters are slim (1.5-6.0 [tm long and 0.2-0.5 [t m wide), Gram-negative rods, 
which are spirally curved with tapering ends. They are microaerophilic and grow best 
in the presence of 5%02,10% C02and 85% N2. The cell usually possesses a polar 
flagellum at one or both ends. Motility is of the darting type with a cork screw like 
movement. 
The clinical spectrum of Campylobacter enteritis ranges from a watery, non- 
inflammatory diarrhoea to a severe inflammatory diarrhoea with abdominal pain and 
fever. Disease is less severe in developing countries than in developed countries 
(Oberhelman and Taylor 2000). C. jejuni infection is the most frequently identified 
infection preceding Guillain-Barre syndrome (GBS), an autoimmune disorder of the 
peripheral nervous system, which is characterized by acute flaccid paralysis 
(Nachamkin et aL 1998). 
Epidemiology Campylobacter enteritis is the most frequent form of acute bacterial 
diarrhoea in industrialised countries, where it is affects people of all ages but with a 
22 
distinctive bimodal distribution, particularly affecting children aged <4 years and 
young adults aged 15-44 years (Tauxe 2001). In developing countries where 
Campylobacter are hyper-endernic, the disease is confined to young children who, 
through repeated exposure to infection, develop immunity early in life (Oberhelman & 
Taylor 2000 and Coker et al. 2002). Disease is normally restricted to children with no 
apparent peak in adults. Campylobacter is part of the natural intestinal flora of a wide 
range of domestic and wild birds and animals. Although identification of the origin of 
a particular infection is rarely made, transmission is probably most commonly via the 
surface of meat as a result of faecal contamination during slaughtering. Other sources 
include untreated water, untreated milk and sewage contamination. Pet contact, 
particularly with puppies with diarrhoea, is also a probable source (Ketley 1997). Most 
estimates of incidence in developing countries are from laboratory-based surveillance 
of pathogens responsible for diarrhoea. Campylobacter isolation rates in developing 
countries range from 5 to 20% (Oberhelman & Taylor 2000). The Campylobacter 
associated with diarrhoea appears to differ between developed and developing 
countries. In the developed world, both children and adults are at risk for 
Campylobacter infection, and transmission of the organism has been associated with 
consumption of un-pasteurized milk, undercooked meats, contaminated water, and 
travel to Campylobacter endemic areas (Andrews 1998). In contrast, Campylobacter is 
endemic in the developing world, and infection is usually limited to children, 
suggesting that a high level of exposure in early life leads to the development of 
protection (Calva et al 1988). In developing countries, Campylobacter enteritis has no 
seasonal preference; in contrast, in developed countries epidemics occur in the 
summer and autumn (Altekruse et aL 1999). The rate of Campylobacter infections 
worldwide has been increasing with the number of cases often exceeding those of 
salmonellosis and shigellosis (Altekruse et al. 1999). Campylobacter spp. are the 
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major cause of bacterial gastrointestinal disease in the United Kingdom: more than 
60,000 cases of infection were reported in 1999. In June 1999, the dioxin crisis, caused 
by dioxin-contaminated food components, resulted in the withdrawal of chicken and 
eggs from the market in Belgium. Through the sentinel surveillance system, a 
corresponding decrease in Campylobacter infections during June 1999 was noticed 
(Vellinga and Van Loock 2002). Barbecues and similar activities appear to present 
special hazards for infection, as they permit easy transfer from raw meat to hands and 
other foods, and thence to the mouth. Raw or inadequately heat-treated milk and 
inadequately treated water have been incriminated as sources of massive outbreaks of 
infection (Frost et al. 2002). Campylobacter can be shed asymptomatically (Ali et al. 
2003). 
Pathogenesis: Infection by Campylobacter leads to enterocolitis involving intestinal 
tissue damage. This host cell invasion and perhaps cytotoxin production with 
subsequent tissue destruction are likely to be key elements in pathogenesis. Enterocyte 
damage (responsible for a loss of net fluid absorption) and eventual destruction of 
epithelia integrity (with a resultant leakage of serosal fluid) leads to diarrhoea. 
Epithelial disruption, however, may not be the only mechanism that results in net fluid 
loss. One of the notable pathological changes associated with clinical disease is 
intestinal inflammation (Ketley 1997). The virulence determinants are generally not 
well characterized and some are rather controversial. In association with food or water, 
Campylobacter enter the host intestine surviving the stomach acid barrier and colonize 
the distal ileum and colon. Following colonization of the mucus and adhesion to 
intestinal cell surfaces, Campylobacters perturb the normal absorptive capacity of the 
intestine by damaging epithelial cell function either directly, by cell invasion or the 
production of toxins, or indirectly, following the initiation of an inflammatory 
response. As these possible mechanisms are not mutually exclusive, any combination 
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may have a role depending on the host status and attributes of the infecting strain 
(Ketley 1997). Effective colonization requires chernotaxis. Thus, Campylobacters 
have mechanisms to detect chemical gradients and linked motility functions that 
enable the cell to move up or down the gradient (Takata et aL 1992). Motility of 
Campylobacter spp. necessitates the production of the flagellum, the best 
characterized virulence determinant of Campylobacter. A combination of the 
flagellum and cell shape is believed to give campylobacter an unusually high level of 
motility in viscous environments. Observations suggest that, at high viscosity, cell 
shape and flagellar conformation (or both) may change and this perhaps results in 
Campylobacter remaining motile with longer path lengths. This behaviour has 
relevance to the penetration of the mucous that overlays the intestinal epithelium. The 
adhesion to host cells is not actually necessary as the bacterium is able to remain in the 
intestine by successfully colonizing the mucus. C. jejuni and C. coli are certainly able 
to adhere to tissue culture cells without subsequent invasion (Everest et aL 1992). 
Assume that adhesion to the epithelial cell surface is necessary for subsequent 
invasion of the cell, although adhesion and invasion may not be needed for intestinal 
colonization per se (Lee at al. 1986). In order to colonize the intestine, 
Campylobacters must be able to compete with the resident flora and to avoid non- 
specific host defences. Iron is an essential element for all living organisms and 
pathogenic bacteria obtain this throughout the infection process. Campylobacters have 
not been shown to produce siderophores, but they are able to use exogenous 
siderophores (Field et al. 1986). There is evidence supporting a role for host cell 
invasion in Campylobacter-mediated disease. Inflammation and bacteraernia strongly 
suggest that cellular invasion is an important pathogenic mechanism (Ketley 1997). 
Campylobacter may cross the intestinal epithelium by translocation or epithelial cell 
invasion followed by cell lysis. An additional epithelial translocation pathway would 
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be via M cells. Such a route has been proposed for several enteric pathogens including 
Shigella (Sansonetti et al. 1991). Intestinal infection with Campylobacter is often 
associated with an inflammatory response where polyrnorpho-nuclear leucocytes 
(PMNLs) and monocytes infiltrate the intestinal epithelium (Russell et al. 1989). 
Given this inflammatory response, the interaction between campylobacter and 
professional phagocytes is of potential importance (Ketley 1997). Although tissue 
invasion could be solely responsible for the clinical picture resulting from infection, 
toxins may also contribute to the disease process. The production of toxins is another 
unclear area. Campylobacter spp. reportedly produces a variety of toxins including a 
cholera-like toxin (CLT) and several cytotoxins (Ketley 1997). Enterotoxin production 
by C. jejuni was first described in 1983 (Ruzi-Palacios et al. 1983). The evidence for a 
role and even the production of the enterotoxin is not convincing. In support (reviewed 
by Wassenaar 1997), there is a cell product that, like cholera toxin, elongates CHO 
cells which is detected with a GMI-based ELISA and fluid cross reacts 
immunologically with E. coli labile toxin (LT) and Vibrio cholera toxin (CT), has 
been partially purified and specific antisera raised to it. CLT production was 
additionally reported to correlate with the watery diarrhoea observed in patients in 
developing countries (reviewed by Guerrant et aL 1992). A newly characterised heat- 
labile and trypsin-sensitive cytotoxin is known as cytolethal distending toxin (CDT). 
In the last decade, the gene encoding CDT, cdtB, has been found in the Campylobacter 
spp. (Pickett et al. 1996) and in several sero-types of E. coli (Elwell et al. 2001 and 
Toth 2003). With the exception of Salmonella enterica serovar typhi in which only 
cdtB gene is found (Haghjoo and Galan 2004), in all other microbes CDT consists of a 
tripartite polypeptide complex of CdtA (30 kDa), CdtB (29 kDa) and CdtC (21 kDa, 
encoded by the corresponding genes cdtA, cdtB and cdtC (Lara-Tejero & Galan 2002). 
Although considerable divergences in the predicted amino acid sequences of each 
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CDT subunit exist among different microbes, the cdtB genes have conserved structural 
similarities to the mammalian DNase I catalytic and Mg2 -binding sites (Lara-Tejero & 
Galan 2000). There is some evidence that CDT is a virulence determinant for naturally 
occurring and experimentally induced enteric diseases associated with C jejuni (Fox 
et al. 2004), E. coli (Pandey et al. 2003) and Shigella (Russell et al. 1989). A recent 
study showed that cdtB gene and CDT activity in C. jejuni strains isolated from 
healthy macaques and from macaques with clinical signs of diarrhoea. Although the 
cdtB gene also present in C. coli strains isolated from symptomatic and asymptornatic 
macaques, only lysates obtained from the C jejuni isolates caused cytoplasmic and 
nuclear enlargement to gather with cell cycle arrest of HeLa cells in the G2/M phase 
that is characteristic of CDT activity (Dassanayake et al. 2005). 
1.10.1.3 Salmonella spp. 
The genus Salmonella is part of the family of enterobacteriaceae. On the basis of host 
preference and disease manifestations in man, the salmonellae can be conveniently 
placed into two broad categories: First S. typhi, S. paratyphi A, S. paratyphi B, and S. 
paratyphi C. These serotypes are primarily host-adapted to man and cause a 
bacteraernic illness also known as enteric fever in which diarrhoea rarely plays a major 
role. Second; S. enteritidis, S. typhimurium and other serotypes, the order of 
prevalence is variable according to geography and time (Hohmann 2001). They have a 
narrow host range and occasionally infect humans. This usually involves invasive 
infection (Chiu et al. 1999). 
Salmonella are important pathogens in human and animals. They are classified 
according to toxins to two species in the genus salmonella: S. enterica (six subspecies) 
and S. bongori (one subspecies). Some serovars such as S. typhi and S. paratyphi are 
highly adapted to the human without other known natural hosts, while others such as S. 
typhimurium have a broad host range and infect a wide variety of animal hosts. A few 
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serovars such as S. choleroesuis have a narrow host range and occasionally infect 
humans (Chiu et al. 2005). 
Morphology: Salmonella spp. are Gram-negative bacilli, motile and non-capsulated. 
Epidemiology The organisms are widely distributed in the animal kingdom. Domestic 
animals, notably cattle, pigs and poultry are ftequent excretors and many wild animals 
are further infected. Household pets such as dogs, cats, birds and turtles are all 
potential, albeit rare, sources of human infection. Human cases and convalescent 
carriers are also critical sources. Inadequately cooked meat or precooked foods are 
contaminated by raw meat in the kitchen and these represent important vehicles of 
transmission. Salmonella may survive deep freezing and adequate thawing is essential 
prior to cooking (Hart and Shears 2003). Transmission of infections by Salmonellae is 
facilitated by low standards of personal and communal hygiene which facilitate faecal- 
oral transfer of micro-organisms; animals can be vectors, and food-borne transmission 
is considerable. Poultry or its products are involved as vehicles of transmission in 
nearly 50% of outbreaks (Duguid and Northe 1991). In recent years, fresh shell hen 
eggs infected through vertical transmission have emerged as an important source of S. 
enterditis infection in both Europe and USA (Cowden 1990). In developing countries, 
the epidemiological pattern is different as large-scale rearing of food animals is not 
common and methods of cooking differ. Salmonella is uncommon in adults. 
Pathogenesis These bacteria grow intracellularly, a condition that seems to be 
facilitated by inhibition of phagocytic respiratory burst and phagolysosome fusion. 
This capacity has been shown to be genetically regulated (Field et al. 1989). 
Enterotoxins similar to E. coli ST and LT have been described for some Salmonella. 
1.10.1.4 Shigella spp. 
Shigellosis, the acute enteric infection caused by bacteria of genus Shigella, has a 
world-wide distribution with an estimated annual incidence of 164.7 million cases, of 
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which 163.2 million occur in developing countries leading to 1.1 million deaths. Sixty- 
nine percent of all episodes and 61 percent of all Shigella-related deaths involve 
children younger than 5 years old (Kotloff et al. 1999). 
Shigella spp. are aerobic, gram negative bacilli, non-motile and non-capsulated. 
Epidemiology Shigellosis is common in many tropical countries and can cause large 
epidemics of diarrhoea. Shigella infection spreads by the faecal-oral route. Because of 
the low infectious dose of 10 to 100 organisms, person-to-person transmission is 
probably the most common (Qzuah 1998). However, transmission by contaminated 
food, drinking water, swimming pools, and flies has also been documented (Edwards 
1999). The highest incidence of Shigellosis is in young children; usually those I to 5 
years old (Kotloff et al. 1999 and Prado et al. 1999). 
In developed countries, Sh. sonnei is the most common species; reports from several 
locations demonstrate an increase in its relative prevalence in the last several years 
(Edwards 1999 and Kotloff et al. 1999). In developing countries, Sh. flexneri is most 
common, with outbreaks that are often caused by Sh. dysenteriae (Qzuah 1998). 
Pathogenesis A key element in the pathogenesis of shigellosis is the ability of the 
bacteria to invade colonic mucosa. The invasion process depends on a 210-to 220-Kb 
plasmid, which is necessary, but not sufficient, for full virulence (Edwards 1999, 
Sansonetti 2001 and Ashkenazi 2002). Sequencing the virulence plasmid of the Sh. 
flexneri 5a strain M90T has allowed investigators to identify the genes encoding 
approximately 25 proteins secreted by the TTSS (Buchrieser et al. 2000). A 31-kb 
segment of the virulence plasmid, called the entry region or ipalmxi-spa locus, 
comprises the pathogenicity island, which is actually sufficient for entry of Shigella 
into intestinal epithelial cells, for apoptotic death of macrophages and activation of 
polymorphonuclear leukocytes (Ingersoll et al. 2002). 
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Shigella spp. produce two enterotoxins, ShET-1 and ShET-2. The former is produced 
mainly by S. flexneri serotype 2a whereas the latter is produced by all Shigella spp. 
(Vargas et al. 1999). Shiga toxin, encoded chromosomally and found mostly in Sh. 
dysenteriae serotype I is a potent protein-synthesis inhibitor that primarily targets 
vascular endothelium (Sandving 2001 and Bitzan & Loo 2003). This toxin mediates 
the Heaemolytic Uraemic Syndrome (Bitzan & Loo 2003). These enterotoxins may 
contribute to the profuse volume and watery diarrhoea often observed in initial stages 
(Ashkenazi 2004). 
1.10.1.5 Vibrio cholerae 
The genus Vibrio is composed of many species of curved bacilli, where 12 species 
have been implicated in human infections. Vibrio cholerae, Vibrio parahaemolyticus 
and Vibrio vulnificus are the most prominent. Vibrios are comma-shaped, aerobic, 
Gram-negative bacteria which have a characteristic darting movement. 
Epidemiology: V cholerae needs to be considered among the possible causes in 
children living in endemic areas (currently south Asia and Africa). V cholerae 01 and 
V cholerae 0139 can cause epidemics and pandernics in areas of extreme poverty, 
and in areas with massive population migrations associated with natural disasters or 
long-lasting wars (Sack et aL 2004). Cholera is also endemic along the Gulf Coast of 
the USA. The disease is closely associated with poverty, overcrowding and low socio- 
economic status (Cook 2003). Humans are the only known natural hosts of V cholera. 
Transmission is by ingestion, of contaminated water or food. The infective dose is 
high, up to 1011 c. fu bacteria being required. The seventh pandernic, which was 
caused by V. cholerae 01 biotype El Tor, began in Asia in 1961 and spread to Africa, 
Europe, and Oceania in the 1970s and 80s. The largest epidemics of cholera since the 
mid 1990s have been in Africa. By June 1995, more than I million cases and 10000 
deaths resulting from the disease had been reported in the Americas. In East Africa, 
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excessive rain and flooding in 1997 were followed by extensive outbreaks of cholera 
in Somalia and northern Kenya. In August 2000 there was an extensive outbreak in 
South Africa, with over 75,000 cases reported in March 2001 (Hart and Shears 2003). 
Pathogenesis Vibrio cholerae is non invasive; Pathogenesis is due to an enterotoxin 
that causes excessive fluid and electrolytes loss. Cholera toxins (CT) consist of two 
subunits A and B. A subunit comprising two polypeptides, AI and A2, linked by a 
disulfide bond. The B subunit binds with high affinity and specificity to GM I, a 
ganglioside present in the epical membranes of all intestinal epithelial. The A subunit 
is then able to migrate through the epithelium cell membrane. This subunit leads to a 
transfer of ADP ribose from necotinamide-adenosine dinucleotide (NAD) to GTP 
resulting increase in cAMP production which, by inhibiting sodium chloride 
absorption and stimulating chloride excretion, leading to loss of water and electrolytes. 
Accessory cholera exotoxin was discribed in 1993, and increases transmembrane iron 
transport (Hart and Shears 2003). Additional toxins and other factors are now known 
to be involved in cholera pathogenesis. Zonula occludens toxin (Zot) increases the 
permeability of small intestinal mucosa by affecting the structure of intrercellular tight 
junctions (Colombo et al. 1994). 
1.10.1.6 Yersinia enterocolitica 
Y enterocolitica may cause illness ranging from a self-limited enterocolitis to a 
potentially life-threatening systemic infection (Cover and Aber 1989). Septicemia 
caused by Y. enterocolitica may occur in normal hosts as well as in those with 
underlying disorders (Bottone 1997). Y enterocolitica invades ileal enterocytes and M 
cells in Peyer, s patches, where it multiplies. This produces an inflammatory diarrhoea. 
Bacteria may pass to local lymph nodes, then produce systemic disease (Hart and 
Shears 2003). 
Epidemiology All Yersinia infections are zoonotic, with humans being the accidental 
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hosts. These are worldwide in distribution, but are more frequently found in temperate 
zones than in the tropics. Even in temperate countries infection is more prevalent in 
colder climates and is more common in the winter (Cover and Aber 1989). In most 
surveys of acute diarrhoeal disease where Y. enterocolitica was sought, it was either 
absent or present in less than 1% of cases (Gomes et al. 1991). The reservoir for Y. 
enterocolitica is a variety of animal species including: birds, frogs, fish, snails, oysters 
and most mammals. The organism is excreted in faeces from pigs and cattle. Y 
enterocolitica causes a range of gastrointestinal illnesses in humans and is primarily 
transmitted via the consumption of contaminated food or water (Bottone 1997). 
Pathogenesis pathogenic Yersinia spp. Including: Y enterocolitica, Y pseudo 
tuberculosis and Y pestis, carry a virulence plasmid (pYV) harboring genes for protein 
TTSS, a set of up to 6 effector proteins Yersinia outer proteins (Yops) and regulators 
for gene expression and Yop secretion. When contacted with target cells, Yersinia spp 
employ their TTSS to translocate six effector Yops (YopH, YopO/YpkA, YopP/YopJ, 
YopE, YopM and YopT) in to the cytoplasm. These interfere with a variety of cell 
functions including adhesion, phagocytosis, superoxide anion release, and cytokine 
secretion and impair the balance of survival versus apoptosis (Cornelis et al. 1998). It 
has recently become evident that polypeptides secreted by the type III machinery may 
represent an exception to this widely held paradiagm (Comelis 2003). 
1.10.1.7 Clostridium spp. 
The organisms are present in soil, water, and sewage and as part of the normal 
microbial flora in the gastrointestinal tracts of animals and humans. Two species 
Clostridium difficile and Clostridium perftingens are associated with diarrhoeal 
disease (Hart and Shears 2003). 
1.10.7.1 Clostridium difficile 
Clostridium difficile is a major cause of nosocomial colitis, generally occurring after 
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antibiotic-induced alterations of bowel flora (Bartlett 2002). C1. difficile has 
been 
recognized as a cause of antibiotic-associated pseudomembranous colitis. The 
organism and toxin can be detected in asymptomatic infants but their presence in older 
individuals is related to disease (Hart and Shears 2003). 
Epidemiology The organism is ubiquitous. C1. difficile is part of the normal intestinal 
flora in a small number of healthy people and hospital patients. Although the 
bacterium can be found worldwide it is probably an unusual cause of diarrhoeal 
disease in developing countries (Griffin 1989). C1. difficile is responsible for almost all 
cases of PBC and for 15 to 25% of cases of antibiotic-associated diarrhoea (Bartlett 
2002). 
Pathogenesis Two large toxin proteins: TcdA or toxin A and TcdB or toxin B are 
thought to be primary virulence of C1. difficile. These toxins are encoded by two 
separate genes, named tcdA and tcdB together with three additional genes they form a 
19.6-kb pathogenicity locus. 
1.10.7.2 Clostridiumperfringens 
Two forms of diarrhoeal disease are associated with Cl. perftingens. The first is a 
food-poisoning illness due to ingestion of C1. perfringens types A or the a-toxin 
(enterotoxin) it produces. Type A strains of Cl. perfringens cause food poisoning with 
abdominal cramps and diarrhoea, soft tissue infections and primary septicaernia. The 
second Cl. perfringens type C, in contrast, is common in certain areas of the tropics 
and produces a severe necrotic enteritis (Hart and Shears 2003). 
Epidemiology: C1. perfringens type C infection may occur sporadically but also in 
epidemics. It occurs at any age but is more likely to present as acute toxic or acute 
surgical problems in children under 10 years of age (Shann et al 1979). 
Pathogenesis The pathogenicity of C1. perftinges is potentially attributed primarily to 
toxins and enzymes produced by this organism. CL perftingens type C produces both 
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a and P-toxins which, it is presumed, are responsible for disease manifestations 
(Hart and Shears 2003). A-toxin, the most important toxin and the one produced by all 
types of the C1. perftingens, is a lecithinase that lyses erythrocytes, platelets, 
leucocytes and epithelial cells. P-toxin is responsible for the necrotic lesions in 
necrotizing enteritis. 
1.10.2 Enteric viruses 
A variety of viruses can be found in the gastrointestinal tract. These include non- 
pathogenic bacteriophages and human viruses that use the gastrointestinal tract as a 
portal of entry such as enteroviruses, hepatoviruses and some adenoviruses (non-group 
F). The latter group rarely if ever cause diarrhoeal disease. (Hart et al. 2003). 
Rotavirus causes from 25 to 70% of GE cases in children severe enough to require 
hospitalization (Parashar et al. 2003a). Astrovirus, human caliciviruses and enteric 
adenovirus together represent as many as 20 to 30% of cases of diarrhoea in areas 
where bacterial infections are found less commonly (0 Ryan, et al. 2005). 
1.10.2.1 Rotaviruses 
Rotaviruses are the leading cause of severe, dehydrating gastroenteritis among 
children, accounting for one-third of all hospitalization for diarrhoea and an estimated 
500,000 deaths worldwide each year (Glass et al. 2003). Rotavirus infection is found 
as frequently in developed as in developing countries. Rotaviruses are classified by 
group, subgroup, and serotypes. Seven groups (A-G) of human and animal rotaviruses 
have been identified. The majority of human infections are with this group A 
rotaviruses. Group B rotavirus infections appear to be uncommon but have been 
associated with large outbreaks of infection in China and India (Krishnan et al. 1999). 
Up to a third of adult humans have serological evidence of infection with group C. 
Rotavirus is a member of the family Reoviridae. 
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Epidemiology Human rotavirus is a major cause of gastroenteritis among infants and 
young children and is the most common cause of severe dehydrating diarrhoea in this 
age group. In hospital-based surveys it is found to be responsible for 25-65% of cases, 
while in community-based surveys rotavirus is detected in 5-40% of cases. The peak 
of infection in most parts of the world occurs from 4 months to 3 years. There is a 
difference in the peak ages of infection between developed and developing countries. 
The median age of children hospitalized with rotavirus gastroenteritis in Africa was 6 
months and 81% were under I year, whereas in developed countries the median age is 
over II months. The total prevalence of rotavirus illness in children in developing and 
inclustrialised nations was estimated to be approximately III million episodes of 
gastroenteritis that require home care only, 25 million clinic visits, and 2 million 
hospitalizations in children <5 years of age worldwide (Parashar et al. 2003a). 
Rotavirus is assumed to be transmitted person to person by the faecal-oral route. Air- 
borne transmission may also be possible. 
The infective dose is IOW (102_103 virus particles). The incubation period is usually 1-3 
days (Hart et al 2003). 
Pathogenesis Rotavirus infects the mature villous enterocytes of the upper small 
intestine. It is unable to infect the immature villous crypt cells or colonic enterocytes. 
Rotavirus enters the cell by endocytosis or by direct penetration if VP4 has been 
cleaved to VP5 and VP8. Rotavirus non-structural protein 4 (NSP4) is an enterotoxin 
that was identified as an important agent in symptomatic rotavirus infection. Three 
mechanisms have been described for the pathogenesis of rotavirus diarrhoea. In the 
first 12-24 hours post infection enterocytes are intact but levels of the brush border 
disaccharides (sucrose, maltose, lactose) are greatly decreased (Batt et al. 1995). This 
is apparently due to interference with transport of the enzymes to the brush border 
(Jourdan et aL 1998). The result of this is that disaccharides in the diet cannot be 
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hydrolysed to monosaccharides and thus cannot be absorbed, producing an osmotic 
diarrhoea. Secondly, NSP4, which is involved in rotavirus assembly, has a collateral 
effect in opening calcium channels in the enterocyte. This causes an efflux of sodium 
and water and thus a secretory diarrhoea (Ball et al. 1996). Finally, the raised intra- 
enterocyte calcium concentration causes them to die by necrosis (Perez et al. 1998). 
Recent studies indicated that a specific cleavage product of NSP4 (aal 12 to 175) is 
actively secreted from infected cells and that NSP4 is released from the apical side of 
infected epithelial cells via an atypical pathway that bypasses the Golgi apparatus cells 
and involves lipids microdomains called rafts (Zhang et al. 2000 and Sapin et al. 
2002). 
1.10.2.2 Adenovirus 40/41 
Human adenoviruses are subdivided into six subgenera (A-F), which contain a total of 
49 serotypes. Only types 40 and 41 (subgenes F) have been clearly associated with 
diarrhoeal disease. In most surveys they are second in importance to rotaviruses in 
causing GE, being responsible for 0.9-11% of cases in hospitalized children. Similarly 
in community-based studies adenoviruses have been shown to be important causes of 
childhood diarrhoea (Cruz et al. 1990). Most infections occur in children under 2 years 
(Barners et al. 1998). Diagnosis: Electron microscopy is unable to distinguish 
adenovirus 40/41 from other adenoviruses but immuno-electron microscopy can. 
There are now a number of antigen detection kits including ELISA and LPA, which 
are highly sensitive and specific. Genomic detection is additionally by DNA 
hybridization or PCR (Hart et aL 2003). 
Epidemiology Most infections occur in children under 2 years (Barners et al. 1998). 
Enteric adenoviruses belonging to serotypes 40 and 41 have been associated with 
persistent diarrhoea, generally in children under 4 years (Matson et al. 2000). They are 
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spread from person to person by the faeco-oral route and are food-borne. There 
is no 
apparent seasonality for infection (Hart et aL 2003). 
1.10.2.3 Small round viruses 
These viruses are a group of morphologically similar but antigenically unrelated or 
only partially related small round viruses. These latter are 25-35 nrn in diameter. 
Astrovirus was first described in 1975. It is small (28 nm) round and unenveloped with 
a star shape. There are at least eight human astrovirus serotypes (Hast V 1-8) but 
serotype I is commonly detected (Shi et al. 1994). However, other serotypes can be 
responsible for outbreaks of food-bome infection (Belliot et al. 1997). Caliciviruses 
are 35-39 nm in diameter. Human caliciviruses (HuCVs) are a group of nonenveloped, 
small, round viruses that belong to two genera in the family caliciviridia; the 
noroviruses and sapoviruses (previously called "Norwalk- like viruses" and "saporo- 
like viruses, " respectively). HuCVs, of which noroviruses are the prototype, cause 
more than 90 percent of outbreaks of acute gastrointestinal illness in the United States 
and account for approximately 23 million cases of diarrhoeal disease per year, 
according to the pathogen-associated method of calculation (Mead et al. 1999 and 
Fankhauser 2002). Attack rates have been as high as 41 percent, reflecting the 
propensity of infection with noroviruses to cause emesis and voluminous stool and 
vomits and the large number of organisms in stools and vomits, plus the low 
inoculums (fewer than 100 viral particles) required to produce infection (Musher and 
Benjamin 2004). Others viruses include: the coronavirus (Zhang et al. 1994), torovirus 
(Jamieson et al. 1998) picobirnaviruses (Ludert & Liprandi 1993) and pestiviruses 
(Yolken et al. 1989). They have been found to be associated with diarrhoeal disease. 
The etiologic role of noroviruses in moderate to severe childhood GE in developing 
countries is being studied, but primarily data from developed countries indicate that 
they may be the second most common viral agent after rotavirus, accounting for 4 to 
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19% of episodes of severe GE in young children (Pang et al. 1999). Noroviruses are 
the most common cause of GE outbreaks and affect all age groups, whereas 
sapoviruses invariably affect children (Fankhauser et al. 2002 and Rockx et al. 2002). 
1.10.3 Parasitic agents 
Human intestinal protozoan infections are discovered worldwide in both developing 
countries and the industrialized world. Pathogenic intestinal protozoa produce disease 
by infecting the small or large intestine, or both. Intestinal protozoa are found in 
highest prevalence in developing countries, where they are responsible for a 
substantial burden of disease. The small intestinal protozoa Giardia lamblia, 
Cryptosporidium parvum (Cr. Parvum) and Cyclospora have their major impact in 
children,, while the large bowel pathogen Entamoeba histolytica infects all age groups 
but has its most profound effects in adults. 
1.10.3.1 Entamoeba histolytica 
Clinical features: Diarrhoea is the major symptom and is watery initially but 
subsequently develops the features of steatorrhoea often associated with nausea, 
abdominal discomfort, bloating and weight loss. Although it is self-limiting in the 
majority of healthy immunocompetent people, possibly 30-50% proceed to suffer 
persistent diarrhoea, usually with features of steatorrhoea. 
EPidemiology Amoebiasis, the infection caused by the parasitic protozoan, Ent. 
histolytica, is responsible for 70,000 deaths per annum (Anon. 1998). Spreading 
occurs via the faecal-oral route and food and drink contaminated through exposure to 
human faeces. Crowding and poor sanitation contribute to its prevalence in Asia, 
Africa and Latin American. Approximately 10% of the world s population is infected, 
yet 90% of infected persons are asymptornatic. Epidemics occur when raw sewage 
contaminates the water supply. High risk groups include travellers, 
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immunocompromised individuals and possibly children in day-care centres. Severe 
infections occur in very young children, pregnant women, the malnourished, and 
individuals taking corticosteroids (Farthing et aL 2003). 
Pathogenesis the cyst of Ent. histolytica is resistant to gastric acid, and on ingestion it 
passes into the small intestine. The amoeba within the cyst becomes active in the 
neutral or alkaline environment of the small intestine. Trophozites use the galactose 
and N-acetyle-D-galactosamine (Gal/gaINAc)- specific lectin to adhere to colonic 
mucins and colonize the large intestine (Petri et al. 2002). Several virulence factors 
have been identified, such as adhesion molecules, contact-dependent cytolysin, 
proteases, haernolysins and phagocytic activity. Trophozoites must subsequently 
penetrate the mucous layer and adhere to the host cells. Ent. histolytica enhance 
mucous secretion, alter its composition and deplete goblet cells of mucin, thereby 
rendering the epithelial surface more vulnerable to invasion. Once the mucous barrier 
has been broken down, Ent. histolytica reaches the luminal surface of enterocytes and 
initially produces a contact-dependent focal and superficial epithelial erosion. Invasion 
of the colonic and caecal mucosa by Ent. histolytica begins in the interglandular 
epithelium (Farthing et al. 2003). 
1.10.3.2 Giardia lamblia 
Epidemiology: Giardiasis is found worldwide but has a high prevalence in the 
developing world, where prevalence rates can reach 20-30%. In the industrialized 
world, prevalence varies between 2% and 5%. Age-specific prevalence rises 
throughout infancy and childhood declining only in adolescence. Giadiasis is well 
recognized as occuring in travellers, although overall it accounts for no more than 5% 
of cases of traveller's diarrhoea. The major reservoirs of Giardia cysts are the human 
host and contaminated surface water. A recent survey in the USA suggested that there 
may be as many as 2.5 million cases of Giardiasis per year (Furness et al. 2000). 
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Giardiasis is a zoonosis and cross-infection by beaver, cattle, dogs and rodents that 
they as a constant reservoir. Ingestion of at least 10 to 100 cysts can cause infection in 
humans. Water-borne transmission probably represents a relatively small proportion 
of the total infections worldwide. The disease is spread by faecal-oral 
transmission. Sexual transmission is also known to occur. (Farthing et al. 2003). 
Pathogenesis when a new host consumes a cyst, the host, s acidic stomach simulates 
cysts for liberate of trophozoites which migrate to the duodenum and proximal 
jejunum, where they attach to the mucosal wall by means of a ventral adhesive disk. 
Giardia growth in the small intestine is stimulated by bile, carbohydrates and low 
oxygen tension. However, recent work in tissue culture cell lines has revealed that 
Giardia trophozoites induce localized condensation of F-actin and loss of perijuctional 
a-actin (Teoh et al. 2000). There is increasing evidence to suggest that T-cell 
activation within the intestinal mucosa can produce villous atrophy (Scott et al. 2000). 
A recent theory suggests that the symptoms are the result of a brush border enzyme 
deficiency rather than invasion of the intestinal wall. There is some evidence to 
suggest that Giardia trophozoites Produce cytopathic substances that might be 
responsible for this disruption of epithelial structure and function. Giardia is known to 
produce a variety of proteinases that could find cleavage sites in proteins of the 
microvillous membrane (Farthing et al. 2003). 
1.10.3.3 Cryptosporidium 
Characteristics; the infected form is the oocyst, which has probably already sporulated 
before shedding, excystation happens in the small intestine, with four sporozoites 
being released from each oocysts. The sporozoite attaches to the apical membrane of 
the host epithelial cell where that attachment induces reorganization of the host-cell 
actincytoskeleton and protrusion of the host-cell membrane around the sporozoite to 
form a vacuole in which the organism remains intracellular but extracytoplasmic 
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(Chen & La Russo 2000 and Tzipori & Widmer 2000). Restriction fragment length 
polymorphism (RFLP) analysis was the first technique to illustrate variation between 
isolates of Cryptosporidium parvum by PCR sequence analysis, especially of the 
rRNA gene loci. These techniques broadly confirm that the species Cr. parvum 
comprises at least two major genotypes, one of which infects humans exclusively and 
the other with a broader range of host specificity infecting animals besides humans 
(McLauchlin et al. 1999). 
Epidemiology Data from the Public Health Laboratory Service in North Wales, based 
on diagnostic laboratory returns, show an age distribution of infection, with peak 
between I and 5 years, and a marked reduction over the age of 35 years (Casemore 
1990). Cryptosporidial infection accounts for 2.2% of cases of diarrhoea in immuno- 
competent persons in developed countries and 6.1 % of cases of diarrhoea in immuno- 
competent persons in developing countries. Cryptosporidial infection is more common 
in immunocompromised persons, especially those with Acquired immunodeficiency 
syndrome (AIDS). In developed countries, it occurs in 14 % of patients with AIDS and 
diarrhoea; in developing countries, it occurs in 24% of such patients (Guerrant 1997). 
In the developed world cryptosporidiosis is found in outbreaks clustered around day- 
care nurseries. Substantial evidence has accumulated implicating Cr. parvum in 
outbreaks of water-borne diarrhoea and in stable endemic childhood diarrhoea among 
the poor of the developing world (Smith & Rose 1990). Infection is frequently spread 
by person-to -person transmission, by animal and indirectly through the environment 
(mainly water). Zoonotic transmission from cattle and sheep to human is known, and 
these animals are the most significant reservoirs of human disease. As few as 10 to 
100 oocysts can cause infection (Chen et al. 2002). 
Pathogenicity Cr. parvum attaches to the microvillous membrane and causes loss of 
microvilli and results in malabsorption. An enterotoxin-like activity has been detected 
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in faecal extracts, which may cause abnormal absorption and impaired epithelial 
permeability, but no enterotoxin has been purified (Farthing 2000). The organism 
activates secondary signal pathways in the host cell, thereby altering cell function 
(McCole et al. 2000). Cr. parvum activates the nuclear factor-kB (NF- . ctivation 
of NF-kB induces the production of cytokines and chemokines, such as interlukin-8, to 
trigger an inflammatory reaction and stimulates an anti-apoptonic survival signal in 
directly infected cells (McDoland et al. 2000). Cr. parvum induces secretion of 5- 
hydroxytryptamine and prostaglandin E2into the lumen. Enterotoxin activity, which 
produces chloride secretion in vitro, has been detected in faecal extracts from infected 
calves (Chen et al. 2002). Cr. parvum also induces apoptosis in epithelial cells, 
resulting in damage to epithelial barrier. 
1.10.3.4 Cyclospora 
Cyclospora is a coccidian parasites that is taxonomically related to Isospora species, 
Cryptosporidium parvum, and Toxaplasma gondi. A single species infecting humans, 
Cyclospora cayetanensis, has been identified. Each oocyst has two sporocysts. 
Excystment results in the liberation of two sporozoites which are crescent-shaped 
approximately 9 [im in length and 1.2 ýtm in width (Ortega et al. 1993). 
Epidemiology Cyclospora spp. were first identified in individuals with a history of 
foreign travel and those infected with AIDS. The global prevalence of the infection is 
unknown, although a prevalence of 4-7% has been reported in foreign residents in 
Nepal, with peak prevalence rates occurring during the warmer months with higher 
rainfall (Hoge et al. 1993). Cyclospora caused diarrhoea has now been described in 
the Americas, the Caribbean, Africa, Bangladesh, South-East Asia, Australia, England 
and Eastern Europe. Transmission appears to be by the faecal-oral route, with water 
being the foremost vehicle. However studies conducted in Guatemala and Peru 
suggested that having certain animals (e. g., dogs, chickens and ducks) increased the 
42 
risk for human infection by Cyclospora (Bem et al. 1999 and 2002). The first 
waterborne outbreaks in the USA were reported in 1995 (Huang et al. 1995). However, 
in 1996 a major outbreak of Cyclosporiasis was investigated in the USA which was 
found to be due to the ingestion of Guatemalan raspberries (Herwaldt et al. 1997). 
Pathogenesis The mechanism by which this organism produces diarrhoea has not 
been clearly established. Still, the organism occupies an intracellular location within 
enterocytes, and histological examination of small intestinal biopsies has demonstrated 
mild reduction in villous height, with associated mucosal inflammation and increased 
numbers of intraepithelial lymphocytes (Bendall et al. 1993). No specific virulence 
factors have yet been identified. Diarrhoea caused by Cyclospora infection has been 
associated with the development of GBS (Farthing et al. 2003). 
1.11 Detection and diagnosis of enteric pathogens 
There are over 40 different enteropathogens with the ability to cause gastroenteritis, 
although not all are sought even in the best-funded laboratories (Hart et al. 2003). 
Detection and diagnosis of aetiological causes of acute diarrhoea due to 
enteropathogens (bacterial, viral and parasitic) infections are the most common agents 
detected in the standard laboratory. Assessment of stool characteristics is a key feature 
in determining potential pathogens causing an acute diarrhoea episode. Liquid non- 
bloody stools are associated predominantly with a secretory/small intestinal 
dysfunction process, whereas dysenteric (blood and pus) or bloody stools are generally 
associated with an inflarnmatory/invasive process of the colon. Mucous can be present 
in both situations and should be differentiated from pus. History and clinical features 
assist in proper investigations that can lead to a swift and accurate diagnosis. Stool 
culture to isolate the pathogens is still the cornerstone of diagnosis (Edwards 1999). 
When a stool specimen is received by a laboratory, firstly inspection of colour, 
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consistency, odour and presence of mucous or blood occurs. The stool will be divided 
into parts, one for examination by light microscope to detect any ova, cyst and then to 
search for faecal leukocytes and spiral bacteria, whilst second part is for bacterial 
culture. The third part is for viral detection and the residual is placed into a refrigerator 
for further investigation. 
1.11.1 Bacterial isolation 
Specific diagnosis of aetiological bacterial cause depends on stool culture on different 
media and other identification and confirmation tests: serological typing, detection of 
toxin, biochemical tests (API) and Polymerase Chain Reaction (PCR). The latter is one 
of the molecular biology techniques now available; these have much greater sensitivity, 
provide results within a short time and may prove useful for organisms that are 
difficult or slow to culture. 
Stool culture on media: MacConkey agar, Salmonella-Shigella agar and 
Campylobacter Blood-Free Selective agar medium. Blood agar for isolation of 
Escherichia coli, Salmonella, Shigella and Campylobacter, respectively, are the most 
common types of media used. Tetrathionate broth, peptone-sorbitol bile broth, and 
alkaline peptone water were used as enrichment media for Salmonella, Yersinia and 
Vibrio bacteria, in that order. The plates are incubated at 35-37 'C for 18-24 hours, 
except for Campylobacter media, which is incubated at 42'C for 48-72 hours in 
anaerobic jar. After the incubation period, if there is growth, the morphology of 
colonies (size, colour, shape, haernolysis and odour) will be noted. If the types of 
colony vary, it will be necessary to perform a subculture to obtain pure colonies for 
bacterial type. 
The second step is direct microscopy following staining (Gram stain) for rapid 
classification and identification of bacterial organism according to the morphological 
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feature of each organism. 
Escherichia coli spp. are Gram negative bacilli, capsulated and motile: their size range 
from 1.1 to 1.5 [tm in width and 2.0 to 6.0 pm in length and the colonies are pink in 
colour due to fermentation of lactose on MacConkey agar medium. 
Identification is performed by using a conventional bacteriological technical method 
and confirmed by serology using appropriate antiserum (slide and tube agglutination 
tests). Two toxins of E. coli production are LT and ST toxin. A GM I receptor ELIZA 
is performed to test for LT production. Commercial competitive STEIA (Oxoid) is 
used for detection of ST production. Non-fermenting E. coli colonies on sorbitol 
MacConkey palates will be tested by anti-0: 157 serum to investigate (Shiga toxin- 
producing E coli). 
Other identification tests are phage typing and commercial biochemical-based 
identification system API 20E (bioMerieux, France) which are used for identification 
and confirmation tests. 
PCR technique for diarrhoeaginic of E. coli; after preparation of Deoxy ribonucleic 
acid (DNA) templates for PCR. A smear of E. coli is inoculated into a tube with 5 ml 
of phosphate-buffered saline then boiled for 20 min followed by centrifugation at 
2.500 xg for 10 min. The supernatant is placed in a PCR machine after preparation of 
programme (Multiplex PCR assay). The DNA templates are subject to multiplex PCR 
with specific primers for the detection of the virulence markers: eaeA (gene of EHEC 
and EPEC), vtl and vt2 (Shiga toxin I and 2 of EHEQ, eltB and/ or estA (gene of 
ETEC), ial (gene of EIEC) and pCVD (gene of EAEC). 
Campylobacter spp. are Gram negative rods, slim (1.5-6.0 [irn long and 0.2-0.5 ýtm 
wide), which are spirally curved, with tapering ends. They are microaerophilic and 
grow best in the presence of 5%02,10% C02,85% N2. The cell usually possesses a 
polar flagellum at one or both ends. Motility is of the darting type with a corkscrew 
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like movement. They are microaerophilic and grow best in the presence of 5%02, 
10% C02,85% N2. The organisms grow well on selective media Modified Charcoal 
Cefoperazone Desoxycholate Agar blood free medium (CCDA), (Oxiod) placed in an 
anaerobic jar and incubated at 42' C for 48 hours. Colonies that arise are colourless or 
grey with a metallic sheen. They are oxidase and catalase positive but urease negative, 
hippurate test is positive in C. jejuni and negative in C. coli. Commercial biochemical 
technique test API Campy (bioMerieux, France) is adopted for identification of 
Campylobacter. Further biochemical tests are used for sPeciation. C jejuni and C. coli 
are sensitive to Erythromycin and Nalidixic acid but C. lari is resistant. Commercial 
kits are available for the direct detection of C. jejuni and C. coli antigens in faeces, e. g., 
by latex agglutination (Hindiyeh et al. 2000). Serotyping of Campylobacter spp by 
Penner method is the most common method utilised to confirm Campylobacter spp 
(Penner et aL 1983). Other serotyping schemes for C jejuni and C. coli are based on 
direct agglutination of heat-stable antigens (Frost et al 1998). 
PCR-based identification methods can detect several Campylobacter spp., including 
some uncommon species that are difficult to culture (Kulkarni et al. 2002). 
A novel PCR for the detection and speciation of thermophilic Campylobacter spp. 
(Jackson et al 1996). DNA is isolated from pure cultures of these strains (the control is 
used; the reference strain of Campylobacter) by use of lysozyme/sodium dodecyle 
sulphate lysis/proteinase K digestion. Redissolved samples were diluted 100-fold in 
pure water, and 50 ýtl used as the target for amplification. DNA primers and PCR 
amplification Oligonucleotides B04263 and B04264 are synthesized by Appligene 
(Illkirch, France). The amplification reaction is performed in a volume 100 ýtl. The 
PCR machine programme used (programmable thermal reactor) was for denaturation 
and primer annealing. After completing the reaction, PCR products are visualized by 
gel efectrophoresis on 2% NuSieve 3: 1 agrose. The stain then used was 
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ethidium bromide. 
Salmonella spp is a genus, Gram-negative bacilli, motile and non-capsulated. 
Cultural characters: aerobes and facultative anaerobes. They grow on nutrient agar, 
MacConkey's medium, Salmonella-Shigella agar medium and (DCA) medium after 
enrichment in selenite F broth. They produce pale non-lactose fermenting colonies on 
XLD. They produce pink colonies with or without a black centre. Biochemical 
activities: S. typhi ferment glucose, maltose and mannite with production of acid only. 
It is indole negative and H2Spositive. S. paratyphi ferments glucose, maltose and 
mannite with production of acid and gas. It is H2S negative and indole negative. S. 
paratyphi B and C possess the same biochemical activities except that H2Sproduction 
is positive. Serological characters: they possess 0 (somatic) and H (Flagellar) antigens. 
Biochemical-based identification system API 20E (bioMerieux, France) is utilised as 
an identification and confirmation test. 
Other bacteria can cause acute diarrhoea and need to use specific medium. 
Shigella spp. Cultural characters: They produce pale non-lactose fermenting colonies 
on MacConkey's medium and Desoxycholate citrate agar (DCA) and pink colonies on 
XLD after enrichment in selenite F broth. Some strains ferment glucose alone with 
production of acid e. g. Sh. dysenteriae. Others ferment glucose and mannite with acid 
only e. g. Sh. flexneri, Sh. boydii and Sh. sonnei. The latter is a late lactose fennenter. 
They are indole variable. Four species (serogroups) are defined on the basis of 
serologic or biochemical reactions, namely, Sh. dysenteriae, serogroup A; Sh. flexneri 
serogroup B; Sh. boydii, serogroup C; and Sh. sonnei, serogroup D (Edwards 1999). 
Immune assay with monoclonal antibodies to the IpaC protein detected with both 
Shigella spp. and Enteroinvasive E. coli in 165 specimens, with high sensitivity and 
sPecificity (Szakal et al. 2003). Biochemical-based identification system API 20E 
(bioMerieux, France). Detection of Shigella is by a PCR assay targeting the ipaH gene. 
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Other bacteria can cause acute diarrhoea and need to use specific medium. 
Vibrio cholerae is Gram-negative, comma-shaped and motile. Aerobic and 
facultatively anaerobic Vibrios possess both flagellar and somatic antigens. They are 
oxidase positive and ferment sucrose and glucose but not lactose. V cholerae strains 
are divided according to O-antigens; V cholerae 01 is the cause of cholera. Other non- 
01 and 0139 V. cholerae strains may occasionally cause diarrhoea. V cholerae are 
characterized by an ability to grow in alkaline conditions (pH >8.0). Alkaline broth is 
used to grow the organism selectively from faecal samples. A special selective 
medium thiosulphate-citrate-bile salt-sucrose agar (TCBS) medium, V cholerae form 
characteristic yellow colonies on this medium. Specific slide agglutination reactions 
for 0 antigens distinguish V cholerae from non-cholera vibrios. Biochemical tests are 
further used for confirmation. 
Yersinia enterocolitica is a Gram-negative bacillus isolated by culture of stool or 
blood culture or by serology. 
Clostridia are anaerobic sporing Gram-positive rods. There are four species, but only 
two cause food poisoning; C1. perfringens is a Gram-positive rod with sub-terminal 
oval-shaped spores which form irregular colonies, it is nonnally surrounded by a zone 
of haemolysis on blood agar and ferments a variety of sugars with production of gas. 
C1. perftingens are recognised based on surface antigens and the major types of lethal 
toxins. C1. difficile is large Gram-positive bacillus with terminal spores. The organism 
can be isolated from faeces by anaerobic culture on elective media. Toxin production 
is confirmed by exposure of tissue culture cells to culture filtrates of the organism. 
Diagnosis can additionally be made by direct detection of toxin in faeces; incubation 
of tissue culture cells with faecal filtrates; typical cytopathic effect can be recognized 
within 48 hours or by use of commercial assays (ELISA, latex agglutination) based on 
specific antitoxin is available (Elliott et al. 1997). 
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1.11.2 Enteric viruses detection 
Four enteric viruses cause diarrhoea in humans: rotavirus, astrovirus, human 
caliciviruses divided into genera, norovirus and sapovirus and enteric adenoviruses (0 
Ryan et al. 2005). 
Rotavirus 
Many laboratories (especially in developing countries) are unable to detect rotavirus or 
other enteric viruses as a routine procedure or it may not form part of their protocol 
due to a scarcity of resources. 
Morphology on electron microscopy. It is approximately 75 nm in diameter and has a 
genome of II double-stranded ribonucleic acid segments. It has a characteristic double 
-shelled capsid which gives it a wheel- shaped appearance, lacks an envelope and is 
composed of an internal core and an inner and outer capsid. Diagnosis is made by 
direct detection in faeces by electro microscopy, ELISA or latex agglutination test and 
PCR 
Adenovirus 40/41 
Adenoviruses are un-enveloped DNA viruses with an icosahedral capsid 70-90 nm in 
diameter. Diagnosis is made by detection of virus by electron microscope in faeces. 
Electron microscopy cannot distinguish adenovirus 40/41 from other adenoviruses 
whereas immuno-electron microscopy can. There are now a number of antigen 
detection kits including ELISA and LPA, which are highly sensitive and specific. 
Genomic detection is also possible by DNA hybridization or PCR (Hart et aL 2003). 
1.11.3 Parasitic identification 
Many parasites are human infections, some pathogenic and others non-pathogenic. 
The identification of parasites from stool specimens requires good personal experience 
and facilities in laboratories enable to detect parasites and differentiate between 
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pathogenic and non-pathogenic. A large number of pathogenic parasites cause 
diarrhoea, but the most common (especially in children) which cause acute diarrhoea 
are Ent. histolytica, G. lamblia and Cryptosporidium. 
Entamoeba histolytica is distinguished from other intestinal amoeba by morphological 
characteristics of diagnostic importance. The classic stool ova and parasite 
examination whereby Ent histolytica is identified by its appearance in trichorome- or 
iron hematoxylin-stained stool specimens. This is insensitive and cannot differentiate 
Entamoeba histolytica from the non-pathogenic Entamoeba dispar (Ent. dispar) 
because, identical-appearing parasite (Haque et al. 2003a). The size of trophozoite 
(infective stage) is large and ranges from 20 to 40 [tm in diameter. Under examination 
by light microscope, trophozoite appears to have two zones within cytoplasma; an 
outer zone and an inner zone in diameter. The cysts are round or oval and 10-16 [tm in 
diameter, in immature cyst a single nuclei is present and mature infective cyst contain 
4 small nucleui. The diagnosis should ideally be based on the detection in stool of Ent. 
histolytica-specific antigens or DNA and by the presence of antibodies in serum 
(Haque et aL 2003a). Several biological differences have been described between Ent. 
histolytica and Ent. dispar, but none fully explains why Ent. dispar is unable to 
produce invasive disease. Ent. dispar produces less protease (Bruchhaus et aL 1996), it 
does not bind to target cells as strongly and is less cytotoxic, has a thinner glycocalyx, 
higher surface charge and has less phagocytic activity than Ent. histolytica (Espinosa- 
Canntellano et aL 1998). Diagnosis of amoebic colitis by antigens capture ELISA 
demonstrate higher isolation rate of Ent. histolytica (Abd-Alla and Ravdin 2002). 
Amplification of amoeba DNA fragments by PCR has been proven to constitute a 
sensitive and specific method to detect Ent. histolytica or Ent. dispar from human 
faeces (Verweij et al. 2000). Recently developed closed-tube, real-time PCR for 
detection and differentiation of Ent. histolytica and Ent. dispar directly from faecal 
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samples (Blessmann et al. 2002). This method reduces the time required and the risk 
of cross-contamination. 
Giardia lamblia The trophozoite when fixed for light microscope is 12-15 ýtm long 
and 5-9 ýtm wide. It has two nuclei and four symmetrically placed flagella. The cyst is 
ovoid, approximately 7-10 [tm. A single stool examination has a sensitivity of 50 to 
70%; the sensitivity increases to 85 to 90% with three serial specimens (Furness et al. 
2000). Sensitive and specific ELISAs for Giardia antigens have been developed and 
some of these assays are now marketed commercially. Sensitivity and specificity are 
reported to be 87- 100% (Fedorko et aL 2000). However, microscopy-negative cases of 
giardiasis do exist and the more sensitive methods of detection such as ELISA or 
DNA-based diagnostic techniques will eventually prove the cases (Butcher and 
Farthing 1988). A PCR-based assay that amplifies the intergenic spacer region of 
multicopy rRNA gene followed by nested PCR appears to be both rapid and reliable in 
detecting Giardia in stool (Ghosh et al. 2000). 
Cryptosporidium spp. oocyst, the shape is oval or spherical and the size 4-6 [tm. Three 
staining methods are in common using: auramine staining modified Ziehl-Neelsen 
staining and immunofluorescence use monoclonal antibodies to oocysts. ELISAs that 
incorporate anti-oocyst antibody to detect cryptosporidial antigen in stool have been 
developed (Ungar 1990). Indirect fluorescent; immunofluorescent antibody test has 
been developed that will detect serum antibodies to oocyst antigens (Farthing et al. 
2003). Several different assays using PCR have been published for detection of DNA 
in stool or biopsies (Webster 1993). Restriction fragment length polymorphism (RFLP) 
analysis was the first technique to demonstrate variation between isolates of (Cr. 
parvum) by PCR, sequence analysis especially of the rRNA gene loci. These 
techniques broadly confirm that the species Cr. parvum comprises at least two major 
genotypes, one of which infects humans exclusively and the other with a broader range 
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of host specificity infecting animals besides humans (McLauchlin et al. 1999). 
1.12 Management of acute diarrhoea 
1.12.1 Assessment of the Patient 
Effective prevention of mortality and management of morbidity associated with acute 
diarrhoeal disease among children is dependent on making a timely and accurate 
assessment of the status of dehydration. The mainstay of management of diarrhoeal 
disease is the assessment of dehydration and the appropriate replacement of fluid and 
electrolytes. The current WHO integrated management of childhood illness as a set of 
guidelines (Anon. 1996a). There are additional practice guidelines for treatment of 
acute gastroenteritis illness in children (Anon. 1996b). Although diarrhoeal disease 
can produce dehydration at any age, its impact is greatest in those aged under 5. This 
is as a result of their relatively greater surface area and thus greater fluid loss through 
skin. Infants require 2.5 times more water per kg. of body weight than older 
individuals. Fluid and electrolyte loss is also greatly exacerbated by vomiting. Both 
the initial degree of dehydration and response to rehydration therapy should be 
monitored clinically. The assessment of dehydration depends on the body weight loss 
(%), clinical state and signs. Mild dehydration is when the child has 5% of body 
weight loss, clinical state is not unwell and there are signs of dehydration; thirsty and 
dry mucous membranes. Moderate dehydration is when the child has 5-10% of body 
weight loss, clinical state is apathetic and there are signs of dehydration; sunken eyes, 
sunken fontanelle, tachypnoea, oliguria and loss of skin turgor. Severe dehydration is 
when a child has 10- 15% of body weight loss, clinical state is shocked and there are 
signs of dehydration; hypotension and peripheral circulatory failure. The critical state 
is when the child has >15% of body weight loss, clinical state is moribund and there 
are signs of dehydration; severe shock and the child may be comatose. 
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1.12.2 Oral rehydration therapy 
For children with mild to moderate dehydration, ORT should be initiated with ORS, 
administered at a rate of 75 ml/kg of body weight per hour over a period of 4 hours 
(Anon. 1995c). ORS contains a mixture of glucose, sodium, potassium, and chloride in 
a bicarbonate base. The optimal osmolarity of ORS, determined by the concentration 
of sodium and glucose, was re-evaluated recently (Hahn et al. 2001 and 2003) WHO 
and the United Nations Children, s Fund (UNICEF) recently revised their guidelines to 
suggest use of ORSs that are hyposmotic to solutions previously promoted after 
several clinical trials documented distinct advantages (Anon. 2002 and Hahn et al. 
2003). The new WHO, ORS contains 13.5 g/L glucose, 75 mmol/L sodium, 20 
mmol/L potassium, 65 mmol/L chloride, and 30 mmol/L base bicarbonate solution, for 
a total osmolarity of 245 mOsm/L (Anon. 2002). For children who are unable to 
tolerate ORS via the oral route, nasogastric feeding can be used (Podewils 2004). 
Amylase-resistant starch added to standard World Health Organization glucose-ORS 
significantly shortened the duration of diarrhoea compared with G-ORS (Raghupathy 
et al. 2006). 
1.12.3 Intravenous rehydration therapy 
Approximately 90% of children will respond to oral rehydration therapy. The 
remainder are generally infants with severe dehydration or those with profuse 
vomiting or a high purging rate. These will require rehydration by the intravenous 
route. Suitable solutions include: Ringer's lactate (Hartman's), consisting of NaCl 
6.2g, KCI 0.4g, sodium lactate 2.3g and 2 ml 50% glucose in I litre of solution; Dhaka 
solution (NaCl 5g, NaHC03 4g, KCL Ig and 50% glucose per litre); or acetate 
solution (NaCl 5g, KCI Ig, sodium acetate 6.5g and 2ml 50% glucose per litre of 
solution). Severe dehydration and shock are a medical emergency, and intravenous 
rehydration therapy should be administered immediately. Lactated ringer solution, 
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normal saline, or similar solution should be administered at a rate of 30 ml/kg of body 
weight until pulse, perfusion, and mental status return to normal; in some instances, 
large doses may need to be administered more rapidly, which might require using 
multiple intravenous lines. Electrolyte levels should be assessed, although therapy can 
be begun safely in the absence of these data (Podewils et al. 2004). As soon as the 
child's condition is stable and mental status is normal, therapy can be altered to the 
oral route, as described previously. 
1.12.4 Antimicrobial drugs 
Anti-microbial agents are not usually recommended for the treatment of acute 
diarrhoea (Anon. 1990). In general, infants with acute watery diarrhoea are best 
managed without recourse to antibiotics. However, if there is evidence of systemic 
spread, V cholera, dysentery, Campylobacter and Shigella, then antimicrobials will 
shorten the course of diarrhoea and ameliorate its effects. With the advent of 
Fluoroquinolones such as Ciprofloxacin and Ofloxacin, debate on the use of 
antimicrobials has been reopened: First, there is no doubt that the widespread 
indiscriminate use of antimicrobials, often in sub-therapeutic regimens, encourages 
resistance in both pathogens and normal enteric flora (Shears 1993). Second, for most 
individuals with acute gastroenteritis, diarrhoea will subside after a few days without 
the use of an antimicrobial agent. Third, indiscriminate use of antimicrobial agents 
will lead to increase in bacterial resistance with in the community, increase in 
antimicrobial-related side effects, in medical costs and to prolonged bacterial excretion 
in some individuals. In addition, for most cases of noncomplicated bacterial 
gastroenteritis, antimicrobials have not proven to be of significant benefit to the 
patient. Erythromycin and Azithromycin dehydrate are adopted for treatment of 
Campylobacter infections. Trimethoprin (TMP)-Sulphamethoxazole (SMX) may be 
used for treatment of V cholera infection in younger children, whereas Doxcycline or 
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Tetracycline are used more frequently for older children and adults. Appropriate 
treatment for shigella dysentery includes TMP-SMX and Ampicillin (Anon. 1995c). 
Oral Nitazoxanide is recommended for the treatment of diarrhoeal disease associated 
with G. lamblia or Cr. parvum and TMP-SMX is effective treatment for cyclosporiasis 
(Anon. 2003). From recent data it emerges that Fluroquinolones should be the first line 
of therapy and Cephalosporins should be used as a second line (Alam and Bhatnagar 
2006) 
1.12.5 Antidiarrhoeal drugs 
1.12.5.1 Anti-motility drugs e. g. Loperamide Hydrochloride, Diphenoxylate with 
Atropine, Tincture of opium and Codeine. These may reduce the frequency of stool 
passage in adults. However, they do not decrease the volume of stool in young 
children. Moreover, sedation may occur at usual therapeutic doses and central nervous 
system toxicity has been reported for some agents. None of those agents should be 
given to infants or children with diarrhoea (Anon. 1995c). Loperamide further does 
not decrease fluid and electrolytes secretion of stool of children with acute diarrhoea. 
Many reports demonstrated a relation between Loperamide and paralytic ileus in 
infants and young children. These drugs should cosequently be avoided (Anon. 1996a). 
Racecadotril could be preferable to Loperamide as it may induce less secondary iteus 
(Wang et al. 2005). There now seems to be a real possibility that anti-secretory 
therapy will become more widely available in the future (Farthing 2006). 
1.12.5.2 Adsorbent drugs such as Kaolin, Pectin, Smectite, activated Charcoal and 
Cholestyramine. These are used for treatment of diarrhoea on the basis of their ability 
to bind and inactivate bacterial toxins. None of these agents has proven practical value 
in the routine treatment of acute diarrhoea in children (Anon. 1995c). In a study in 
critically ill tube-fed patients receiving antibiotics, Pectin tended to prevent diarrhoea 
more efficiently than placebo (Sohultz et al. 2000). In contrast, a recent meta-analysis 
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on the randomized trials of enteral solutions enriched with fibres discovered no benefit 
in the subset of critically ill patients (Yang et al. 2005). Clearly, larger studies are 
warranted to make recommendations for the use of fibres (Wiesen et al. 2006). 
1.12.6 Nutritional supplements 
Breast milk can be given to infants even during acute rehydration; otherwise, food 
should not be given during the acute rehydration phase but should be initiated as soon 
as possible after fluid levels are restored. Energy intake should continue to be 
increased as tolerated following the diarrhoeal episode to allow for catch-up growth 
and continued development (Anon. 1995c). Micronutrient deficiencies have been 
associated with increased incidence, severity and duration of diarrhoea and other 
diseases. During and after weaning, infants need to receive calories, proteins, and 
micronutrients. Increasing the energy density of weaning food is crucial in settings 
where malnutrition is common. A few randomized trials have demonstrated that 
vitamin A supplementation reduced the incidence and duration of diarrhoeal disease 
(Huttly et al. 1997), especially among children with measles (Anon. 2002) or with 
vitamin A deficiencies (Chowdhury et al. 2002). A trial of zinc supplementation in 
India also demonstrated a clinically significant decrease in the severity and duration of 
diarrhoea (Sazawal et al. 1995). In contrast, a recent study in infants in Pakistan, India 
and Ethiopia showed no differences (Fischer et al. 2006) This randomized, placebo 
controlled trial was designed to assess the safety and efficacy of 10-mg Zinc 
supplementation for the treatment of acute diarrhoea in infants. There are no 
differences zinc and placebo groups. Young infants do not appear to benefit from zinc 
supplementation for the treatment of diarrhoea (Fischer et al. 2006). Recently, clinical 
trials study suggest potential beneficial effects of probiotic therapy for preventing and 
treating antibiotic-associated diarrhoea, acute diarrhoea including rotavirus-including 
diarrhoea, traveller's diarrhoea and diarrhoea-predominant irritable bowel syndrome. 
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Probiotics may serve as a functional food in the treatment of diarrhoea (Yan 2006). 
1.13 Control and prevention of diarrhoea 
In industrialized countries it has been the separation of human and animal excreta 
from potable water and foodstuffs that has contributed to the great decline in the 
incidence of diarrhoeal disease. The relative importance of the various programs and 
the specific cost- effective interventions that should be pursued in developing regions 
where resources are scarce remains uncertain. Development of strong collaborative 
research programs are necessary to help identify the optimal approach to reducing the 
health consequences of diarrhoea (DuPont 1991). Specific areas known to be critical 
are outlined below. The two most cost-effective measures in the control of diarrhoea 
and its consequences are probably promotion of breast feeding and widespread 
implementation of oral rehydration treatment programmes. Measures of potential 
value in controlling infantile diarrhoea include: safe supply of water, sewage removal 
systems, personal and food hygiene, avoiding use of human excreta for fertilizing 
crops, breast feeding, food and nutrient supplementation, health care, family planning, 
controlling the fly population and measles immunization. The household 
characteristics relating to diarrhoea occurrence include: number of household children, 
homes with a poor state of repair, water service, sanitation system, food being exposed 
to room temperature between meals, poor rodent control and presence of animals in 
the home (Wright et al. 1991). Education concerning food hygiene principles resulting 
in the discontinuance of the practice of leaving prepared foods at ambient temperatures 
between meals should lead to a reduced rate of enteric disease. Individual measures 
include careful personal hygiene, especially hand washing, and limited use of antacids, 
anti-motility drugs and antimicrobial agents. 
Despite the high-quality water and food supplies available in the United States and 
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other socioeconomically developed areas of the world, outbreaks of food-bome and 
waterborne disease continue to occur, generally due to improper handling and storage 
of food (Olsen et al. 2000). Promotion of hand washing has proven to be a highly 
effective measure in decreasing the incidence of diarrhoea among people living in 
high-risk areas, such as settlements in Pakistan (Luby 2004). 
1.14 Vaccines 
The number of vaccines available to prevent enteric infections is scarce but expected 
to increase in the future with the development of new technologies (Nataro and barry 
2004). Two typhoid vaccines are currently approved for clinical use. The Vi capsular 
polysaccharides vaccine is approved for children older than 2 years. A single 
parenteral dose provides a high level of protection (Dizer et al. 2002). 
The live attenuated vaccine, Ty2l a, is similarly efficacious for a period of at least 5 
years (Cryz et al. 1995). Live genetically attenuated vaccines for Shigella are currently 
in various stages of development. The vaccines are serotype-specific, meaning that 
multivalent vaccines will be required to protect against the most prevalent serotypes 
worldwide (e. g. Sh. dysenterie type 1, Sh. sonnei, and Sh. flexneri 2a, 3a and 6) (Hala 
and Venkatesan 1997). Two oral vaccines, one live-attenuated and one inactivated, 
have been licensed in industrialized countries. CVD 103 HgR was the first 
recombinant live-attenuated cholera vaccine that proved to be well-tolerated, 
immunogenic and protective and is the only such vaccine presently licensed for human 
use (Podewils et al. 2004). An oral cholera vaccine consisting of non-toxic, highly 
immunogenic cholera toxin B subunit protein in combination with heat-and formalin- 
killed V cholera 01 classical and EI Tor Vibrios has been developed in Sweden. This 
B subunit-whole cell (D-WC) vaccine has proved to be safe and protective against 
cholera. 
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The most advanced ETEC vaccine is a killed whole cell formulation plus recombinant 
cholera toxin B subunit. This vaccine proved safe and immunogenic in adult 
volunteers as well as in children aged between 2 and 12 (Ahren et al. 1998 and 
Savarino et al. 1998). Efforts to develop rotavirus vaccines were pursued when 
improvements in hygiene and sanitation did not appear to reduce disease incidence 
because rates were similar in less developed and industrialized countries (Podewils et 
al. 2004). In 1998, a rotavirus vaccine was licensed in the United States and was 
recommended for routine immunization of infants. This vaccine, a tetravalent rhesus- 
human reassortment rotavirus tetravalent vaccine RRV-TV was developed to target the 
four most common G serotypes of rotavirus, GI-G4. However, RRV-TV was 
withdrawn in 1999 when it was causally linked with intussusception at an estimated 
rate of I case per 11,000 vaccinated infants and the manufacturer ceased its production 
(Podewils et al. 2004). Other rotavirus vaccines are now being developed. Two live 
oral rotavirus vaccines (Rotarix) and (RotaTeq) have been licensed in Europe and the 
USA respectively and in several other countries (Heaton et al. 2005). These vaccines 
are based on slightly different principles to achieve broad immunity against the diverse 
strains of rotavirus in circulation. Rotarix was prepared from an individual human 
strain that replicates well in the intestine and is shed in the stool. RotaTeq is a 
combination of five bovine-human reassortant that replicate poorly in the gut. Each 
vaccine has proven to be highly effective in preventing severe rotavirus diarrhoea in 
children and found safe from the possible complication of intussusception (Glass et al. 
2006). 
1.15 Brief history of acute diarrhoea in Libya 
1.15.1 Introduction and background information 
Libya is located in North Africa between Egypt to the east, Tunisia and Algeria to the 
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west and Sudan and Chad to the south (Fig. 1). It covers approximately 1,750,000 sq 
km and the population was approximately 4 million in the 1984 census and estimated 
to be 5.5 million in 2000. Most of the people inhabit the towns of Tripoli, Zawia, 
Misrata, Sert, Benghazi and Sabha. Tripoli is the capital city of Libya and is located in 
the northwest of the country besides the Mediterranean sea. 
Health Programmes especially those related to childhood illness were developed at 
national level in Libya, e. g. Expanded Programme of Immunisation (EPI), Control of 
Diarrhoeal Diseases (CDD), Acute Respiratory Illness (ARI). Some were successful, 
but others not. EPI was the most successful programme where the uptake rate of the 
six main vaccines reached more than 95%. 
Control of Diarrhoeal Diseases. This programme was established during 1986. 
A national plan was implemented and many activities were performed and the oral 
rehydration therapy (ORT) uptake rate reached above 80%. Libya was among the most 
successful countries to cease using anti-diarrhoeal drugs for management of diarrhoea 
in children aged under 5 years. A breast feeding programme was developed but more 
activities need to be carried out and an evaluation effort is required. Unfortunately, 
there have been no significant activities related to CDD since the mid- 1990s. The 
programme was not evaluated although diarrhoea related admission to hospitals was 
reduced. Since the era of ORS recommended by WHO, the incidence of acute 
diarrhoea morbidity (668.4 per 1000 infant), and mortality (18.45 per 1000 infant) 
declined to a satisfactory level in only a few areas of the country e. g. Tripoli and 
Benghazi, Libya (Sehary 1999). 
1.15.2 Review of previous studies carried out on acute diarrhoeal disease in 
children aged under 5 years in Libya 
The few studies that have been carried out relating to acute diarrhoea in children aged 
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under 5 in Libya have been based upon reviewing hospital records. Analysis of a 2- 
year study of 1249 admissions with GE (1988-1989) revealed its tremendous impact 
on Tripoli Children's Hospital morbidity (31%) and mortality (45%) statistics (Ben 
Halim 1991). Infants comprised 92% of patients and 59% were aged 6 months or 
younger. More boys (55%) than girls were admitted. GE was equally common in both 
summer and autumn. Dehydration was isonatraernic in 94%, hyponatraernic in 4% and 
hypematraernic in 2%; and 97% of patients were wholly artificially fed. Pathogenic 
bacteria were isolated from 32% of patients, stools. Incidence of Salmonella was 
21.3%; of E. coli 6.7%; of Staph. aureus. 2.1 %; and Shigella 1.9%. The mortality rate 
was 2.9% and case fatality rate was 9% for boys and 10.3% for girls. 94% were infants 
and 75% of patients were aged 6 months and under. Conditions detrimental to survival 
were identified as protein energy malnutrition (22%); shock (20%); and aspiration 
pneurnonitis - bronchopneurnonia (7.5%) (Ben Halim 199 1). 
Another study was conducted between September, 1992 and August, 1993 to 
determine the aetiology of diarrhoea in Libyan children within the Tripoli area 
(Ghenghesh 1997). It included 161 children with diarrhoea (cases) and 161 age and 
sex matched controls. The age of children ranged from a few days up to 3 years. Most 
(86%) of the children were less than one year of age. Standard methods were adopted 
to detect enteropathogens (bacterial agents and rotavirus but parasitic agents were not 
sought in this study). Rotavirus and Campylobacter spp. studied 147 and 100 cases 
and 90 and 100 controls respectively. Rotavirus was detected in 35% of cases and 2% 
of controls, Salmonella spp. in I I% and 4%, Shigella spp. in 6% and I%, Aeromonas 
spp. in 15% and 17%, Campylobacter spp. in 6% and 3%, Yersinia enterocolitica in 
0.6% and 0.0%, enteropathogenic E. coli in 15% and 9%, enterotoxigenic E. coli in 
I I% and I I%, enteroinvasive E coli in 0% and enterohaernorrhagic E. coli (serogroup 
01 57: H7) in 7% and 4% respectively (Ghenghesh 1997). 
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1.16 The reasons for these studies 
1. The lack of studies focusing upon acute diarrhoea in children under 5 years of 
age. 
2. The studies that have been made are dated and limited. They are additionally 
too short, not exceeding one year. 
3. The lack of cooperation between pediatricians and microbiologists in this field, 
meaning that previous studies concentrated on either the clinical or 
microbiological aspect, but not both. 
1.17 The aims of the study include: 
1. Establishing a relationship between clinical symptoms and the aetiology of 
acute diarrhoea. 
2. Finding the factors contributing to the cause of acute diarrhoea besides the age 
group (s) that are prone to infection. 
3. Finding the relationship between the cause of acute diarrhoea and time of year 
it occurs (seasonal variation). 
4. Using new methods to diagnose the aetiology of acute diarrhoea not used in 
Libya e. g. selective media, API and PCR. 
Increasing the detection rate of the aetiologY of acute diarrhoea. 
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CHAPTER 2 
PATIENTS AND SAMPLING METHODS 
2.1 Selection of patients and case controls 
Two studies were performed to detect the aetiology of acute diarrhoea in hospitalized 
children in Tripoli, Libya. There are variations between the two studies according to 
the study protocol. 
The first study was conducted over a short period of time (3 months), with a small 
number of cases (118 patients) and routine laboratory techniques (light microscopic 
examination, Gram stain, oxidase test, blood and MacConkey agar media and selective 
medium for Campylobacter isolation were used). In the light of results from the first 
study, the second study was performed over a whole year. A large number of cases 
(405 patients) were enrolled and advanced laboratory techniques were completed (API 
20Eý API Campy and PCR) besides as routine laboratory techniques. Other data 
collected was along the same lines. 
In the first study, stool samples were collected from children (patients and controls) 
between the age of I to 60 months who were admitted to AIjala Children's Hospital in 
Tripoli, Libya, during the period between August and October 1997. The second study 
ran from January 1", 2003 to December 31", 2003. The age of children here was 
between I to 60 months who were admitted to the same hospital aforementioned. 
Faecal specimens were obtained from children who had acute diarrhoea and from a 
control group. The criterion for diagnosis of acute diarrhoea was that the children 
passed three or more loose or watery stools per day for a minimum of one day and for 
no longer than two weeks prior to admission. Controls were selected from children 
who were admitted to hospital for a reason other than acute diarrhoea, such as upper 
and lower respiratory infection, asthma, uriary tract infection and heart diseases, and 
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they were matched for age and gender. An additional criterion was that neither patients 
nor controls had received antibiotics in the preceding two weeks. A questionnaire 
(case sheet) used to collect information related to the protocol of this study from 
mothers of patients who were interviewed in detail upon first contact. This 
questionnaire was ompleted for each patient where details of clinical history, feeding 
practice, household environment and demographic information (age, sex, etc. ) were 
recorded. Other additioned information about the patient's health was also taken from 
their files. The questionnaire was prepared by clinician and microbiologist, with the 
remit that information sought might be relevant to the aims of the study. All 
information was analysed by statistical programmes. A copy of the questionnaire used 
is displayed in appendix I and laboratory results are shown in appendix 2. 
2.2 Definition of diarrhoea 
Diarrhoea can be defined as increased frequency and fluidity of stool, that is, the 
passage of stool containing excess water and electrolytes losses. For this study, acute 
diarrhoea was defined as the presence of three or more loose watery stools within a 24 
hours period (Anon. 1995c). 
2.3 Data collection 
The collecting information included: 
2.3.1 Clinical history, examination and investigation on admission 
Acute diarrhoea usually manifests as an increase in the frequency or volume of stool. 
Fever is a regular occurrence; vomiting and dehydration are also common clinical 
features which need careful observation. Assessment of dehydration requires a great 
deal of experience. Symptoms and signs used in assessment of dehydration (were 
assessment by Junior doctors at admission) and monitoring of rehydration include: 
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thirst, radial pulse, blood pressure, skin elasticity, anterior fontanella in infants, and 
appearance of the tongue, mucous membranes, eyes, eyeball tension, tears, respiration, 
urinary output and central nervous system manifestations. The classification of the 
type and degree of dehydration was according to WHO guidelines for clinical 
assessment of signs of dehydration to detect the degree of dehydration (mild, moderate 
and severe) and serum sodium of patient to detect the type of dehydration (isotonic; 
130 to 150, hypotonic <130 and hypertonic dehydration >150 mmol/1). The degree of 
dehydration at the time of admission was calculated by subtracting the naked weight at 
admission from the naked weight following rehydration using the same weight scale 
(Angela et al. 1989). 
Degree of true dehydration (%) = post rehydration weight - admission weight 
post rehydration weight 
X100 
In general when stool and vomiting are extremely profuse then dehydration is severe. 
Patients with mild dehydration appear almost clinically normal yet they may have lost 
considerable body fluid (4-5% body weight loss, in mild dehydration, moderate 
dehydration: 6-9% body weight loss, severe dehydration: 10% or more body weight 
loss). 
2.3.2 Body weight 
The weight of patient was monitored on admission and daily after admission (by 
Nurses) until resolution of diarrhoea and biochemical results returned to normal. 
Body weight is classified into four groups according to the standard charter percentile 
of Libyan children (Tajouri 1978, personal connection, see Appendix 3) as used in 
Libyan paediatric hospitals; <I 0%, 10 to <50%, 50% and >50% of age for weight. The 
weight for age of patients after rehydration and weight for age controls offer a good 
indication for the nutritional status of Libyan children. 
67 
2.3.3 Haematology and biochemistry 
The cut-off point where a child is considered to have anaernia when haernoglobin 
(HB) is concentrated in the blood is <- 9 gdl-1. 
Haernoglobin concentration, serum sodium, potassium and urea were analyzed in 
AIjala hospital's laboratory; Hb% as part of complete blood counts (CBC) analysis by 
machine (Sysmex-1000), serum sodium and potassium by machine (AVL 988-3 
Electrolyets analyzer) and blood urea by machine (Beehman-BLN analyzer). All 
investigation of haernatology and biochemistry was done by the laboratory of AIjala 
Children's Hospital in Tripoli, Libya. 
2.4 Specimen collection 
Faecal specimens were obtained from all patients and controls as soon as possible after 
the patient was admitted to the hospital. For each stool specimen, the consistency and 
presence of blood or mucous (or both) were noted. Two stool specimens were collected 
from each patient and case control. The first fresh stool sample was examined under 
light microscope within I hour for the presence of ova, cysts and parasites at the 
hospital's laboratory in the hospital. The second stool specimen was transported in an 
ice bag to the central laboratory in Tripoli within 2 hours of collection for detection of 
micro-organisms; stool culture for bacteria, identification of rotavirus by agglutination 
latex test and detection of Cryptosporidium cysts by staining. Residual stool specimens 
were refrigerated for a few days and then stored in a deep freezer. 
2.5 Storage of bacteria 
The colonies of any bacteria was isolated (after subculture to obtain pure culture), was 
picked up with a sterilised cotton swab and placed into small tubes containing storage 
medium and stored in deep a freezer (-20 'C) for other confirmation tests. 
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Figure 2. Protocol of stoolsamples for detect of diarrhoeal agents 
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medium and stored in deep a freezer (-20 OC) for other confirmation tests. 
The protocol of detection and identification of micro-organisms in both studies will be 
summarized in (Figure 2). 
2.6 Identification of micro-organisms 
2.6.1 Identification of parasites 
Two methods were used for detection of parasites: 
2.6.1.1 Wet preparation for ova, cysts, and parasites. A drop of normal saline and 
iodine was placed on the slide and a small amount of stool was mixed in using a 
wooded stick. This was then examined under a light microscope. 
2.6.1.2 An air dried smear for Cryptosporidium 
A small amount of stool was picked up on a cotton swab and this was then spread onto 
a slide which was dried in air at room temperature. A positive control slide was used 
with each batch. 
2.6.1.3 Method of staining of Cryptosporidium (Nicols and Thom 1984). 
Auramine phenol/potassium permanganate was used for staining for Cryptosporidium. 
The film was fixed in methanol for 3 minutes, the slide was stained with Auramine- 
phenol (1% solution) for 10-15 minutes, then was washed with tap water. 
Subsequently it was decolourised with 0.5 % acid alcohol for 2 minutes, then washed 
again with tap water, the slide was then finely counter-stained with 0.01 % (w/v 
aqueous) potassium permanganate for 1- 3 minutes. The slide was rinsed in tap water 
and air-dried. After drying, a drop of oil was placed on the slide and was examined 
under a fluorescent microscope to detect the cysts of Cryptosporidium. 
2.6.2 Isolation of bacteria 
All faecal specimens (patients and controls) were cultured for pathogens: Escherichia 
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coli and Campylobacter, because both bacteria were the most common bacterial cause 
of acute diarrhoea in Libyan children according to the last studies performed in Libya. 
The following media were used: Blood agar, MacConky agar and Campylobacter 
selective media. 
2.6.2.1 Blood agar base (oxoid blood agar base): 
Typical formula (in g1 -1): Protease peptone 15.0; Liver digest 2.5; Yeast extract 5.0; 
sodium chloride 5.0; Agar 12.0; Ph 7.4 ± 0.2 (CM271). 
Medium was prepared according to manufacturer's instruction (Oxoid Ltd, Wade 
Road, Basingstoke, Hampshire, RG 24 8PW, UK). 
Method: The powder was suspended 40 g in I litre of distilled water. The suspension 
was brought to the boil so all solids were dissolved evenly. The medium was sterilised 
by autoclaving at 1210C for 15 minutes for blood agar, the base was cooled to 50'C 
and then 7% (v/v) of defibrinated horse blood SR was added. This was mixed 
with gentle rotation and poured into Petri dishes. 
2.6.2.2 MacConkey agar: 
Formula: (in g 1-1): Peptone 20.0; Lactose 10.0; Bile salts No. 3 (Oxoid L56) 1.5; 
sodium chloride 5.0; Neutral red 0.03; Crystal violet 0.001; Agar No. 3 (Oxoid L13) 
15.0; Ph 7.1 ± 0.2 (CMI 15). 
Method: The powder was suspended 51.5 g in I litre of distilled water. The suspension 
was brought to the boil so all the solids were dissolved evenly. It was then sterilised by 
autoclaving at 121'C for 15 minutes, cooled to 50 'C and poured into Petri dishes. The 
surface was dried of the gel before inoculation. 
Faecal samples of patients and controls were inoculated directly on MacConkey and 
Blood media were incubated aerobically at 37 'C for 24 h. 
The result was read after 24 h for MacConkey and Blood agar media. The detection of 
bacteria growth was confin-ned by tests according to the protocol of the Central Tripoli 
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la (colonal morpholoov, lactose termentation, non-lactose lerment, Laboratory in LibN 
Gram stain, biochemical tests, oxidase test and sensitivity to antibiotics). 
2.6.2.3 Preparation of Modified Charcoal Cefoperazone Desoxycholate Agar 
blood free medium (CCDA) 
Campylobacter Blood-Free Selective Agar Base modified (CCDA-Preston). It was 
prepared according to the manufacturer's instruction (Oxoid CM 739). 22.75gm of 
Campylobacter blood free selective agar base was suspended in 500 ml of distilled 
water and brought to boiling point to dissolve the solids. It was then sterilised by 
autoclaving at 121'C for 15 minutes. The medium was cooled to 50'C. One vial of 
antibiotic supplement was added aseptically. This step inhibits the growth of bacteria 
except Campylobacter. CCDA selective supplement (SR 155) was reconstituted with 2 
ml of sterilized water. This was mixed well and poured into sterile Petri dishes. (Batch 
No: CM 239) 500 Gm. (Unipath Ltd, Basingstoke, Hampshire, UK). 
Faecal samples of patients and controls were inoculated directly on CCDA medium 
which was incubated in an anaerobic jar after adding 10 ml of water to the 
Campylobacter gas generating kits (BBL pack plus Becton and Dickinson, UK), 
which was placed in the jar and incubated at 42'C for 48 h. 
2.6.2.4 Maximum recovery deluent 
Maximum recovery deluent media was prepared according to the manufacturer's 
instruction (Oxoid CM 733). 9.5 gm of powder were added to I litre of distilled water 
mixed well and distributed to a final container 9 ml sterilised by autoclaving at 121T 
for 15 minutes. The medium was then cooled and placed in the fridge prior to use. 
Faecal suspension was prepared to inoculate on to CCDA medium by putting Ig of 
stool in 9 ml of maximum recovery diluent and mixing well on a vortex mixer. 
A sample was removed with a sterile loop and spread on the Petri dishes containing 
CCDA medium, which together with a positive control were incubated in an anaerobic 
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ar. 
The result was read after 48 h for CCDA medium. The detection of Campylobacter 
was confirmed by tests according to the protocol of the Public Health Laboratory (now 
Health Protection Agency), Royal Preston Hospital in the UK (colonal morphology of 
Campylobacter, Gram stain, oxidase test, biochemical tests and biotyping). 
If growth occurred and the morphological features of colonies were typical of 
Campylobacter an oxidase test was performed, otherwise plates were discarded. If the 
cultures were oxidase positive a Gram stain was performed to confirm the morphology 
of campylobacter. 
2.6.2.5 Oxidase test 
Method A few crystals of NNN'N'-tetramethyle-p-phenylene-diamine dihydrochloride 
(Sigma-Aldrich Co. Fancy Road, Poole, Dorset, BH 12 4QH, England) were dissolved 
in 5 ml sterile deionized water. A sterile cotton swab was soaked into prepared oxidase 
reagent and was used to select a single colony of the test organism. The appearance of 
a pink /violet colour within 10 seconds was taken as indicative of a positive reaction. 
Cultures were then streaked to form single colonies from CCDA medium onto Blood 
agar and CCDA media to obtain pure cultures and incubated microaerophilically at 
47'C for 48 h in an anaerobic jar. The colonies of campylobacter from Blood agar 
medium were picked up with a sterilised cotton swab and put into small tubes 
containing storage medium (Brain- heart- infusion broth medium). 
2.6.2.6 Brain heart infusion 
Brain heart infusion media was prepared according to the manufacturer's instruction 
(Oxoid CM 225). 37 gm of media were added to I litre of distilled water and mixed 
well and distributed into 2 ml screwed tubes and sterilized by autoclaving at 121T for 
15 minutes. Stored cultures were removed from the freezer, subcultured and prepared 
for API 20E (for bacterial isolation) and API Campy for Campylobacter was isolated. 
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Campylobacter was also stored onto the FTA-Card and transported to the UK for 
PCR. 
2.6.2.7 Identification of bacteria 
2.6.2.7.1 API 20E and API Campy 
Identification for enterobacteiaceae and other non-festidious Gram-negative rods: 
API 20E and API campy (Biomeireux, UK) were prepared according to the 
manufacturers instruction. These tests were performed in Libya while Campylobacter 
identification by PCR was performed in the UK. 
2.6.2.7.2 Polymerase Chain Reaction 
Methods for the microbiological isolation of Campylobacter using selective 
enrichment culture lack sensitivity and are unreliable for detecting low numbers of 
these organisms. 
Recovery may be particularly poor if large numbers of indigenous micro flora are 
present, or overgrowth with co-contarninating species occurs. In addition, relatively 
fastidious pathogens such as Campylobacter spp. may lose viability before samples 
can be processed in the laboratory (Jackson et aL 1996). Recent modifications to 
enrichment culture methods have increased selectivity and decreased the time to 
necessary detect positive samples (Raben and Slavik 1994). These improvements do 
not substantially improve the recovery of damaged organisms, and still require a 
prolonged period of incubation (Jackson et al. 1996). 
The polymerase chain reaction offers a highly sensitive and specific alternative to 
selective enrichment for detection and identification of bacterial pathogens (Lampel et 
al. 1990). 
2.6.2.7.2.1 Materials and methods of PCR 
The reference strain of Campylobacterjejuni NCTC 11168 was provided by Dr. D. 
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Wareing (Dynal Biotech Ltd, Microbiology R&D, Department of Biological Science, 
University of Central Lancashire, Preston PR I 2HE, UK). 
Campylobacter isolated from patients and controls were removed from storage (deep 
I 
freezer) and prepared for storage on FTA-Cards according to the manufacturers 
instruction (Whatman BioScience Ltd. Granta Park, Abington, Cambridge, CB I 6GR, 
United Kingdom) and transported to the UK. 
2.6.2.7.2.2 FTA-Card 
FTA products are composed of a sophisticated filtration matrix impregnated with a 
patented formulation of powerful protein denaturants, a chelating agent, and a free- 
radical trap designed to protect and capture nucleic acids, It is non-toxic to humans yet 
prevents the growth of bacteria and other microorganisms. It additionally rapidly 
inactivates organisms such as blood-borne pathogens, offering user safety. Such 
protective qualities permit nucleic acids collected on FTA matrices to be stored at 
room temperature without degradation for many years. 
A colony in 5 to 10 ýtl was resuspended of phosphate buffer solution (PBS) in a micro 
centrifuge tube. A single spot (5 ýtl) was applied onto the FTA matrix card 
immediately after spotting on the card and a pencil was used to outline each sample 
spot. This was useful before the FTA matrix had dried for locating samples on the 
matrix. The samples were allowed to dry one h or overnight at room temperature. The 
cards were then stored in an environmental ly-controlled dark location at room 
temperature. 
2.6.2.7.2.3 DNA primers and PCR amplification 
Oligonucleotides B04263 (5'-AGAACACGCGGACCTA-TATA-3') and B04264 (5'- 
CGATGCATCCAGGTAAT-GTAT-3') were synthesized by Appligene (IllKirch, 
France). These primers amplify a 250 base pair product, and are designed from the 
sequence of an open reading frame ad acent to and downstream of a novel C. jejuni j 
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two component regulator gene (Jackson 1995). 
The amplification reaction was performed in a volume of 100 ýtl containing: 50 ttl of 
test DNA sample; 50 mmol 1-1 Tris-HCL (ph 9.0); 16 mmol 1-1 
(NH4)2SO4; 50 mmol 
1-1 KCL; 7 mmol 1-1 MgCL2; 0.2 mg ml-1 BSA; 200 ýtmol 1-1 each dATP, dCTP, dTTP 
and dGTP; mol 1-1 of each primer, and 2.5 units of Tag DNA polymerase (Promega). 
After overlying samples with 50 ml mineral of oil, the PCR was carried out on a 
Hybaid HB-TRI programmable thermal reactor (Hybaid Ltd, Teddington, Middlesex, 
UK). The amplification parameters were an initial 4 minutes, denaturation at 95'C, 
followed by 40 cycles of primer annealing (60'C, 45 seconds), chain extension (72T, 
45 s) and denaturation (95T, 45 s). A terminal extension step (72T, 5 minutes) 
completed the reaction. PCR products were visualized by gel electrophoresis on 2% 
NuSieve 3: 1 agarose (FMC Bioproducts, Rockland, ME, USA), stained with ethidium 
bromide (50 [tg ml-1). 
2.6.3 Rotavirus screen 
The Rota screen, a rapid and simple latex agglutination test for detection of rotavirus 
in faecal specimen (Rota screen M 80 Microgen Biopredaclis Ltd England) was 
utilised. The test was performed according to the manufacturers literature. Faecal 
specimens were tested within 2 hours of collection or stored overnight at 2-8 'C. 
The standard method was as follows: a 10 % suspension of faeces was prepared by 
transferring 0.1 g of sample into I. Oml of extraction buffer in a screw capped tube and 
mixing the contents well. The tubes were then centrifuged at 1000 g for 10 minutes. 
Supernatant (5 ml) was pipetted onto each of two wells on the test slide. One drop of 
well-mixed test latex reagent was added to one well and one drop of well-mixed 
control latex reagent was added to the other well. The contents of each well were 
mixed by using a separate mixing stick for each sample covering the entire area of the 
well. The slide was gently rocked and left for 2 minutes before reading the results. A 
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positive result was indicated by agglutination of the test latex reagent with no 
agglutination of the control latex reagent. Results were negative where no 
agglutination of either the test latex reagent or the control latex reagent appeared 
within 2 minutes. 
2.7 Statistical analysis 
Analyses were generated using statistical software package SPSS version 11.0 (SPSS, 
Inc., Chicago, IL). The correlation between diarrhoea and potential risk factors as 
registered in the questionnaire was assessed. McNemar, s chi sequare test p-values 
were calculated using the two-tailed test and significance was measured at the P <0.05 
level. The strength of the correlation of risk factors was estimated by odds ratio (OR) 
and their corresponding 95% confidence intervals (Q. The most of clinical variables 
will be analysed by univariate and multivariate. Averages, ranges and percentages of 
positive samples were calculated. 
For seasonal distribution, Spring, Summer, Autumn and Winter (March to May, June 
to August, September to November and December to February) were used. 
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CHAPTER 3 
Demouaphy, Clinical Findino and Aetioloaical Aunts Detection 
Completed questionnaires were received from two studies and were analyzed by using 
the statistical package SPSS version 11.0 (SPSS, Inc., Chicago, IL). 
In the first study, two hundred and thirty-six stool samples from children were 
examined. Of these, 118 were from patients admitted for acute diarrhoea (called 
patients) and 118 were from children who were admitted to hospital for a reason other 
than acute diarrhoea (called controls). All were admitted to the AIjala Children s 
Hospital in Tripoli, Libya, between I" August and 3 I't October 1997. 
The second study ran from I't January to 31" December 2003. Eight hundred and ten 
stool samples from children were examined here. Of these, 405 were from patients 
admitted for acute diarrhoea and 405 were from controls as before. All were admitted 
to the same hospital. 
3.1 Demographical findings 
3.1.1 Age 
The age distribution of patients is shown in tables la and lb. 
The age distribution ranged from I to 60 months in both studies. Children were 
divided into six groups. In the first study, the largest number of patients was in the I to 
6 months age group. This represented 55 children (46.6%). The smallest group was 
among children aged from twenty-five to thirty-six months and included only three 
children (2.5%). The second largest number of patients was in the 7 to 12 months age 
group and represented 38 children (32.2%). The age group below one year was 
represented by 93 (78.8), while the age group from above one year to two years 
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Table 1. Age and gender characters of patients (a) First study 
Age of children Gender Total of children 
/months Male (%) Female (%) number (X2) (%) 
1-6 31 26.3 24 20.3 55 46.6 
7-12 22 18.6 16 13.6 38 33.2 
13-18 7 5.9 5 4.2 12 10.1 
19-24 3 2.6 3 2.5 6 5.2 
25-36 2 1.7 1 0.8 3 2.5 
37-60 2 1.7 2 1.7 4 2.6 
Total 67 56.8 51 43.2 118 100 
Table 1b. Second study 
Age of children Gender Total of children 
/months Male Female (%) (N2) (%) 
1-6 96 23.7 79 19.5 175 43.2 
7- 12 57 14.1 52 12.8 109 26.9 
13-18 21 5.2 18 4.4 39 9.6 
19-24 18 4.4 14 3.5 32 7.9 
25-36 15 3.7 9 2.2 24 5.9 
37-60 16 4.0 10 2.5 26 6.5 
Total 223 55.1 182 44.9 405 100 
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represented 18 patients (15.3%). 
In the second study, the largest number of patients was again in the I to 6 months, age 
group and represented 175 children (43.2%). The smallest age group was aged from 
25 to 36 months and included 24 children (5.9%). Again, the second largest number of 
patients was in the 7 to 12 months, age group and represented 109 (26.9%). 
The age group below one year represented 284 (70.1), while the age group from above 
one year to two years represented 71 patients (17.5%). Acute diarrhoea was most 
frequently encountered in children aged below one year and was observed in 93 cases 
(78.8%) in the first study and 284 (70.1 %) in the second. 
3.1.2 Gender 
The prevalence of acute diarrhoea was slightly greater in males than in females in both 
studies (Table la and lb). The number of males was 67 (56.8%) and the number of 
females 51 (43.2%) in the first study. In the second study, the number of males was 
223 (55.1 %) and that of females 182 (44.9%). The ratio of male: female was (1.3: 1) in 
the first study and (1.2: 1) in the second. There were no significant differences between 
males and females in either study (p > 0.05). 
3.1.3 Maternal educational level 
The maternal educational level of mothers of patients and mothers of controls is 
displayed in table 2a and 2b. The type of maternal education was classified into five 
groups. For convenience we use the first group (illiterate) as baseline. Every other 
group is compared to the baseline. The first group contained mothers of patients 
without formal education (illiterate); the second group, primary school education, the 
third group, secondary, the fourth group, teacher or college. The fifth group had the 
highest education level (graduated from university or high college). 
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Table 2. Maternal educational level (a) First study 
Level of Mother of patients Mother of controls 
education X2 of mothers (%) X2 of mothers (%) 
OR p-value 95% Cl 
Illiterate 24 20.3 
Primary school 36 30.5 
Secondary school 22 18.6 
Teacher or college 31 26.3 
Higher education 5 4.2 
Total 118 100 
21 17.8 1 1 to I (by default) 
34 28.8 0.915 0.820 0.425 to 1.968 
27 22.9 0.719 0.419 0.323 to 1.601 
28 23.7 0.909 0.804 0.430 to 1.922 
8 6.8 0.553 0.361 0.155 to 1.974 
118 100 
Table 2b. Second study 
Level of 
education 
Mothers of patients 
N2 of mothers (%) 
Mothers of controls 
N2 of mothers (%) 
OR P-value 95% CI 
Illiterate 63 15.6 57 14.1 1 1 to I (by default) 
Primary school 102 25.2 96 23.7 0.979 0.929 0.619 to 1.549 
Secondary school 75 18.5 79 19.5 0.872 0.559 0.552 to 1.378 
Teacher or college 124 30.6 119 29.4 0.954 0.835 0.613 to 1.484 
Higher education 41 10.1 54 13.3 0.690 0.177 0.403 to 1.183 
Total 405 100 405 100 
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In the first study, the first group contained twenty-four mothers of patients (20.3%) 
and 21 mothers of controls (17.8%). The second group had thirty-six mothers of 
patients (30.5%), compared to thirty-four mothers of controls (28.8%). The third group 
comprised twenty-tow mothers of patients (18.6%) and twenty-seven mothers of 
controls (22.9%). The fourth group had thirty one mothers of patients (25.3%) and 
twinty-eight mothers of controls (23.7%) and the fifth group consisted of five mothers 
of patients (4.2%) and eight mothers of controls (6.8%). The run of the McNemar, s 
test has shown that children from educated mothers at any level are at lesser risk than 
(odds ratio <1) illiterate ones but the evidence is not statistically significantly (p> 
0.05). See table 2a. 
In the second study, the first group contained sixty-three mothers of patients (15.6%) 
and fifty-seven mothers of controls (14.1%). The second group was one hundred and 
two mothers of patients (25.2%) and ninety-sixe mothers of controls (23.7%). The 
third group was seventy-five mothers of patients (18.5%) and seventy-nine mothers of 
controls (19.5%). The fourth group consisted of one hundred and twenty-four mothers 
of patients (30.6%) and one hundred and ninten mothers of controls (29.4%). Forty- 
one mothers of patients (10.1%) and fifty-four mothers of controls (13.3%) were 
represented within the fifth group. The run of the McNemar, s test has shown that the 
level of education of mothers of patients in both studies again did not statistically 
differ from the control mothers (p> 0.05). See table 2b. 
3.1.4 Family size 
Family size was divided to four groups: in the first group, the number of families with 
a single child, in the second, families with 2 to 4 children, the third, families with 5 to 
9 children; and the fourth group, families with 10 to 12 children (Table 3a and 3b). 
In the first study, the number of children ranged from I to 12 with a median of 4 
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children mean 4.6. For the first group, the number was 7 families of patients (5.9%) 
and 19 families of controls (16.1 %). For the second group, the number was 57 families 
of patients (48.3%) and 63 families of controls (53.4%). The third group 
contained 46 families of patients (39.0%) and 34 families of controls (28.8%). 
The number was 8 families of patients (6.7%) and 2 families of controls (1.7%) in the 
fourth. The largest group was where the number of children was from 2 to 4 (57; 
48.3%) families of patients and (63; 53.4%) of families of controls. The smallest group 
was families where the number of children was from 10 to 12 (8; 6.7%) families of 
patients and (2; 1.7%) families of controls. The McNemar's chi sequare test is showing 
that children from family with more than one child are significantly more at risk of 
illness than children from single child family (baseline), but the confidence interval is 
too wide becauuse of the small unmber of cases in the category (10- 11). See table 3a. 
In the second study, the numbers of children in the families examined in this study, the 
range was from I to II children with a median of 4 children mean 4.5. For the first 
group, the number was twenty-eight families of patients (6.9%) and 56 families of 
controls (13.8%). The second group was 200 families of patients (49.4%) and 208 
families of controls (51.4%). The third group was 156 families of patients (38.5%) and 
130 families of controls (32.1%). The fourth group was 21 families of patients (5.2%) 
and II families of controls (2.7%). The largest group contained families where the 
number of children was from 2 to 4 (200; 49.4%) families of patients and (208; 51.4%) 
of families of controls, and the smallest group contained families where the number of 
children was from 10 to 11 (2 1; 5.2%) families of patients and (11; 2.7%) of families 
of controls. The McNemar, s chi sequare test is showing that children from family with 
more than one child are significantly more at risk of illness than children from single 
child family (baseline). See table 3b. 
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Table 3. Family size of patients and controls (a) First study 
Number of Families of patients Families of controls OR p-value 95% Cl 
childm/family X2 of family (%) X2 of family (%) 
1 7 6.0 19 16.1 1 1 to I (by default) 
2-4 57 47.5 63 53.4 2.409 0.071 0.926 to 6.268 
5-9 46 39.8 34 28.8 3.966 0.008 1.426 to 11.029 
10-12 8 6.7 2 1.7 11.294 0.008 1.862 to 68.492 
Total 118 100 118 100 
Table 3b. Second study 
Number of Families of patients Families of controls OR p-value 95% CI 
children/family X2 of family (%) X2 of family (%) 
1 28 6.9 56 
2-4 200 49.4 208 
5-9 156 38.5 130 
10-11 21 5.2 11 
13.8 1 
51.4 2.205 0.004 
32.1 2.795 0.000 
2.7 3.999 0.002 
I to I (by default) 
1.279 to 3.800 
1.571 to 4.977 
1.672 to 9.568 
Total 405 100 405 100 
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3.1.5 Number of children who lived in Tripoli and other areas 
In the first study, the number of children who lived in Tripoli was 142/236 (60%) and 
those who lived outside the capital was 94/236 (40%). In the second study, the number 
of children who lived in Tripoli was 453/810 (56%) whilst 352/810 (44%) lived 
outside Tripoli. No specefic area with more cases could be identified but children lived 
from outside Tripoli or those referred from primary hospitals were usually suffering 
from sever diarrhoea. 
3.2 Clinical findings 
3.2.1 Stool nature of patients 
3.2.1.1 Number of motions per day 
The number of motions per day are shown in table 4a and 4b. 
In the first study, the number of stools per day for each patient was reported. Children 
were divided to three groups: the first group comprised patients with 4 to 6 motions 
per day and had 60 Patients (50.8%); the second group had from 7 to 9 motions per 
day and had 43 patients (36.5%); the third group >-10 motions per day contained 15 
patients (12.7%). The mean was 5.4 and the median was 6. The second study yielded 
similar results. Patients with from 4 to 6 motions per day numbered 198 (48.9%), the 
second group with 7 to 9 motions per day had 147 (36.3%), and the third group from > 
10 motions per day had 60 (14.8%). The mean was again 5.4 and the median 6. 
3.2.1.2 Consistency of stool 
The stool consistency was noted for every patient and the results are illustrated in table 
4. Both studies gave similar results. In the first study, the number of patients who 
passed loose mucous stool was thirty-nine (33.1 %), the number of Patients who passed 
watery stool was sixty-nine (58.5%) and the number who passed mixed stool with 
blood was ten (8.4%). Watery stool was the most common stool consistency of stool 
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patients and proved to be statistically different from loose, mucous or bloody stool 
(x 2 
= 15.42, p<0.05). 
In the second study, the number of patients who passed loose mucous stool was 133 
(32.8%), the number of patients who passed watery stools were 229 (56.6%) and the 
number of patients who passed stool mixed with blood 43 (10.6%). Watery stool was 
once more the most common stool consistency of stool patients and statistically 
different from loose, mucous or bloody stool (X 2= 20.57, p<0.05). Both studies 
provided similar results for the stool nature of patients. 
3.2.1.3 Duration of diarrhoea 
Duration of diarrhoea was reported before admission of patients until it ceased and the 
results are shown in table 4. The results were again similar in both studies. 
In the first study, diarrhoea started prior to admission and ceased after one day in 32 
(27.1 %) patients, from two to three days in 56 (47.5%) patients, from four to six days 
in 23 (19.5%) patients and from >- 7 days in 7 patients (5.9%). The mean was 3.6 and 
the median was 3 days. 
In the second study, diarrhoea started one day before admission in 101 (24.9%) 
patients, from two to three days in 197 (48.6%) patients, from four to six days in 86 
(21.3%) patients and from >7 days in 21 patients (5.2%). The mean was also 3.9 and 
the median 3 days. Both studies gave similar results for the duration of diarrhoea. 
Duration of diarrhoea of 2-3 days was found to be the most common in the first and 
second stidies with 56 (47.5%) and 197 (48.6%) respectively. 
3.2.2 Abdominal cramps 
The number of patients who had abdominal cramps was reported before or during 
admission. In the first study, the number of patients who had these was 38 (32.2%) and 
the number of patients who did notwas 80 (67.8%). For the second study, the number 
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Table 4. Stool nature of patients (a) First study 
Number of motion Stool appearance Duration 
Motion/day (X2)patients Consistency (X2)patients Durati on/day (X2)patients, 
4-6 60 50.8 loose + 39 33.1 1 32 27.1 
mucous 
7-9 43 36.5 watery 69 58.5 2-3 56 47.5 
>10 15 12.7 mixed 10 8.4 4-6 23 19.5 
with blood 
>7 7 5.9 
Total 118 100 118 100 118 100 
Table 4b. Second study 
Number of motion Stool appearance Duration 
Motion/day (X2)patients Consistency (X2)patients Duration/day (X2)pati ents 
4-6 198 48.9 loose + 133 32.8 1 101 24.9 
mucous 
7-9 147 36.3 watery 229 56.6 2-3 197 48.6 
>10 60 14.8 mixed 43 10.6 4-6 86 21.3 
with blood 
>7 2 5.2 
Total 118 100 118 100 118 100 
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of patients who had abdominal cramps was 96 (23.7%) and the number who did not 
have them was 309 (76.3%). 
3.2.3 Fever 
The number of patients who had fever reported before and during admission is 
displayed in table 8. The cut-off point for definition of fever was > 38.0 'C. If the 
patients had temperatures < 38 T the patient was not recorded as having fever. 
3.2.3.1 Fever grade 
Fever grade was classified in five groups: from 38.0 to 38.4,38.5 to 38.9,39.0 to 39.4, 
39.5 to 39.9 and >- 40 'C (Table 5a and 5b). 
In the first study, the number of patients who had fever was 86 (72.9%), while the 
number of patients not reporting fever was 32 (27.1 %). The number of patients in the 
first group was 37 (31.4%), the second was 11 (9.3%), the third was 25 (21.2%), the 
fourth was 8 (6.8%) and the fifth group was 5 (4.2%). Fever was a clinical feature 
associated with acute diarrhoea. 
In the second study, the number of patients who had fever was 290 (71.6%), while the 
number of patients not reporting fever was 115 (28.4%). The number of patients in the 
first group was 95 (23.4), in the second 49 (12.1%), the third 78 19.3%), the fourth 
54 (13.3%) and the fifth 14 (3.5%). Fever was again a clinical feature associated with 
acute diarrhoea. 
There were some dissimilarities between the two studies. The group of patients who 
had low grade fever (38.0 to 38.4) was higher in the first study (37; 31.4%) than in the 
second (95; 23.4%) while high grade fever (39.5 to > 40) was higher in the second 
study (68; 16.8%) when compared to the first (13; 11 
3.2.3.2 Duration of fever 
The duration of patients, fever before and during admission was varied (Table 5a and 
89 
Table 5. Fever* of patients (a) First study 
Fever grade 'C N2 of patients (%) duration/days X2 of patients 
38.0-38.4 37 31.4 
38.5-38.9 11 9.3 
39.0-39.4 25 21.2 
39.5-39.9 8 6.8 
> 40 5 4.2 
Total 
1 20 16.9 
2-3 41 34.8 
4-6 18 15.3 
>77 5.9 
86 72.9 86 72.9 
* Only patients with temperatures >- 38 T were recorded 
Table 5b. Second study 
Fever grade 'C N2of patients 
38.0-38.4 95 23.4 
38.5-38.9 49 12.1 
39.0-39.4 78 19.3 
39.5-39.9 54 13.3 
> 40 14 3.5 
duration/days N2 of patients 
1 49 12.1 
2-3 167 41.2 
4-6 52 12.9 
>7 22 5.4 
Total 290 71.6 290 71.6 
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5b). The minimum was one d and the maximum seven d. In the first study, the number 
of patients who had fever for one d was 20 (16.9%), from two to three d was 41 
(34.8%), from four to six d was 18 (15.3%) and seven d or more was 7 (5.9%). The 
mean was 3.06 and the median was 2 d. 
In the second study, the number of patients who had fever for one d was 49 (12.1 
from two to three d was 167 (41.2%), from four to six d was 52 (12.9%) and seven or 
more d was 22 (5.2%). The mean was 3.42 and the median 2 d. 
There was some disparity between the two studies. The group of patients who had 
fever for one day was higher in the first study (20; 16.9%) while duration of fever 
from 2-3 days was higher in the second study (167; 41.2% table 5b). 
3.2.4 Vomiting of patients 
The vomiting results of patients are displayed in table 6. The number of vomits per d 
(frequency) and for how long (duration/days) per patient were recorded. 
In the first study, the number of patients who had vomiting before and during 
admission was 61 (51.7%), while the number of patients who had no vomiting at 
admission was 57 (48.3%). Vomiting as a clinical feature was not associated with 
acute diarrhoea in the first study (p > 0.05). In the second study, the number of 
patients who had vomiting before and during admission was 236 (58.3%), while the 
number of patients who had no vomiting was 169 (41.7%). Vomiting as a clinical 
feature was associated with acute diarrhoea (p < 0.05). 
4.2.4.1 Frequency of vomiting 
The frequency of vomiting per day was classified into three groups: the first group 
From I to 3 times per day; the second 4 to 6 times per d; the third 7 times or more per 
day. 
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Table 6. Vomiting patients (a) First study 
Frequency/day N2 of patients (%) Duration/days X2 of patients (%) 
1-3 15 12.7 1 16 13.6 
4-6 42 35.6 2-3 32 27.1 
>7 4 3.4 4-6 9 7.6 
>7 4 3.4 
Total 61 51.7 1 61 51.7 
Table 6b Second study 
Frequency/day N2 of patients (%) Duration/days N2 of patients (%) 
1-3 55 13.6 1 47 11.6 
4-6 164 40.5 2-3 151 37.3 
>7 17 4.2 4-6 23 5.7 
>7 15 3.7 
Total 236 58.3 1 236 58.3 
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In the first study, the number of patients in the first group was 15 (12.7%), the second 
group was 42 (35.6%) and the third group was 4 (3.4%). The mean was 4.6 and the 
median was 5. 
In the second study, the number of patients in the first group was fifty-five (13.6%), 
the second group was one hundred and sixty-four (40.5%) and the third was seventeen 
(4.2%). The mean was 4.9 and the median 5. The minimum frequency was one and the 
maximum ten. The frequency of vomiting was higher in the second study (44.7%) than 
in the first (39%). 
3.2.4.2 Duration of vomiting The frequency of vomiting per day was classified into 
four groups: the first I time per day; the second 2 to 3 times per d; the third 4 to 6 
times per d; the fourth 7 times or more per 
In the first study, the number of patients in the first group was 16 (13.6%), the second 
group 32 (27.1 %), the third 9 (7.6%) and the fourth 4 (3.4%). The mean was 3.25 and 
the median 3. 
In the second study, the number of patients in the first group was forty-seven (11.6%), 
the second group was one hundred and fifty-one (37.3%), the third twenty-three 
patients (5.7%) and the fourth group fifteen patients (3.7%). The mean was 3.45 and 
the median 3. The minimum duration was one day and the maximum was eight days. 
The duration of vomiting was longer in the second study (46.7%) than in the first 
(3 8.1 %; table 6). 
3.2.5 Dehydration 
Dehydration is a clinical feature of acute diarrohea. The estimation of the type and 
degree of dehydration at admission is crucial in order to commence the proper 
treatment by correction of dehydration. Fig. 3. 
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3.2.5.1 Type of dehydration 
The type of dehydration was classified into three types (according to the serum sodium 
concentration). Fig. 3. 
3.2.5.1.1 Isotonic dehydration 
In the first study, the number of patients who had isotonic dehydration was 90 (76.3%). 
In the second, the number of patients who had isotonic dehydration was 307 (75.8%). 
3.2.5.1.2 Hypotonic dehydration 
In the first study, the number of patients who had hypotonic dehydration was 16 
(13.5%). In the second study, the number of patients who had hypotonic dehydration 
was 42 (10.4%). 
3.2.5.1.3 Hypertonic dehydration 
In the first study, the number of patients who had hypertonic dehydration was 12 
(10.2%). In the second study, the number of patients who had hypertonic dehydration 
was 56 (13.8%). The type of dehydration did not differ between the two studies. 
3.2.5.2 Degree of dehydration 
The degree of dehydration was classified into three types; (according to the percentage 
of body weight loss): mild dehydration is when the patient has 4-5% of body weight 
loss, moderate dehydration when the patient has 6-9% of body weight loss, and severe 
dehydration when the patient has 10% or more of body weight loss. 
3.2.5.2.1 Mild dehydration 
In the first study, the number of patients who had mild dehydration at admission was 
38 (32.2%). In the second, the number of patients who had mild dehydration at 
admission was 134 (33.1 
3.2.5.2.2 Moderate dehydration 
In the first study, the number of patients who had moderate dehydration at admission 
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Figure 3. Type and degree of dehydration of patients (a) First study 
Figure 3b. Second study 
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was 61 (51.7%). In the second study, the number of patients who had moderate 
dehydration at admission was 225 (55.5%). 
3.2.5.2.3 Severe dehydration 
In the first study, the number of patients who had severe dehydration at admission 
was 19 (16.1%), whilst in the second the number of children who had severe 
dehydration at admission was 46 (11.4%). 
Moderate dehydration was more frequent in the second study, while severe 
dehydration was more frequent in the first. 
3.2.6 Haemoglobin concentration in blood of patients and controls 
The haernoglobin concentration in blood of patients and controls was classified into 
four groups: first group, haernoglobin (Hb) -< 
9 gdl-l (anaemia), second group Hb from 
9.1 to 10.9, third group Hb from II to 11.9, and the fourth group Flb > 12. See table 
7a and 7b. In the first study, the number of patients of the first group was 4 (3.4%) and 
was I only (0.8%) of control, the number of patients of the second group was 58 
(49.2%) and was 49 (41.5%) of controls, the number of patients of the third group was 
24 (20.3%) and was 35 (29.7%) of controls and the number of patients of the fourth 
group was 32 (27.1%) and was 33 (28.0%) of controls. By using a haernoglobin 
concentration level <9 as a baseline, the test is showing that higher haernoglobin 
concentration is associated with lower risk but this association is not statistically 
significant. 
In the second study, the number of patients in the first group was 24 (5.9%) and was 
17 (4.2%) of the controls, the number of patients in the second group was 162 (40.0%) 
and was 154 (38.0%) of controls, the number of patients in the third group was 118 
(29.1%) and was 129 (31.9%) of controls, and the number of patients in the fourth 
group was 101 (24.9%) and was 105 (25.9%) of controls. By using a haernoglobin 
96 
Table 7. Haemoglobin concentration of patients and controls (a) First study 
Haernoglobin gdl-' N2 of patients (%) JV2 of control (%) OR p-value 95% Cl 
<9 4 3.4 1 0.8 1 1 to I (by default) 
9.1-10.9 58 49.2 49 41.5 0.253 0.217 0.029 to 2.241 
11.0-11.9 24 20.3 35 29.7 0.146 0.087 0.0 16 to 1320 
> 12 32 27.1 33 28.0 0.205 0.156 0.023 to 1.826 
Total 118 100 118 100 
Table 7b. Second study 
Haemoglobin gdl-1 X2of patients (%) X2of controls (%) OR p-value 95% Cl 
<9 24 6.0 17 4.2 1 1 to I (by default) 
9.1-10.9 162 40.0 154 38.0 0.485 0.390 0.387 to 1.449 
11.0-11.9 118 29.1 129 31.9 0.652 0.205 0.336 to 1.264 
> 12 101 24.9 105 25.9 0.674 0.266 0.337 to 1.349 
Total 405 100 405 100 
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concentration level <9 as a baselne, the test is showing that higher haernoglobin 
concentration is associated with lower risk but this association is not statistically 
significant. The variances were not significant between the two studies, in the first 
study where Hb <9 (mild anaemia) represented 4 (3.4%) patients and 1 (0.8%) of the 
controls and was represented 24 (5.9%) patients and 17 (4.2%) of the controls in the 
second study. 
3.2.7 Blood urea and serum electrolytes of patients 
The blood urea, serum potassium and sodium of patients were classified in three 
groups; first group, urea < 19 mg/dI, potassium < 3.3 mmol/I and sodium < 130 mmol 
second group, urea 20 - 59 mg/dI, potessium 3.4 - 5.3 mmol/I and sodium 130 -150 
mmol and third group urea > 60 mg/dI, potassium >- 5.4 and sodium > 150 mmol/l. 
(See table 8). 
3.2.7.1 Blood urea 
In the first study, the number of patients of the first group was 44 (37.3%), the number 
of patients of the second was 63 (53.4%) and the number of the third group was II 
(9.3%). The mean was 27.68 and the median 23.90. In the second study, the number of 
patients in the first group was 155 (38.3%), the number in the second group was 209 
(51.6%) and that in the third group was 41 (10.1%). The mean was 27.24 and the 
median 23.48. 
3.2.7.2 Serum potassium 
In the first study, the number of patients in the first group was 20 (17.0%), the number 
of patients in the second was 93 (78.8%) and the number in the third group was 5 
(4.2%). The mean was 3.94 and the median 3.90. In the second study, the number of 
patients in the first group was 67 (16.5%), the number of patients in the second was 
318 (78.5%) and the number in the third group was 20 (5.0%). The mean was 3.95 and 
98 
Table 8. Blood urea and electrlytes of patients (a) First study 
Urea mg/dI N2of 
Patients(%) 
Potassium 
mmol 
N2of 
patients (%) 
Sodium 
mmol 
JN2 Of 
patients (%) 
< 19 44 37.3 < 3.3 20 17.0 < 130 16 13.5 
20-59 63 53.4 3.4-5.3 93 78.8 130-150 90 76.3 
> 60 11 9.3 > 5.4 5 4.2 > 150 12 10.2 
Total 118 100% 118 100% 118 100% 
Table 8b. Second study 
Urea mg/dl N2of Potassium N2 Of Sodium 
Patients mmol patients (%) mmol 
X2 of 
patients 
< 19 155 38.3 <- 3.3 
20-59 209 51.6 3.4-5.3 
> 60 41 10.1 >- 5.4 
67 16.5 < 130 42 10.4 
318 78.5 130-150 307 75.8 
20 5.0 > 150 56 13.8 
Total 405 100% 405 100% 405 100% 
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the median 3.92. 
3.2.7.3 Serum sodium 
In the first study, the number of patients in the first group was 16 (13.5%), the number 
of patients in the second was 90 (76.3%) and that of patients in the third group was 12 
(10.2%). The mean was 137.8 and the median 135.5. In the second study, the number 
of patients in the first group was 42 (10.4%), the number in the second group was 307 
(75.8%) and the number of patients in the third group was 56 (13.8%). The mean was 
137.6 and the median 137.3. 
3.2.8 Treatment of dehydration 
Three types of treatment were used for correction of dehydration among patients; 
firstly ORT, secondly IVT and thirdly mixed (ORF and IVD; Table 9a). In the first 
study, the number of patients given ORT was 10 (8.5%), the number of patients given 
IVT was 31 (26.3%) and the number of patients administered both ORT and IVT was 
77 (65.2%). In the second study, the number of patients given ORT was 56 (13.8%), 
the number of patients given IVT was 102 (25.2%) and the number of patients 
administered both ORT and IVT was 247 (61.0%). ORT was used more frequently in 
the second study (Table 9b). 
3.2.9 Stay of patients in hospital 
The duration of stay of patients in the hospital was classified in three groups; the first 
group spent from one to three d, the second from four to seven d and the third from 
eight to eleven d. In the first study, the number of patients in the first group was 17 
(14.4%), the number of patients in the second was 89 (75.4%) and the number in the 
third was 12 (10.2%). The mean was 5.4 and the median 5.0 d. In the second study, the 
number of patients in the first group was 90 (22.2%), in the second 2 84 (70.1 %) and in 
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Table 9. Type of rehydration therapy and duration of stay in hospital (a) First 
study 
Type of fluid N2of patients Stay in hospital/days N2 of patients 
Oral 10 8.5 1-3 17 14.4 
lVF 31 26.2 4-7 89 75.4 
Oral + IVF 77 65.3 8-11 12 10.2 
Total 118 100% 1 118 100% 
Table 9b. Second study 
Type of fluid N2of patients (%) Stay in hospital/days X2of patients (%) 
Oral 56 13.8 1-3 90 22.2 
IVF 102 25.2 4-7 284 70.1 
Oral + lVF 247 61.0 8-11 31 7.7 
Total 405 100% 1 405 100% 
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the third 31 (7.7%). The mean was 5.03 and the median 5.00 d. More patients required 
hospitalisation for 4-7 d in the second study (Table 9a and 9b). 
3.2.10 Body weight of patients and controls 
The body weight of children was classified in four groups; first group < 10% of age 
for weight, second group from 10 to < 50%, third group 50% and fourth group > 50%. 
In the first study, the number of first group was 30 (25.4%) patients and 8 controls 
(6.8%; table 10a). The number of patients of second group was 48 (41.7%) and 29 
(24.6%) in the controls. The number of patients in the third group was 13 (11.0%) and 
24 (20.3%) in the controls. The number of patients in the fourth group was 27 (22.9%) 
and 57 (48.3%) in the controls. The weight range of all patients and controls was 3.2 - 
18.1 kg. The mean was 7.2 and the median 6.8. The patient group was significantly 
different from the control group in their weight for age of first group under nutrition < 
10% of patients (X 2= 15.18, p <0.05). In the second study, the number of patients in the 
first group was 115 (28.4%) and the controls 32 (7.9%; table l0b). The number of 
patients in the second group was 150 (37.0%) and the controls 91 (22.5%). The 
number of the patients in the third group was 57 (14.1 %) and the controls 98 (24.2%). 
Finally the number of patients in the fourth group was 83 (20.5%) and the controls 184 
(45.4%). The weight range of all patients and controls was 3.3 - 17.8 kg. The mean 
was 7.1 and the median 6.7 kg. None of the patients with acute gastroenteritis 
demonstrated signs of marasmus or kwashiorkor in both studies. The number of 
patients with undernutrition was 115 (28.4%) and 32 (7.9%) in the controls in the 
second study. The patient group was significantly different from the control group in 
their weight for age of the first group under nutrition < 10% (p < 0.05) of the second. 
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Table 10. Body weight of patients and controls (a) First study 
Age for weight N2 of patients N X2 of controls N 
< 10% 30 25.4 8 6.8 
10 -< 50% 48 40.7 29 24.6 
50% 13 11.0 24 20.3 
> 50% 27 22.9 57 48.3 
Total 118 100% 
Table 10b. Second study 
118 100% 
Age for weight (%) X2of patients (%) X2 of controls (%) 
< 10% 115 28.4 32 7.9 
10 -< 50% 150 37.0 91 22.5 
50% 57 14.1 98 24.2 
> 50% 83 20.5 184 45.4 
Total 405 100% 405 100% 
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3.2.11 Extraintestinal manifestations associated in some patients 
In the first study, certain other diseases were found in 19/118 (16.1 %) of patients with 
diarrhoea. Chest infection was the most common disease associated with diarrhoea 
(9/19; 47.4%), followed by febrile convulsion (4/19; 21%), meningitis (3/19; 15.8%) 
and heart disease (3/19; 15.8%). In the second study, other diseases were discovered in 
87 (21.5%) patients with diarrhoea. Chest infection was again the most common 
disease associated with diarrhoea 45/87 (51.7%), followed by febrile convulsion 18/87 
(20.7%), meningitis 13/87 (14.9%), heart disease 6/87 (6.9%) and renal disease 5/87 
(5.8%). 
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3.3 Aetiological detection agents isolated from patients and controls 
Bacteria, viruses and parasites were detected in stool specimens obtained from patients 
and controls as described in sampling and methods. The results are displayed in table 
II and figure 4. Bacteria were responsible for most cases in the first study, but 
rotaviruses applied to the second. 
In the first study, the microbiological aetiology of 118 stool specimens from children 
with acute diarrhoea was identified as either single or mixed infection in 66/118 
(55.9%) of patients. The aetiology of the remaining 52/118 (44.1%) patients was un- 
determined. 
Bacterial agents were isolated from 50/118 patients (43.3%), rotaviruses were 
identified in 18/118 patients (15.3%) and parasites were identified in 10/ 118 (8.4%) 
patients (Table II a). Infection of patients by a single pathogen was present in (46.6%) 
and infection by mixed pathogens in 11/118 patients (9.3%) where more than one 
pathogen was detected in the same patient (table II a). Mixed infections were either 
two 10/118 (8.4%) or three pathogens 1/118 (0.8%). Bacteria + rotavirus were present 
in 5/118 (4.2%) patients, mixed two types of bacteria were present in 2/118 (1.7%) 
patients, bacteria + parasite were present in 2/118 (1.7%) of patients and rotavirus 
parasite were present in 1/118 (0.8%) patients. A mixed infection by three agents, 
two bacterial agents + rotavirus was present in 1/118 (0.8%) patients. No mixed 
infections by more than one parasitic agent were detected in this study. Stool 
specimens from the 118 children in the control group were examined for enteric 
pathogens which were identified in 16/118 (13.6%) children. Bacterial agents were 
isolated from 9/118 (7.6%), rotaviruses from 3/118 (2.6%) and parasites from 4/118 
(3.4%) controls. No mixed infections were observed in the control group. Pathogens 
detected in the patients, group were significantly different from the control group 
p<0.05). 
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Table 11. Identification of bacteria, rotavirus and parasites in faecal specimens of 
patients and control with single or mixed infections (a) First study 
Type of infection Patients 66/118 Control 16/118 
N2 of patients (%) X2 of controls 
I agent 55 46.6 16 13.6 
2 age 10 8.5 
3 agents 1 0.8 
No agents detected 52 44.1 102 86.4 
Total 118 100% 118 100% 
Single agent 
E. coli 
Campylobacter 
Proteus 
Klebsiella 
Rotavirus 
Ent histolytica 
G. lamblia 
Cryptosporidium 
2 agents 
Enthistolytica + Campylobacter 
Ent. histlytica + E. coli 
Ent. histolytica + rotavirus 
E. coli + Proteus 
E. coli + rotavirus 
Rotavirus + Campylobacter 
Rotavirus + Proteus 
3 agents 
Rotavirus + E. coli 
klebsiella 
Total 
* No mixed pathogens. 
21 17.8 5 4.3 
6 5.1 1 0.8 
6 5.1 2 1.7 
4 3.4 1 0.8 
11 9.3 3 2.6 
2 1.7 2 1.7 
2 1.7 1 0.8 
3 2 1 0.8 
1 0.8 
1 0.8 
1 0.8 
2 1.7 
2 1.7 
2 1.7 
1 0.8 
1 0.8 
66 55.9 16 13.6% 
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Table 11. Identification of bacteria, rotavirus and parasites in faecal specimens of 
patients and control with single or mixed infections (b) Second study 
Type of infection Patients 276/405 Control 51/405 
N2 of patients N X2 of controls (%) 
I agent 239 59.0 51 12.6 
2 agents 36 8.9 
3 agents 1 0.2 
No agents detected 129 31.9 354 87.4 
Total 405 100% 405 100% 
Single agent 
E. coli 
Campylobacter 
Proteus 
Klebsiella 
Rotavirus 
Ent. histolytica 
G. lamblia 
Cryptosporidium 
2 agents 
E. coli + Proteus 
E. coli + rotavirus 
E. co/ + Ent. histolytica 
E. coli + G. lamblia 
Campylobacter + rotavirus 
Campylobacter + Ent histolytica 
Rotavirus + Klebsiella 
Rotavirus + Ent histolytica 
52 12.8 11 2.7 
16 4.0 4 1.0 
6 1.5 3 0.7 
5 1.2 2 0.5 
98 24.2 12 3.0 
37 9.1 11 2.7 
12 3.0 5 1.2 
13 3.2 3 0.7 
3 0.7 
6 1.5 
2 0.5 
3 0.7 
4 1.0 
4 1.0 
7 1.7 
7 1.7 
3 agents 
Rotavirus + E. coli + klebsiella 1 0.2 
Total 276 68.1 51 12.6% 
* No mixed pathogens. 
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In the second study, the microbiological aetiology of 405 stool specimens from 
children with acute diarrhoea were identified as either single or mixed infections in 
276/405 (68.1%) patients. The aetiology of the remaining 129/ 405 (31.9%) was not 
detected. Bacterial agents were isolated from 113/405 (27.9%) patients, rotaviruses 
were identified in 123/405 (30.4%) patients and parasites were identified in 79/405 
(19.3%) patients. Infection of patients by a single agent was present in 239/405 (59.0%) 
and infection of patients by mixed agents was present in 37/405 (11.4%; table I lb). 
Mixed infections were with either two pathogens in 36/405 (8.9%) patients or three 
pathogens in 1/405 (0.2%) patients. Of the mixed agents, two bacteria were in 3/405 
(0.7%), bacteria + rotavirus in 17/405 (4.2%) patients, bacteria + parasite in 9/405 
(2.2%) and rotavirus + parasite were detected in 7/405 (2%) patients and mixed 
infection by three agents, bacteria + rotavirus + parasite was present in 1/405 (0.2%) 
patients. No mixed infections with greater than one parasitic agent were detected. 
Stool specimens from 405 children as a control group were investigated for detection 
of bacteria, rotavirus and parasites were in 51/405 (12.6%) controls. 
Bacterial agents were isolated from 20/405 (4.9%) controls, rotavirus was detected in 
12/405 (3%) controls and parasites were discovered in 19/405 (4.7%). Again, no 
mixed agents were observed in the control group. Bacterial, rotavirus and parasites 
detected in the patient group were again significally different from the control group 
(Xý= 3.99, p<0.02). 
3.3.1 Bacteriological findings 
3.3.1.1 Isolation of bacteria 
The type of bacteria isolated from patients and controls in the first study is shown in 
table I Ia. The most common bacterial pathogens was Escherichia coli found in 
27/118 (22.9%) patients and lowest isolation of bacterial Pathogens was Klebsiella 
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found in 5/118 (4.2%) of patients (Xý= 19.65, p<0.05). A single infection by E coli 
was discovered in 21/118 (17.8%) and in 6/118 (5.1 %) as mixed infections with other 
pathogens. E. coli + Proteus was discovered in 2 patients, E. coli + rotavirus was 
found in the same number, K coli + Ent. histolytica was identified in I patient and E 
coli + rotavirus + Klebsiella was found in found in I patient. E. coli were identified 
in stool specimens from 5/118 (4.2%) of the control group. Campylobacter was 
isolated from 9/118 (7.6%) patients as the single pathogen in 6/118 (5.1%) and as 
mixed infections in 3/118 (2.5%). Campylobacter + rotavirus were discovered in two 
patients and Campylobacter + Ent. histolytica was discovered in one patient. 
Campylobacter was isolated from only 1/118 (0.8%) of the control group. Proteus was 
identified in 9/118 (7.6 %) of patient stool specimens. Proteus was the sole pathogen 
in 6/118 (5.1 %) and in 3/118 (2.5%) as mixed infections. Proteus + E. coli were found 
in two patients and Proteus + rotavirus was traced in only one patient. Proteus was not 
isolated from any stool specimens of the control group. Klebsiella was discovered in 
5/118 (4.2%) stool specimens of patients. Klebsiella was a single pathogen in 4/118 
(3.4%) patients and in 1/118 (0.8%) as a mixed infection. Klebsiella +E coli 
rotavirus was found in one patient alone (0.8%). 
The most common type of pathogen isolated from the control group was bacteria. 
Bacteria were the most common agents identified in this study compared to rotavirus 
and parasites (Figure 5a). 
In the second study, the type of bacteria that were isolated from patients and the 
controls are shown in table I lb. The most common bacterial pathogens was again E. 
coli found in 67/405 (16.5%) patients and a lesser one was proteus 9/405 (2.2%) 
patients (X 2=4.00, p<0.05). A single infection by E. coli was discovered in 52/405 
patients (12.8%) and in 15/405 (3.7%) patients with E. coli infection was found as a 
mixed infection with other pathogens; E. coli + Proteus were discovered in 3 patients, 
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Figure 5. The number of bacterial, viral and parasitic were identification from 
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E. coli + rotavirus was found in 6 patients, E. coli + Ent. histolytica was found in 2 
patients E. coli + G. lamblia were found in 3 patients and E. coli + rotavirus + Ent. 
histolytica in just I patient. 
E. coli was identified in stool specimens in 11/405 (2.7%) of the control group. 
Campylobacter was isolated from 24/405 (6.7%) patients. Campylobacter was the 
single pathogen in 16/405 (4%) and as a mixed pathogen was 8/405 (2%) patients; 
Campylobacter + rotavirus were found in 4 patients, Campylobacter + Ent. histolytica 
were found in the same number. Campylobacter was isolated from stool specimens in 
4/405 (1%) of the control group. Proteus was identified in 9/405 (2.2%) of patient 
stool specimens. It was the single pathogen in 6/405 (1.5%) and in 3/405 (0.7%) as a 
mixed infection. Proteus + E. coli were found in 3 patients. Proteus was identified in 
3/405 (0.7%) of stool specimens among the control group. Klebsiella was identified in 
13/405 (3.2%) patients. Klebsiella was the single pathogen in 5/405 (1.2%) and in 
8/405 (2%) as a mixed infection. Klebsiella + rotavirus were found in 7 patients and I 
/405 (0.2%) in combination with other pathogens Klebsiella + E. coli + rotavirus. 
Klebsiella was identified in 2/405 (0.5%) of the control group's stool specimens. 
The number of patients with rotavirus in the second study was higher than those with 
bacterial infections (Figure 5b). 
3.3.1.2 AN 20E and AN Campy 
In the first study, confirmation of identification of organisms by biochemical testing 
was not performed because, although cultures were put in storage media for transfer to 
England, the organisms did not survive transportation. In the second study 
biochemical testing was conducted in Libya. Here there was a dissimilarity between 
the number of bacteria isolated from patients, stools by cultures and identified by 
cultural characteristics. Those were confirmed by the API technique. The number of 
bacteria identified by culture was 142/405 (35.1%) from stool of patients and the 
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number of bacteria confirmed by API was 112/405 (27.7%). The difference was 30 
(7.4%) of bacterial agents. The number of bacterial organisms unconfirmed by API 20 
E was 27; Escherichia coli 19 (12 as a single and 7 as a mixed infection), Proteus 4 (2 
as a single and 2 as a mixed infection) and Klebsiella 4(2 as a single and 2 as a mixed 
infection; Table 12). 
The number of Campylobacter isolated by culture was 27 and the number 
unconfirmed by API Campy was 3 (2 as a single and I as a mixed infection; Table 13). 
The number of bacterial organisms isolated from stools of the control group by 
cultures was 27/405 (6.7%) and the number of bacteria confirmed by API technique 
was 20/405 (4.9%). The difirence was 7 (1.7%) of bacterial agents. The number of 
bacterial agents not confirmed by API 20E 6; Escherichia coli was 3, Proteus 2, 
Klebsiella I (Table 14). The number of Campylobacter unconfirmed by API Campy 
was I (Table 15). 
AN 20E results 
Diarrhoeagenic Escherichia coli of a number of biotypes were isolated by cultures 
from stool specimens of patients and confirmed by identification with the API 20E. 
The number of E. coli confirmed was 76; 32 E. coli had very good identification (ID 
79.9-99.8%, T 0.57-0.96) and 35 had good identification (ID 78.5-98.1%, T 0.35-0.8). 
The number of Proteus confirmed was 9; 2 Proteus had v. good identification (ID 72 - 
99.9%, T 0.72), 3 Proteus with acceptable identification of the genus (ID 66.9%, T 
0.72) and 4 proteus doubtful profiles (99.8-99.9%, T 38-39). The number of klebsiella 
confirmed was 12; 2 v. good identification (ID 99.1%, T 0.77), 4 Klebsiella good 
identification to the genus (ID 76.3%, T 0.44), 3 Klebsiella good identification (ID 
97.4%ý T 1.0) and 3 Klebsiella doubtful profiles (ID 82.8%, T 0.42; Table 12). 
71-. 
Escherichia coli were isolated by culture from stool specimens of the control group 
and confirmed with API 20E. The number was IIE. coli; 4 E. coli was identified as 
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very good (ID 99.2% to 99.4%, T 0.57 to 0.96), one v. good identification to the genus 
(ID 79.9%, T 0.73) and 6 good identification (ID 92.2% to 98.1%, T 0.6-0.63). The 
number of Proteus confirmed was 3; 1 v. good identification (ID 99.9%, T 0.72) and 2 
acceptable identification to the genus (ID 66.9%, T 0.72). The number of Klebsiella 
confirmed was 2; 1 good identification (ID 97.4%, T 1.0) and I good identification to 
the genus (ID 76.3%, T 0.44; Table 13). 
API Campy result 
Campylobacter spp. were isolated by selective medium (CCDA) from stool specimens 
of patients and confirmed by identiflying with the API Campy. The number was 24 
Campylobacter spp; 19 Campylobacter jejunil, 7 v. good identification (ID 99.0- 
99.8%ý T 0.86-0.92), and 12 good identification (ID 97.6-98.9%, T 0.87-0.99). 5 
Campylobacterjejuni were identified as Campylobacterjejuni sppjejuni2 and 14 as 
Campylobacter jejuni spp. jejuni 1. The number of Campylobacter coli was 5; 1 v. 
good identification (ID 99.6%, T 0.9 1) and 4 good identification (ID 98.2 to 98.9%, T 
0.9 to 0.93; table 14). 
Campylobacter spp. were isolated by selective medium from stool specimens of the 
control group and confirmed by identifying with API Campy. The number was 4 
Campylobacter spp; 3 Campylobacterjejuni, I very good identification (ID 99.8%, T 
0.86) and 2 good identification (ID 97.9-98.4%, T 0.87-0.9). One Campylobacter 
jejuni was identified as Campylobacter jejuni spp jejuni2 and 2 as Campylobacter 
jejuni sppjejunil. The number of Campylobacter coli was one, good identification (ID 
98.6%, T 0.9; table 15). 
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Table 12. Comparison between bacterial isolation by cultures and API 20E from 
stool of patients 
Type of N2of bacterial agents X2of profiles X2 of bacterial 
bacteria isolated by cultures (%) of API 20E identified (%) ID T 
1. Escherichia coli 86 74.1 67 77.9 
7 144 572 x (2) 99.8 0.63 
7 044 142 x (4) 78.5 0.35 
5 544 572 x (3) 99.2 0.63 
5 144 772 x (5) 97.2 0.63 
5 144 752 x (3) 99.7 0.67 
5 144 562 x (3) 99.8 0.85 
5 144 712 x (5) 98.1 0.6 
5 144 560 x (4) 99.5 0.57 
4 044 532 x (2) 81.5 0.67 
5 144 452 x (3) 99.8 0.75 
5 104 570 x (5) 98.0 0.53 
5 144 572 x (3) 99.5 0.96 
5 144 550 x (2) 99.5 0.72 
5 144 150 x (4) 92.8 0.56 
5 144 002 x (3) 79.5 0.66 
5 144 500 x (2) 79.9 0.73 
5 044 442 x (3) 93.0 0.58 
4 044 553 x (4) 94.8 0.54 
1044 542 x (2) 93.4 0.76 
1044 402 x (3) 93.0 0.75 
1044 110 x (2) 96.7 0.8 
2. Proteus 13 11.2 9 69.2 
0 456 021 x (2) 99.9 0.72 
0 474 060 x (3) 99.8 0.38 
0 436 000 x (3) 66.9 0.72 
2734000 99.9 0.39 
3. Klebsiella 17 14.7 13 76.5 
5 014 573 x (5) 76.3 0.44 
5 255 773 x (3) 97.4 1.0 
5 204 543 x (2) 99.1 0.77 
5 204 777 x (3) 82.8 0.42 
Total 116 100.0 89 77.4 
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Table 13. Comparison between bacterial isolated by cultures and API 20E from 
stool of control group 
Type of N2 of bacterial profiles of N2 of bacterial 
bacterial isolated by cultures (%) API 20E identified (%) ID T 
1. Escherichia coli 14 63.7 11 78.6 
5544572 99.2 0.63 
5 144 712 x (2) 98.1 0.6 
5 144570 99.5 0.68 
5 144572 99.5 0.96 
5 144500 99.9 0.73 
5 044 513 x (3) 92.2 0.61 
5 144772 97.2 0.63 
5 144560 99.5 0.57 
2. Proteus 5 22.7 3 60 
0 436 000 x (2) 66.9 0.72 
0456021 99.9 0.72 
3. Klebsiella 3 16.6 2 66.7 
5014573 97.4 1.0 
5255773 99.1 0.77 
Total 22 100.0 16 72.7 
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Table 14. Comparison between campylobacter isolated by culture and API 
Campy from stool of patients 
Type of X2 of Campylobacter profiles of N2 of Campylobacter 
Campylobacter isolated by culture (%) API Campy identified (%) ID (%) T 
1. Campylobacterjejuni 
2. Campylobacter coli 
Total 
21 77.8 19 90.5 
6 100 554 x (3) 97.6 0.89 
6 501555 x (2) 99.0 0.92 
6 100 544 x (2) 98.5 0.9 
6 701 555 x (3) 99.8 0.89 
6 101 514 x (2) 98.4 0.87 
6 101 554 x (2) 98.4 0.99 
6 101 555 98.9 0.94 
6 301 504 x (2) 99.8 0.86 
6 500 554 x (2) 97.7 0.87 
6 22.2 5 83.3 
6 401 524 x (2) 98.9 0.9 
6420534 99.8 0.94 
6 421 514 x (2) 98.2 0.93 
27 100.0 24 88.9 
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Table 15. Comparison betwwen campylobacter isolated by culture and AN 
Campy from stool of control group 
Type of N2 of Campylobacter profiles of X2 of Campylobacter 
Campylobacter isolated by culture (%) API Campy identified (%) ID T 
Campylobacterjejuni 5 
Campylobacter coli 2 
71.4 
28.6 
6301504 
6 101514 
6500554 
6421504 
3 60 
99.3 0.95 
99.8 0.86 
99.4 0.93 
50 
98.9 0.9 
Total 7 100.0 4 57.1 
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3.3.1.3 Polymerase Chain Reaction 
The polymerase chain reaction gives a highly sensitive and specific alternative to 
selective enrichment for the detection and identification of bacterial pathogens (Hill et 
al. 1990). A novel PCR assay that will detect and identify the thermophilic, enteropa- 
thogenic Campylobacter spp. commonly associated with human infection was utilised. 
Restriction analysis was not employed. 
In this study the method was adopted as described in chapter 2 to confirm detection 
and identification of 28 Campylobacter spp. isolated from stool specimens of Libyan 
children; 24 from children with acute diarrhoea and 4 from children without diarrhoea 
by use of selective medium (CCDA) and identified by API Campy technique in 
Tripoli central laboratory, Libya. All Campylobacter were subcultured and pure 
Campylobacter colonies were placed on FTA card sample collection and transferred to 
England for the PCR technique. 
Results 
Amplification of Campylobacter from children of the second study and control 
(Campylobacterjejuni NCTC 11168 was provided by Dr. D. Wareing (Dynal Biotech 
Ltd, Microbiology R&D, Department of Biological Sciences, University of Central 
Lancashire, Preston PRI 2HE, UK). The profiles of which on gel electrophoresis 
commencing were characteristic for the species amplified (Figures 6 and 7). 
When commencing work, the amount of hyperLadder V (marker) 25 pl was taken and 
the marker spaced bands were joined together, especially lower bands due to the large 
amount used (25 ýtl) instead of the proper amount (5 ýtl). HyprLader V 
produces 12 regularly spaced bands, ranging from 25 to 500 bp. After correction the 
amount of HyperLader V by (5 [il), the reaction was more distinct and identification of 
the site of restriction was detected. 
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Figure 6. PCR amplification products from the two Campylobacter spp. 
(lane 1) molecular weight marker, (lane 2) C jejuni positive control, (lane 3) 
Negative control, (lanes 4-6) C jejuni isolated from stool specimens of patients and 
control, (lane 7) C coli. 
1 I)t) 
In the first samples the site of restriction showed between 200 and 300 bp. Moreover 
the upper bands were more clear than the lower bands and reaction was satisfied. This 
indicated that the Campylobacterjejuni and Campylobacter coli samples and positive 
control were on the same line at approximately 250 bp (Figure 6). 
When the second sample of hyperLader V was reduced to 5 pml the reaction was 
clearer and the site of restriction of Campylobacter jejuni was the same band at 
approximately 250 bp. 
24 of Camylobacter spp. (19 Campylobacterjejuni and 5 Campylobacter coli) were 
isolated from stools of patients and 4 (3 Camplobacter jejuni and I Campylobacter 
coli) from the control group were identified by PCR to compare the results of API 
Campy. The detection of Campylobacter spp. was 100%. 
3.3.2 Virological findings 
Rotavirus test results are displayed in (Table IIa and II b). 
In the first study, rotavirus was detected in 18/118 (15.3%) of patient stool specimens. 
The single pathogen was identified in 11/118 (9.3%) and in 7/118 (5.9%) patients as a 
mixed infection with other pathogens. Rotavirus + E. coli were also detected in 2 
patients, rotavirus + Campylobacter were detected in 2 patients, rotavirus + Proteus 
were discovered in I patient too, rotavirus + Entamoeba histolytica were detected in I 
patient and rotavirus + E. coli + Klebsiella were detected in a sole case. Rotavirus was 
present in 3/118 (2.6%) stool specimens from the control group. 
Rotavirus infection of patients was significantly different from the control group (p < 
0.05). 
In the second study, rotavirus was detected in 123/405 (30.4%) patient stool specimens, 
the single pathogen in 98/405 (24.2%) and in 25/405 (6.2%) patients as a mixed 
infection with other pathogens. Rotavirus + E. coli were identified in 6 patients, 
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Figure 7. PCR Amplification products showing one Campylobacter spp. 
restriction site of enzyme. (lane 1) marker, (lane 2,3) negative, (lane 4) 
Campylobacterjejuni, (lane 5-7) and (lane 8) negative control. 
rotavirus + Camyplobacter were identified in 4 patients, rotavirus + Klebsiella were 
identified in 7 patients, rotavirus + Entamoeba histolytica were identified in 7 patients 
and rotavirus + E. coli + Ent. histolytica in I patient. Rotavirus was discovered in 
11/405 (2.7%) stool specimens of the control group. Patients, infection with rotavirus 
was again significantly different from the control group (p < 0.05) and was much 
higher than in the first study. 
3.3.3 Parasite findings 
The results of examination of stool specimens for parasites are displayed in table 11. 
In the first study, parasites were discovered in 10/118 (8.5%) stool specimens of 
patients and as a single pathogen was in 7/118 (6.0%) patients besides being a mixed 
pathogen in 3/118 (2.5%) patients. Entamoeba histolytica was the most common cause 
of parasitic infection. Ent. histolytica was detected in 5/118 ( 4.2%) stool specimens of 
patients, as a single pathogen in 2/118 (1.7%) and in 3/118 (2.5%) as a mixed 
infection. Ent. histolytica + E. coli were discovered in one patient, Ent. histolytica 
Campylobacter in one patient and Ent. histolytica + rotavirus also in one patient. Ent. 
histolytica was detected in 2/118 (1.7%) stool specimens from the control group. 
Giardia lamblia was identified in 2/118 (1.7%) stool specimens of patients and in 
1/118 (0.8%) stool specimens from the control group. No mixed infections with 
G. lamblia were detected. Cryptosporidium was discovered in 3/118 (2.5%) patient 
stool specimens and in 1/118 (0.8%) control group specimens. In first study, 
Cryptosporidium was not detected as mixed infection with other pathogens. Parasite 
infection of patients was not statistically significantly different from the control group 
(p < 0.05). In the second study, parasites were detected in a higher number of stool 
specimens of patients (79/405; 19.5%). A single parasite was detected in 62 (15.3%) 
patients and as mixed infections in 17/405 (4.2%). Entamoeba histolytica was the most 
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common cause of parasitic infection and was detected in 51/405 (12.6%) stool 
specimens of patients, as a single pathogen in 3 7/405 (9.1 %) and in 14/405 (3.5%) as a 
mixed infection. Ent. histolytica + E. coli were detected in 2 patients, Ent. histolytica 
Campylobacter were detected in 4 patients, Ent. histolytica + rotavirus were detected 
in 7 patients and Ent. histolytica + E. coli + rotavirus were detected in I case. Ent. 
histolytica was detected in 11/405 (2.7%) stool specimens of the control group. G. 
lamblia was detected in 15/405 (3.7%) stool specimens of patients, as a single 
pathogen in 12/405 (3%) and in 3/405 (1.2%) patients as a mixed pathogen. G. lamblia 
E. coli were detected in 3 patients. G. lamblia was further detected in 5/405 (1.2%) 
stool specimens of the control group. Cryptosporidium was detected as a single 
pathogen in 13/405 (3.2%) patient stool samples. No mixed infections with 
Cryptosporidium were detected in the second study also. Cryptosporidium was 
detected as a single pathogen in 3/405 (0.7%) of stool specimens of the control group. 
Parasitic infection of patients varied significantly from the control group in the second 
study (p < 0.05). 
3.3.4 Summary 
Libyan children of below I year were the most susceptible to acute diarrhoea requiring 
hospitalisation in both studies (78.8% and 70.1% respectively). There was no 
difference between males and females in either study. In addition, there was no 
statistically significant difference between patients and controls vis a vis educational 
level of mothers. Family size differed in both studies, except the group family size >5 
child (P < 0.05). Watery stool was the most common stool consistency in both studies 
(P < 0.05). Bloody diarrhoea was approximately 5 to 6% and there was slight variance 
between the two studies for duration of diarrhoea. The mean was 3.6 and 3.9 and the 
median was 3 days in both studies. Fever was present in 72.9% of patients in the first 
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study and in 71.6% in the second. Fever was the most prevalent clinical feature 
associated with acute diarrhoea in both studies (P < 0.05). The group of patients who 
had fever for one day was higher in the first study while the group from 2-3 days was 
higher among the second. 
Vomiting was present in 51.7% of patients in the first study and 58.3% among the 
second study. Vomiting was not associated with acute diarrhoea in the first study (P > 
0.05) but was in the second (P < 0.05). Type and degree of dehydration was most 
commonly isotonic and moderate at more than 70% and 50% in both studies. Very few 
children had low haernoglobin <9 (mild anaernia; 3.4% and 3.7%) of patients. %) 
respectively. Serum potassium and sodium were within their normal limits in more 
than 75% of cases in both studies. Urea > 60 (abnormal) was present at 9% in first 
study and 10% of the second. ORT proved to be of little use for treatment of 
dehydration, representing only 8.5% in the first study and 13.8% in the second. 
Regarding the duration for patient stay in hospital, the mean was 5.39 and the medium 
was 5 in the first study, and the mean was 5.03 and median 5 in the second. No 
patients with acute diarrhoea demonstrated signs of marasmus or kwashiorkor. a 
patient group was significantly different from the control group in their weight for age 
for the group of under-nutrition in both studies (P<0.05). No complications were 
recorded in either study (HUS or GBS). Chest infection was the most prevalent 
disease combined or associated with diarrhoea. 
One or more enteric pathogens were detected from stool of patients (55.9%) and 
(13.6%) of controls in the first study and from 68.1 % of patients and 12.6% of controls 
in the second study. 
Bacteria were most common (43.3%) in the first study while rotavirus was most 
common in the second. Campylobacter was the second most frequently isolated 
bacteria in both studies. Entamoeba histolytica was the common parasite identification 
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in both studies. Cryptosporidium was more frequently detected in the second study. 
Watery stool, fever, and vomiting were common in patients with rotavirus infection in 
both studies. 
API 20E and API Campy were used to identifiy bacterial isolated by cultures and the 
number of confirmed cases decreased from 142 to 112 samples in the second study. 
Polymerase chain reaction was adopted in the second study to confirm detection of 
Campylobacter spp. These were identified by APA Campy technique, where all 
Campylobacter spp. were identified as the same as detected by API Campy and for 24 
samples. 
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CHAPTER 4 
Epidemiolou and Risk Factors for Childhood Diarrhoea 
4.1 Seasonal distribution 
The first study was conducted over a relatively short period (3 months) at the end of 
summer and beginning of autumn and no seasonal variation could be determined. 
During the second study, the seasonality of detection of variation enteropathogens was 
determined and the results are shown in (Fig. 8). The highest frequency of isolation of 
enterobacteria was in the summer season (June, July and August). Parasites were 
detected more frequently in summer and autumn whereas infection with rotavirus was 
higher in winter (December, January and February). Enteropathogen detection rates in 
summer, winter, spring and autumn were 32.6% (112/344), 25.3% (87/344), 18.9% 
(65/344 and 23.2% (80/344) respectively (Fig. 8). The highest incidence was 42/314 
(13.4%) in July and the lowest in April (16/314; 5.1%). The peak in July was due to 
the high prevalence of bacterial and parasite infections during that month (Fig. 8). 
4.1.1 Seasonal variation of bacteria 
Bacteria were more frequently isolated in the hot months from June through to 
October (74/112; 66.1 %; Figure 8). The peak of bacterial isolation was July (22/112; 
19.6%). Bacteria were most frequently isolated in the summer season (56/112; 50%). 
Bacteria were less frequently isolated in winter (12/112; 10.7%). The prevalence of 
bacterial infections in autumn and spring was 20.5% (23/112) and 18.8% (21/112) 
respectively. 
4.1.2 Seasonal variation of rotavirus 
The seasonality variation in the frequency of rotavirus infections differed markedly 
from that of bacterial and parasite infections (Fig. 8). The highest frequencies of 
rotavirus infection were found in the relatively cool months of November through to 
March (87/123 (70.7%). Rotavirus was most frequently detected in the winter season 
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(62/123; 50.4%). The peak month of prevalence of rotavirus identification was 
January with 25/123 (20.3%). Rotavirus infection was less prevalent in summer with 
10/123 (8.1%). The frequencies of rotavirus infection in autumn and spring seasons 
were 29/123 (23.6 %) and 22/123 (17.8%) respectively. 
4.1.3 Seasonal variation of parasites 
The seasonal variation of parasite infection was similar to that for bacteria where the 
highest number of parasites were discovered in the hot months 54/79 (68.4%; Figure 
8). The summer was the most common season for prevalence of parasites detected in 
this study 40/79 (50.6%). The peak month of prevalence of parasite infection was July 
with 16/79 (20.3%). Parasite infection was less common in winter (5/79; 12.7%). 
Parasite infections in autumn and spring were 18/79 (22.8%) and 16/79 (20.3%) 
respectively. 
4.2 Type of feeding: 
The type of feeding patients and controls received is displayed in tables 16a and l6b. 
In the first study, the number of patients who were breast fed was only five (4.2%) 
whilst this rose to ninteen in the controls (16.1%). The number of patients that were 
bottle fed was 73 (61.9%) and 25 (21.2%) in the control group. The number of patients 
with mixed feeding (breast and bottle) was 28 (23.7%) in the patient group and 50 in 
the control group (42.4%). Finally, the number of patients with solid feeding 
(normal food) was 12 (10.2%) and 24 in the controls (20.3%). For feeding type, bottle 
feeding is higher risk than breast feeding (baseline), whereas mixed feeding shows a 
protective effect and it marginally significant at 10% (p-value=0.108). The odds of 
having the diarrhoea for bottle feeding is 5 times higher than those who are breast fed. 
In the second study, the number of patients who were breast fed was 47 (11.6%) and 
98 (24.2%) in the controls. The patients were again significantly different from the 
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Table 16. Type of feeding of patients and controls (a) First study 
Type of N2 of patients (%) X2 of controls OR p-value 95% Cl 
Feeding 
Breast feeding 5 4.2 
Bottle feeding 73 61.9 
Mixed feeding 28 23.7 
Solid feeding 12 10.2 
19 16.1 11 to I (by default) 
25 21.2 4.483 0.005 1.590 to 12.644 
50 42.4 0.244 0.108 0.044 to 1.360 
24 20.3 Unstable solution 0.988 0 to 00 
Total 118 100 118 100 
Table 16b. Second study 
Type of X2 of patients (%) N2 of Controls 
feeding 
OR p-value 95% Cl 
Breast feeding 47 11.6 
Bottle feeding 189 46.7 
Mixed feeding 86 21.2 
Solid feeding 83 20.5 
98 24.2 11 to I (by default) 
104 25.7 4.927 0.000 2.827 to 8.587 
167 41.2 1.348 0.390 0.682 to 2.664 
36 8.9 Unstable solution 0.985 0 to 00 
Total 405 100 405 100 
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control group in their breast feeding patterns (x2 = 18.19, p<0.05). The number of 
patients who were bottle fed was 189 (46.7%) and 104 (25.7%) in the controls. The 
number of patients with mixed feeding was 86 (21.2%) and 167 (41.2%) among 
controls. The number of patients with solid feeding was 83 (20.5%) and 36 (8.9%) in 
the controls. For feeding type, bottle and mixed feeding are higher risk than breast 
feeding (baseline). However the McNemar's chi sequere test shows that only bottle 
feeding is significantly associated with diarrhoa and the odds of having the diarrhoea 
is 5 times higher than those who are breast fed. 
4.3 Type of water supply 
The water supplies used by patients, families and controls in these studies were 
classified into four types (Table 17a and 17b): (1) tap water (chlorinated and therefore 
safe water supply), (2) bottled water, (also likely to be safe), (3) well water, (usually 
unsafe because it is a private source and not chlorinated), (4) storage water, (not safe 
and easily contaminated because the water is stagnant and there is no chlorination). 
In the first study, tap water was drunk by 65 (5 5.1 %) patients and 55 (46.6%) controls. 
Bottled water was drunk by 8 (6.8%) in the patient group and by 9 (7.6%) in the 
control group. Well water was drunk by 35 (29.7) patients and by 32 (27.1 %) of the 
controls. Storage water was drunk by 5 (4.2) patients and by 3 (2.5%) of the controls. 
Using the McNemar, s chi square test and using water tap as the baseline, there is no 
statistical evidence of an association between water type and diarrhoea. 
In the second study, tap water was drunk by 237 (58.5%) in the patient group and by 
212 (52.3%) in the control group. Bottled water was drunk by 75 (18.5%) of the 
patients and by 72 (17.8%) of the controls. Well water was drunk by 20 (4.9%) of the 
patients and 14 (3.5%) of the controls. Storage water was drunk by 26 (6.4%) in the 
patients and by 9 (2.2%) of controls. 
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Table 17. Type of water supply of patients and controls (a) First study 
Type of water X2of patients (%) X2of controls (%) OR p-value 95% CI 
Tap water 65 55.1 55 46.6 1 1 to I (by default) 
Bottle water 8 6.8 9 7.6 0.696 0.151 0.234 to 2.069 
Well water 35 29.7 32 27.1 0.806 0.532 0.410 to 1.584 
Storage water 5 4.2 3 2.5 0.845 0.842 0.161 to 4.431 
Total 113* 95.8 99** 83.8 
This excludes (5) of patients which were exclusively breast fed. 
* This excludes (19) of controls which were exclusively breast fed. 
Table 17b. Second study 
Type of water X2 of patients (%) N2 of controls (%) OR p-value 95% CI 
Tap water 237 58.5 212 52.3 1 1 to I (by default) 
Bottle water 75 18.5 73 18.0 0.957 0.848 0.612 to 1.497 
Well water 20 4.9 14 3.5 1.361 0.410 0.633 to 2.836 
Storage water 26 6.4 9 2.2 1.854 0.145 0.809 to 4.251 
Total 358* 88.4 308** 76.0 
This excludes (47) of patients which were exclusively breast fed. 
* This excludes (97) of controls which were exclusively breast fed. 
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Using the McNemar, s chi square test and using water tap as the baseline, there is no 
statistical evidence of an association between water type and diarrhoea. 
4.4 Animal contact of patients and controls 
The number of patients and controls who had contact with animals was reported in 
patients as thirty-seven (31.4%) and among controls as thirty-five (29.7%) in the first 
study. Animal contact was not significantly statistically different between patient and 
control groups (X2 = 0.08, p>0.05). In the second study, the number of patients who 
had contact with animals was one hundred and seventeen (28.9%) and the number of 
controls was one hundred and four (25.7%). Animal contact was again not 
significantly statistically different between the patient and control groups (p >0.05). 
4.5 Use of dummies 
In the first study, the number of patients who used dummies was sixty-eight (57.6%) 
and twenty-two (18.6%) of the controls and the number of not used dummies was fifty 
(42.4%) of the patients and ninty six (81.4%) of the controls (Table 18a). Those 
patients who used a dummy were substantially more likely to contract diarrhoea when 
compared with the control, by using McNemar's chi sequere test shows that dummy 
usage is highly associated with diarrhoea, that is the odds of being diarrhoea for 
dummy users are 2.5 times the odds of non dummy users. 
The second study provided similar results. The number of patients who used dummies 
was 147 (36.3) and 65 (16%) of controls and the number of not used dummies was 
two hundred and fifty eight (63.7%) of the patients and three hundredand fourty (84%) 
of the controls (Table 18b). By using McNemar's chi sequare test shows that dummy 
usage is highly associated with diarrhoea, that is the odds of being diarrhoea for 
dummy users are 3 times the odds of non dummy users. 
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Table 18. Dummies used by patients and controls (a) First study 
Use of dummies Patients Controls 
or non-use X2 of patients (%) X2 of controls (%) OR p-value 95% CI 
Dummies used 68 57.6 22 18.6 2.5 11.57p<0.0007 1.42to4.59 
Dummies not used 50 42.4 96 81.4 
Total 118 100 118 100% 
Table 18b. Second study 
Use of dummies Patients Controls 
or non-use X? of patients (%) X2 of controls OR p-value 95% Cl 
Dummies used 147 36.3 65 16.0 3.28 43.7 p<0.001 2.24 to 4.90 
Dummies not used 258 63.7 340 84.0 
Total 405 100 405 100 
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4.6 Age distribution of patients with different enteric pathogens 
In the first study, the distribution of age of patients according to the aetiological agent 
was determined (Table 19a). 
Bacteria were more prevalent in stools from 18/37 (48.6%) patients aged under 6 
months and in 12/37 (32.4%) patients aged between 6-12 months. The lowest 
prevalence of bacterial infections was observed in patients aged over 12 months 7/37; 
19%). The most common age range of patients with rotavirus infection was 6 to 12 m 
in 5111 (45.4%) patients and <6m in 3/11 (27.3%). The prevalence of rotavirus 
infection was observed in patients aged > 12 months in 3/11 (27.3%). The most 
common age range of patients with parasite infection was > 12 months in 4/7 (5 7.1 %) 
and in 2/7 (28.6%) patients aged from 6 to 12 m. The lowest prevalence of parasite 
infections was observed in patients aged under 6m (1/7; 14.3%). 
The patients, age group <6 months was most common. A single infection was detected 
in 22/55 (40.0%), of the age group 6 to 12 months in 19/55 (34.6%) and the age group 
> 12 months in 14/55 (23.6%). Libyan children younger than I year were the most 
susceptible to infection with acute diarrhoea (76.4% of patients). 
In the second study, bacterial infection was again more prevalent in patients aged <6 
m (36/79; 45.6%) and in 25/79 (31.6%) patients aged 6-12 m. The lowest prevalence 
of bacterial infections was observed in patients aged > 12 m (18/79; 22.8%). 
Rotavirus was detected in stool specimens in 52/98 (53.1%) patients aged between 
6-12 m and in 28/98 (30.6%) > 12 m. The lowest prevalence of rotavirus infection was 
observed in patients aged <6m (18/98,16.3%). Parasites were detected in 30/62 
(48.4%) of stool specimens of patients aged > 12 m and in 21/62 (33.9%) patients 
aged 6- 2 m. The lowest prevalence of parasitic infections was observed among 
patients aged <6m (11/62,17.7%). Libyan children younger than I year were, again, 
the most likely to be found with acute diarrhoea (68.2%). 
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Table 19. Age distribution of patients with different enteric pathogens* (a) First 
study 
Type of Patients aged <6 m Patients aged 6-12 m Patients aged > 12 m Total 
pathogen N2ofpatients (%) X2of patients (%) X2of patients (%) (%) 
Bacteria 18/37 48.6 12/37 32.4 7/37 19.0 100 
Rotavirus 3/11 27.3 5111 45.4 3/11 27.3 100 
Parasite 1/7 14.3 2/7 28.6 4/7 57.1 100 
Total 22/55 19/55 14/55 
* age distribution of patients for single infection only 
Table 19b. Second study 
Type of Patients aged <6 m Patients aged 6-12 m Patients aged > 12 m Total 
pathogen N2ofpatients (%) X2of patients (%) X2of patients (%) (%) 
Bacteria 36/79 45.6 25/79 31.6 18/79 22.8 100 
Rotavirus 18/98 16.3 52/98 53.1 28/98 30.6 100 
Parasite 11/62 17.7 21/62 33.9 30/62 48.4 100 
Total 65/239 98/239 76/239 
* age distribution of patients for single infection only 
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There were slight variances between the two studies. In the first study, the prevalence 
of bacterial infections was higher than in the second study for infection of patients 
aged <6 months 18/37 (48.6%) while the prevalence of rotavirous infection in the 
second study was higher than the first for infection of patients aged from 6 to 12 m 
Bacteria were more prevalent in stools from 18/37 (48.6%) patients aged under 6 
52/98 (53.1%). The prevalence of parasite infections were higher for infection of 
patients aged > 12 m 4/7 (5 7.1 %) in the first study and 3 0/62 (48.4%) in the second. 
However, statistically is not significant because the number of child for age groups is 
not enough and p values were (P > 0.05). 
4.7 Clinical features associated with each enteric pathogen 
Clinical features associated with the pathogens are shown in (Table 20). 
4.7.1 Fever 
In the first study, fever was a presenting feature in significantly more patients with 
rotavirus infection 9/11 (81.8%) than with Crypytosporidium (reported in 1/3; 33.3%). 
Fever was the most clinical feature of acute diarrhoea associated with rotavirus 
infection of patients. Parasites and bacteria were intermediate and ranged between 
50% and 70.3% manifesting fever. 
In the second study, rotavirus infection was once more highly associated with fever 
and was reported in 76/98 (77.7%) while Cryptosporidium was only reported with 
fever in 5/13 (38.5%). Fever was the most clinical feature of acute diarrhoea 
associated with rotavirus infection of patients. Parasites and bacteria were intennediate 
and ranged between 48.7% and 67.3% of patients with fever. 
4.7.2 Vomiting 
In the first study, vomiting occurred more commonly in patients with rotavirus 
infection 8/11 (72.7%) and less commonly in patients with Klebsiella infection 1/4 
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(25%). Parasites and bacteria were intermediate and ranged between 42.8% and 51.5%. 
Vomiting was the second most clinical feature of acute diarrhoea associated with 
rotavirus infection (p < 0.05). 
In the second study, rotavirus infection was again associated with vomiting 
which was observed in 74/98 (75.5%) while proteus was weakly associated with 
vomiting and observed in 2/6 (33.3%). Other bacteria and parasites were intermediate 
at 63.5% and 41.7%. Vomiting was the second most clinical feature of acute diarrhoea 
associated with rotavirus infection of patients (p < 0.05 
4.7.3 Dehydration 
In the first study, mild dehydration was noted in 38/118 patients and was most 
common in patients with parasite infection; Cryptosporidium and G. lamblia (3/3 and 
2/2; 100%) and less common in patients with rotavirus (2/11; 18.2%). Bacteria and Ent. 
histolytica were intermediate and ranged between 27% and 50%. Mild dehydration 
was the most clinical feature of acute diarrhoea associated with parasite infections (p < 
0.05). 
Moderate dehydration was reported in 61/118 patients and was more common in 
patients with infection by Campylobacter 4/6 (66.7%) and less so in patients with 
Proteus 2/6 (33.3%). Rotavirus, bacteria, and Ent. histolytica were intennediate and 
ranged between 27.3% and 50%. 
Severe dehydration was reported in 19/118 patients and was most prevalent in patients 
with rotavirus infection 6/11 (54.5%) and least common in those with Proteus 
infection 1/6 (16.7%). Severe dehydration was the most common clinical feature of 
acute diarrhoea associated with rotavirus infection of patients. Ther bacteria were 
intermediate and ranged from 19% to 25%. No severe dehydration was reported in 
patients who had parasitic infections or Campylobacter. 
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Table 20. Clinical features associated with different enteric pathogens (a) First 
study 
Type of 
Pathogen* 
N2 of 
Patients 
Fever Vomiting Abdominal 
Cramp 
Type of dehydration 
Mild Moderate Severe 
Escherichia coli 21 16 10 7 4 13 4 
Campylobacter 6 4 3 3 2 4 
Proteus 6 3 4 2 3 2 1 
Klebsiella 4 3 1 2 1 2 1 
Rotavirus 11 9 8 3 2 3 6 
Ent. histolytica 2 1 1 1 1 1 
G. lamblia 2 1 1 1 2 
Cryptosporidium 3 1 1 2 3 
* single infection only 
Table 20b. Second study 
Type of 
Pathogen* 
X2 of 
Patients 
Fever Vomiting Abdominal 
Cramp 
Type of dehydration 
mild Moderate Severe 
Escherichia coli 52 35 33 16 17 26 9 
Campylobacter 16 9 10 9 7 9 
Proteus 6 3 2 3 2 4 
Klebsiella 5 3 2 3 2 3 
Rotavirus 98 76 74 18 19 47 32 
Ent. histolytica 37 18 16 15 23 12 2 
G. lamblia 12 6 5 4 9 3 
Cryptosporidium 13 5 6 8 13 
* single infection only 
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In the second study, mild dehydration was noted in 134/405 patients and once more 
was common in patients with parasite infection; Cryptosporidium was detected in 
13/13 (100%), and G. lamblia 9/12 (75%) and proved less common in patients with 
rotavirus infection in 19/98 (19.4%). Mild dehydration was the most clinical feature of 
acute diarrhoea associated with parasite infections (p < 0.05). Mild dehydration in Ent. 
histolytica infection was 23/37 (62.2%) and bacteria were intermedite and ranged 
between 32.7% and 40%. 
Moderate dehydration was noted in 225/405 (55.5%) patients and was most common 
in patients infected by Proteus (4/6; 66.7%) and was less common with infection by 
G. 1amblia (3/12; 25%). Other bacteria were intermediate and ranged from 50% to 60%, 
whereas Ent. histolytica in 12/37 (32.4%) and rotavirus was in 47/98 (48%). 
Severe dehydration was reported in 46/405 (11.4%) and was most common in patients 
with rotavirus infection (32/98 ; 32.7%) and less common in Ent. histolytica infection 
(2/37; 5.4%). Severe dehydration was the most clinical feature of acute diarrhoea 
associated with rotavirus infection (p < 0.05). Severe dehydration was intermediate 
(9/52; 17.3% of patients with E. coli infection). 
No severe dehydration was reported in patients who had other parasitic or other 
bacterial (Proteus, Klebsiella and Campylobacter) infections. 
4.7.4 Abdominal cramps 
In the first study, abdominal cramps were reported as a more common feature in 
patients with Cryptosporidium infection in 2/3 (66.7%) than rotavirus infection in 
3/11 (27.3%; Table 2 1). Abdominal cramp was the most clinical feature of acute 
diarrhoea with Cryptosporidium infection (p < 05). Rotavirus, parasites, and bacteria 
were intennediate and ranged between 33.3% and 50% of Patients. 
In the second study, abdominal cramps were again reported as a more common feature 
in patients with Cryptosporidium infection in 8/13 (61.5%) and in this study with 
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Campylobacter 9 /16 (56.3%). Abdominal cramps in rotavirus infection were again 
lowest at 18/98 (18.4%). They were the most clinical feature of acute diarrhoea 
associated with Cryptosporidium infection (p < 0.05). Other parasites, and other 
bacteria were intermediate and ranged from 30.8% to 60%. 
4.8 Stool appearance associated with aetiological pathogens in patients 
The results are displayed in (Table 21). 
In the first study, watery stools were common in 8/11 (72.7%) of rotavirus. Watery 
stool occurred in significantly more of the patients with rotavirus infection (X2 = 8.2 8, 
< 0.05 ) than in those with E. coli infection (6/21; 28.6%). Watery stools in other 
bacterial and parasite infections were intermediate and ranged between 50% and 
66.7%. No watery stools occurred in infections with G. lamblia or in Campylobacter 
infections. 
Mucous in the stool was a presenting feature in patients with Cam lobacter infection 
(5/6; 83.3%) and was less common in patients with rotavirus infection 3/11 
(27.3%). Other bacterial and parasite infections were intermediate and ranged between 
33.3% and 66.7%. Mucous in the stool was significantly greater among patients with 
Campylobacter infection. Stool mixed with blood was common in patients with G. 
lamblia infection in 1/2 (50%) and less common in patients with Campylobacter 
infection 1/6 ( 16.7%). E. coli infection, bloody stool was detected in 5/21 (23.8%) 
patients. No bloody diarrhoea was observed in patients with rotavirus, 
Cryptosporidium or other bacterial infections. 
In the second study, watery stools were further common in patients with rotavirus 
infection (74/98; 75.5%). Watery stool occurred in significantly more patients with 
rotavirus infection than patients with Ent. histolytica 7/37 (18.9%). For bacterial 
infections, watery stool was intermediate and ranged between 32.8% and 62.5%. 
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Table 21. Type of stool appearance associated with aetiological pathogens* (a) 
First study 
Type of N2 of patients Stool appearance 
Pathogen Watery Mucous Bloody 
Escherichia coli 21 6 10 5 
Campylobacter 6 51 
Proteus 6 4 2 
Klebsiella 4 2 2 
Rotavirus 11 8 3 
Ent. histolytica 2 1 1 
G. lamblia 2 11 
Cryptosopridium 3 1 2 
* Single infection only 
Table 21b. Second study 
Type of X2of patients Stool appearance 
Pathogen Watery Mucous Bloody 
Escherichia coli 52 9 27 16 
Campyylobacter 16 13 3 
Proteus 6 3 3 
Klebsiella 5 3 2 
Rotavirus 98 74 24 
Ent. histolytica 37 7 28 2 
G. lamblia 12 9 3 
Cryptosporidium 13 3 10 
* Single infection only 
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Cryptosporidium infection, watery stool was noted in 3/13 (23%) of patients. No 
watery stools occurred in infection with G. lamblia or Campylobacter. 
Mucous in the stool was most prevalent in patients with Campylobacter infection 
(13/16; 81.3%) and also in patients with Ent. histolytica infection (28/37; 75.7%). It 
proved less common in patients with rotavirus infection (24/98; 25.5%). Other 
parasites and bacteria were intermediate and ranged from 37.5% to 77%. Mucous with 
the stool was significantly greater in patients with Campylobacter infection. 
Stool mixed with blood was common in patients with E. coli infection in 16/52 
(30.8%) and less common in patients with Ent. histolytica 2/37 (5 %), G. lamblia in 
3/12 (25%) and Campylobacter in 3/16 18.8%). No bloody diarrhoea was determined 
in patients with rotavirus, Cryptosporidium or other bacterial infections. 
4.9 Frequencies of other parameters associated with different etiological agents 
The results are shown in table 22. 
In the first study, the mean frequency of motion per day was highest in patients with 
rotavirus infection (7.3 motions) than those with G. lamblia infection (4.6 motions). 
Other parasites and bacteria were intermediate and ranged between 5.4 and 6.9 
motions. The mean duration of diarrhoea was shortest in the rotavirus infection at 3.2 
days and longest in Cryptosporidium infection at 7.2 days. Other parasites and bacteria 
were intermediate and ranged between 4.6 and 6.8 days. 
The mean stay in hospital was longest in patients with Cryptosporidium infection (7.3 
days) and lowest in those with rotavirus infection (4 days). Other parasites and 
bacteria were intermediate and ranged from 4.5 to 6.4 days. 
In the second study, the mean frequency of motion per day was greatest in patients 
with rotavirus infection (8.9 motions) and contrasted with those with G. lamblia 
infection (4-6 motions). 
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Table 22. Mean frequency of motions, mean duration and mean stay in hospital 
associated with aetiological pathogens (a) First study 
Type of 
Pathogen* 
Escherichia coli 
Campylobacter 
Proteus 
Klebsiella 
Rotavirus 
Ent. histolytica 
G. lamblia 
Cryptosporidium 
X2 of patients mean frequency mean duration mean stay 
motions/day diarrhoea/days in hospital/days 
21 6.9 4.7 5.6 
6 5.2 6.8 6.8 
6 5.4 4.6 4.3 
4 5.6 5.2 4.5 
11 9.3 3.2 4.0 
2 5.0 6.7 6.2 
2 4.6 6.2 6.4 
3 7.3 7.2 7.3 
* Single infection only 
Table 22b. Second study 
Type of X2 of patients mean frequency mean duration mean stay in 
Pathogen* motions/day diarrhoea/days hospital/days 
Escherichia coli 52 6.7 4.3 5.8 
Campylobacter 16 6.5 6.3 6.8 
Proteus 6 5.2 4.6 4.6 
Klebsiella 5 5.4 5.2 4.5 
Rotavirus 98 8.9 3.4 4.3 
Ent. histolytica 37 5.0 6.7 6.6 
G. lamblia 12 5.3 6.5 6.5 
Cryptosporidium 13 4.4 7.4 7.2 
*Single infection only 
145 
Bacteria and other parasites were intermediate and ranged between 5.2 and 6.7 
motions. The mean duration of diarrhoea was shortest in the rotavirus infection (3.4 
days) and longest in the Cryptosporidium (7.4 days). Other parasites and bacteria were 
intermediate and ranged between 4.6 and 6.7 days. 
The mean stay in hospital was longest in patients with Cryptosporidium infection (7.3 
days) and lowest in patients with rotavirus infection at (4.3 days). Other parasites and 
bacteria were intermediate and ranged between 4.5 and 6.8 days. 
4.10 Univariate and multivariate analysis 
4.10.1 First study 
Multivariate analysis is a natural extension of the univariate analysis. It enables us to 
see the effect of each prognostic factor but allowing for other confounding factors. 
Adjusted odds ratio will be obtained rather than crude odds ratio from univariate 
analysis. As mentioned in section (1.1), the design is a 1: 1 matched case-control, 
therefore the appropriate method for multivariate analysis is the conditional logistic 
regression (or fixed-effects logit). The dependent variable is the variable describing 
whether a child is a "control" or a "patient". The dependent variable is binary that is 
The reason why we use logistic regration. 
For the multivariate analysis, we used the feeding type, dummies, family size, and 
haernoglobin concentration, the other variables were making the model diverge and 
unstable. The results of the multivariate analysis is shown in the table 23. We can 
observe that only dummy use and bottle feeding are showing statistical significance 
and the effect of using dummy is 18-fold that of not using dummies, while bottle 
feeding increases the risk by 89. The effect of dummies and bottles on diarrhoea can 
be explained as these two items are exposed to all sorts of gerrns and often are picked 
up by children from a dirty floor without the parent noticing. 
146 
Table 23. The results of multivariate analysis (feeding type, dummies, family size 
and haemoglobin concentration) for first study 
Predictors Odds ratio p-value 95% confidence 
interval for OR 
Feeding type 
Breast feeding (baseline) I I to I 
Bottle feeding 89.04 0.000 11.373 to 697.056 (too wide) 
Mixed feeding 2.54 0.424 0.257 to 25.142 
Solid feeding Unstable 
Dummies 
No dummy use (baseline) I I to I 
Dummy use 18.26 0.000 4.151 to 80.332 
Family size 
I child (baseline) I I to I 
2-4 0.73 0.692 0.151 to 3.505 
5-9 4.22 0.098 0.768 to 23.213 
10-11 5.35 0.200 0.412 to 69.636 
Haemoglobin concentration 
<9 (Baseline) I I to 1 
9.1-10.9 7.663 0.145 0.495 to 118.392 
11.0-11.9 3.007 0.424 0.202 to 44.690 
ý: 12 8.269 0.151 0.463 to 147.611 
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4.10.2 Second study 
The same procedure as the first study will be used for the second study, namely the 
conditional logistic regression. Feeding type has been removed because of non stability of the 
solution. Storage water, dummy usage and family size are showing the most significant effect 
for the presence of the diarrhoea. The results of the multivariate analysis is shown in the 
table 24. 
4.10.3 The correlation between fevef and vomiting with each other clinical 
feaures 
In this section we are investigating association of presence of fever with other factors 
such as presence of pathogens, stool duration, feeding type, vomiting, age and use of 
dummies in both study for univariate and multivariate, analysis. See appendix 4. 
4.10.3.1 Univariate analysis from first study 
For this we created a binary variable "Fever" which has a value 0 if there is a body 
temperature below 38'C, and a value I if presence of temperature of 38'C and above. 
We must bear in mind that this procedure enables us to test the factor affecting fever 
and not the cause of the fever. The following table shows a crosstabulation of fever 
with stool duration. In order to test for association we used a chi square test which 
shows a little evidence of association as the p-value slightly higher than the cut-off 
value of 0.05 ( v' = 7.3, p-value=0.064), a larger sample show give significance. 
We also tested the association of fever with the presence of pathogens as shown in the 
following table. A chi square test shows clearly no evidence of association ( X' = 0.5 1, 
p-value=0.773). Association between Fever and feeding type has also shown no 
evidence ( X' = 1.02, p-value=0.797). We also tested vomiting and fever association, 
which also was not statistically significant ( X' = 1.15, p-value=0.283). 
The association of fever with age is also not significant ( X' = 0.093, p-value=0.954). 
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Table 24. The results of multivariate analysis (water type, dummies, family size 
and haemoglobin concentration) for first study 
Predictors Odds ratio p-value 95% confidence interval for OR 
Water Ove 
Tap water (baseline) I I to I 
Bottle water 1.755 0.078 0.938 to 3.284 
Well water 0.924 0.873 0.348 to 2.449 
Storage water 7.055 0.001 2.199 to 22.643 
Dummies 
No dummy use (baseline) I I to I 
Dummy use 2.893 0.000 1.689 to 4.855 
Family size 
I child (baseline) I I to 1 
2-4 2.786 0.046 1.019 to 7.620 
5-9 3.566 0.018 1.242 to 10.23 
10-11 9.633 0.003 2.208 to 42.010 
Haemoglobin concentration 
<9 (Baseline) I I to 1 
9.1-10.9 1.411 0.475 0.549 to 630 
11.0-11.9 0.889 0.803 0.354 to 2.233 
> 12 11.921 0.000 3.419 to 41.553 
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We also tested dummy use and fever shows no association ( X' = 0.0, p-value= 1 . 00). 
Finly we tested the number of motion per also shows no evidence of association with 
fever (X' = 1.86, p-value=0.394). 
We are looking at association between vomiting and factors such as stool duration, 
number of motion, presence of pathogens, type of feeding and age using the chi square 
test as previously. No evidence of association between vomiting and stool duration 
(; r' =3.28, p-value=0.350). 
For the number of motions no evidence no was found for this sample (Z' =0.564, p- 
value=0.754). 
For the presence of pathogens no association was found with vomiting in the sample 
(X' = 2.34, p-value=0.31 1). 
4.10.3.2 Univariate analysis from second study 
As previously for study 1, we will carry out univariate analyis by means of the chi 
square test. The test is showing a strong association between fever and stool duration, 
where longer periods favour the presence of fever (X' =23.3, p-value<0.001). See 
appendix 4. 
For the effect of number of motion per day the test is showing no significant effect 
(X' =2.27, p-value=0.322). The presence of pathogen does not seem to significantly 
affect fever (; r' =2.94, p-value=0.230). Feeding type is significantly associated with 
fever as shown by the chi square test ( Z' = 9.56, p-value=0.023). There is no evidence 
to show that vomiting is associated with fever ( X' = 1.84, p-value=O. 175). 
Older children seems associated with fever ( X2 = 8.3 8, p-value=O. 0 15). 
The use of dummies has no effect on the presence of fever as shown by the chi square 
test (X2=1.88, p-value=O. 170). 
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There is a significant association between stool duration and vomiting for this sample; 
(; r' = 20.45, p-value=0.00 1). The number of motion per day is marginally significant 
(; r' = 5.5 1, p-value=O. 064). 
The presence of pathogen is significantly associated with vomiting in this sample 
especially rotavirus infection; (X' = 18.19, p-value=0.001). There is no evidence that 
feeding type is associated with vomiting; (, X' =2.16, p-value=0.539). 
4.10.3.3 Multivariate analysis from first study 
In this section we will carry out a multiple logistic regression to show the adjusted 
effect on fever of all the factors we used in the univariate analysis. The effect will be 
displayed as odds ratios and their 95% confidence intervals. See appendix 4. 
After adjustment it appears that the effect of stool duration on fever shows some 
significance especially for longer period above 3 days, but even a period of 2 to 3 days 
has p-value relatively small (p-value =0.112). This effect has been observed in the 
univariate analysis where the p-value was relatively close to significance (p=0.064). 
Age is showing an increasing risk but not significantly. Vomiting and feeding type are 
also showing increasing risk of fever but not significantly. Motion on the other hand 
is showing a decreasing risk although not significant, that is the more motion the less 
likely a presence of fever. All these results need to be checked in the analysis using 
data from study 2. The sample size could play a role in reinforcing the power of the 
significance test. See table 25 and 26. 
4.10.3.4 Multivariate analysis from second study 
In this section we will carry out a multiple logistic regression to show the adjusted 
effect on fever of all the factors we used in the univariate analysis as before in study 1. 
The effect will be displayed as odds ratios and their 95% confidence intervals. Age, 
stool duration, vomiting, number of motion and feeding type will be used as the 
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Table 25 Logistic regression summary of first study (fever) 
Odds 
ratio p-value 
95.0% C. I. for OR 
Lower Upper 
Age 1.104 0.068 0.993 1.228 
1 day (baseline) I I I 
Stool 
duration 2-3 7.195 0.116 0.614 84.343 
4-6 12.693 0.041 1.115 144.503 
>=7 days 14.757 0.035 1.206 180.496 
Vomit No (baseline) I I I 
Vomiting vomit Yes 1.502 0.325 0.669 3.373 
4-6 (baseline) 1.00 1.00 1.00 
Motion/ 
day 7-9 0.623 0.475 0.170 2.284 
>=10 0.850 0.814 0.219 3.297 
Breast (baseline) I I I 
Type of 
feeding Bottle 6.579 0.282 0.213 203.463 
Mixed 5.269 0.230 0.349 79.582 
Solid 3.232 0.306 0.341 30.604 
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Table 26 Logistic regression summary second study (fever). 
Odds 
p-value 
95.0% C. I. for OR 
ratio 
Lower Upper 
Age 1.137 0.000 1.076 1.201 
1 day (baseline) I I I 
Stool 
duration 2-3 2.485 0.105 0.827 7.466 
4-6 7.039 0.000 2.373 20.881 
>=7 days 8.877 0.000 2.790 28.251 
I I 
Vomit No (baseline) 
Vomiting vomit Yes 1.657 0.038 1.028 2.672 
4-6 (baseline) I I I 
Motion/ 
day 7-9 1.083 0.849 0.477 2.458 
>=10 0.873 0.746 0.385 1.980 
Breast (baseline) I I I 
Type of 
feeding Bottle 11.129 0.013 1.677 73.864 
Mixed 10.095 0.002 2.399 42.486 
Solid 6.409 0.002 1.939 21.181 
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confounder factors to predict the presence of fever. See appendix 4. 
The logistic regression is showing that when the factors are used together in a 
regression model some effects become more significant. All the factors are showing 
significant effect except the number of motion per day. The confidence interval are 
now less wide than those of the study 1, and this can be explained by the larger 
number of cases included. Stool duration has an increasing effect, the longer the 
duration the more likely a presence of fever. Older children seem more exposed to 
fever than younger ones. See tables 27 and 28. 
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Table 27. The logistic regression summary of first study (vomiting). 
Odds 
p-value 
95.0% C. I. for OR 
ratio 
Lower Upper 
Age 0.942 0.160 0.868 1.024 
1 day (baseline) I I I 
Stool 
duration 2-3 1.905 0.501 0.292 12.446 
4-6 1.786 0.541 0.278 11.463 
>=7 days 3.499 0.208 0.497 24.606 
No (baseline) I I I 
Fever 
Yes 1.438 0.368 0.652 3.173 
4-6 (baseline) I I I 
Motion/ 
day 7-9 0.527 0.308 0.153 1.808 
>=10 0.549 0.362 0.151 1.992 
Breast (baseline) I I I 
Type of 
feeding Bottle 0.048 0.075 0.002 1.357 
Mixed 0.088 0.072 0.006 1.247 
Solid 0.158 0.115 0.016 1.567 
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Table 28. the logistic regression summary of second study (vomiting) 
Odds ratio 95.0% C. I. for OR p-value 
Lower Upper 
Age . 838 . 000 . 764 . 921 
1 day I I I (baseline) 
Stool 2-3 5.204 . 038 1.091 24.819 
duration 4-6 . 910 . 906 . 191 4.341 
>=7 days 1.744 . 512 . 330 9.207 
No 
(baseline) Fever . 854 . 703 . 379 1.921 
Yes 
4-6 
Motion (baseline) 
1 1 1 
7-9 . 290 . 068 . 077 1.096 
>=10 . 261 . 036 . 075 . 915 
Bacteria 
(baseline) I I I 
Pathogens 
Rotavirus 2.679 . 390 . 284 25.313 
Parasite 10.913 . 055 . 948 125.610 
Breast I I I (baseline) 
Feeding type Bottle . 002 . 000 . 000 . 042 
Mixed . 004 . 000 . 000 . 054 
Solid . 009 . 000 . 001 . 086 
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4.11 Summary 
In the second study, rotavirus peaked during the winter (cold season) while bacteria 
and parasites peaked during the summer and autumn seasons. Breast feeding of Libyan 
children was found to be very low in patients (4.2%) and 15.3% of controls. In the 
second study 11.4% of patients were breast fed compared to 24% of controls. 
Dummies used is the risk factor for occurs of diarrhoea in Libyan children (OR: 2.5 
95% Cl: 1.42-4.59, p<0.0007) in the first study and (OD: 3.28,95% Cl: 2.24-4-90, 
p<0.001 in the second. Other risk factor is bottle feeding (OR: 6.256,95%, Cl: 3.509- 
11.152, p<0.00 1) in the first study and (OR: 4.146,95%, Cl: 3.066-5.605, p<0.00 1) in 
the second. No differences between patients and controls for water supply were 
established in the first study but in the second study there was a variation in use of 
storage water (P<0.05). Animal contact was not significant different between patients 
and controls in either study (p>0.05). The age distribution of patients with variation 
enteric pathogens differed in both studies. In the first study, the prevalence of bacterial 
infections was higher than in the second for infection of patients aged <6 moths 18/37 
(48.6%). The prevalence of parasite infections was higher for infection of patients 
aged > 12 m 4/7 (5 7.1 %) in the first study and 3 0/62 (48.4%) in the second. 
Rotavirus infection in the second study was greater than in the first study for infectin 
of patients aged 6 to 12 m 52/98 (53.1 
The presence of pathogens is significantly associated with vomiting especially 
rotavirus (X' = 18.19, p-value=0.001). 
There is a significant association between stool duration and vomiting (; r' =20.45, p- 
value=0.001). 
Feeding type is significantly asssociated with fever as shown by the McNemer, chi 
sequare test ( ; r2 = 9.5 6, p-value=0.0 15) in the second study. 
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CHAPTER 5 
DISCUSSION AND CONCLUSIONS 
5.1 The background to these studies 
Two studies were performed to detect aetiologY of acute diarrhoea in hospitalized 
children aged under five years in Tripoli, Libya. In the first study, two hundred and 
thirty-six stool samples were obtained. Of these, 118 were from patients admitted for 
acute diarrhoeal disease, and 118 age and sex-matched concurrent controls were 
admitted for other reasons. In the second study, eight hundred and ten stool specimens 
were collected 405 from patients and the same number from controls. All were 
admitted to the AIjala Children's Hospital, Tripoli, Libya. The first study was 
conducted between August I't 1997 and 3 I't October 1997 and the second study was 
conducted between January I't 2003 and 3 I't December 2003. One or more enteric 
pathogens were isolated from 55.9% of patients and 13.6% of controls in the first 
study and 68.1 % of patients and 12.6% of controls in the second study. 
5.2 The aims of these studies include: 
1. Establishing a relationship between clinical symptoms and the aetiology of 
acute diarrhoea. 
2. Finding the factors contributing to the cause of acute diarrhoea besides the age 
group (s) that are prone to infection. 
3. Finding the relationshiP between the cause of acute diarrhoea and time of 
year it occurs (seasonal variation). 
4. Using new methods to diagnose the aetiology of acute diarrhoea not used in 
Libya e. g. selective media, API and PCR. 
5. Increasing the detection rate of the aetiology of acute diarrhoea. 
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5.3 The results obtained in these studies show that: 
Aetiological agents were detected in 55.9% of diarrhoeal patients in the first study and 
68.1% in the second. Bacteria were the most common agents detected in 43.3% 
patients in the first study, whereas rotavirus was the most common agent identified in 
30.4% patients in the second study. Parasites were detected in 8.4% of patients in the 
first study and 19.3% in the second. These findings suggest that rotavirus GE remains 
a common disease in hospitalized Libyan children and causes a substantial burden of 
disease. 
In the second study, API 20E and API Campy were adopted to identify bacteria 
isolated by cultures and the number of confirmed cases decreased from 142 to 112. 
Rotavirus peaked during the winter season (cold months) while bacteria and parasites 
peaked during the summer and the beginning of autumn (hot months). 
PCR technique was adopted for the first time in identification of Campylobacter in 
Libya, where all Campylobacter spp. were identified (Campylobacter jejuni and 
Campylobacter coli) as the same as detected by API Campy technique. The total 
number was 24 cases. 
Libyan children under six months of age were the most susceptible to acute diarrhoea 
requiring admission to hospital. This was noted in 46.6% children among the first 
study and 43.2% among the second. The highest prevalence of acute diarrhoea was in 
children aged one year. 
Exclusive breast feeding of Libyan children was of a very low percentage, merely 
4.2% of patients and 15.3% of controls in the first study and 11.4% of patients and 
17.7% of controls in the second. Children using dummies were about 2.5 times more 
at risk of diarrhoea than the non users in the first study (OR: 2.5,95% Cl: 1.42-4.591, 
p<0.001) and (OR: 3.28,95% CI: 2.24-4-90, p<0.001) in the second, this fell to 
children being 3 times much at risk of contracting diarrhea. Other risk factor is bottle 
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feeding, in the first study, the odds of having the diarrhea for bottle feeding is 5 times 
higher than those who are breast fed. 
Watery stool was the most common stool consistency of diarrhoeal patients in both 
studies consisting of 58.5% in the first study and 56.6% of the second. 
Fever was the most clinical feature associated with acute diarrhoea for both studies. In 
the first study, the percentage of patients who had fever was 72.9% and in the second 
study this amounted to 71.6%. 
Moderate dehydration was the most common degree of dehydration. The percentage of 
patients who had this at admission was 51.7% of patients in the first study and 55.5% 
in the second. Isotonic dehydration was the most common type of dehydration in both 
studies. The percentage of patients totaled 76.3% of the first study and 75.8% of the 
second. 
In Libya, oral rehydration therapy is still not extensively used. From the history and 
medical records of patients, it was remarked that ORT was used for rehydration of 
patients in a very low percentage of cases. This equaled 8.5% in the first study and 
13.8% of the second study. 
5.4 Aetiological agents 
In the first study, microbiological agents were obtained from the stool specimens of 
118 patients. Of those 55 (5 5.9%) were identified as either single or mixed infections. 
The detection of microbiological agents from the control group was 16/ 
118 (13.6%) as a single infection. 
In the second study, aetiological agents were detected in 68% of patients as either 
single or mixed infections and in 12.6% of controls as a single infection. The 
aetiological agents were detected in patients which were significantly different of 
the controls (P <0.05) in both studies. The highest rate of detection in 
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the second study may be due to the dissimilar protocols and duration of both studies, 
the protocol in the second study included more investigations. The first study was 
carried out at the end of summer and the beginning of autumn while the second was 
conducted throughout the year. The sample size of the second study was also much 
larger than that of the first study. Other studies have displayed similar results in 
developing countries. In northern Jordan, the aetiological agents of acute diarrhoea 
were identified in 66.4% of children <5 years of age. A single enteric pathogen was 
detected in 50.9% of patients and multiple pathogens were detected in 15.5%. 
(Youssef et al. 2000). In Uruguay, the detection of diarrhoeal pathogens were 
discovered in 63.8% of patients and 34.4% of controls (Torres et al. 2001). In Brazil, 
intestinal pathogens were detected in stool specimens among 72.8% of patients and 
21.5% of controls from children aged <5 years with and without diarrhoea (Souza et 
al. 2002). In Tanzania, the aetiology of acute diarrhoea was 67.6% in stool patients 
under 5 years old and 35.7% of controls (Vargas et al. 2004). In Vietnam, the 
aetiological identification of pathogens in faccal samples of children below five years 
of age with diarrhoea was 67.3% of patients (Vu Nguyen et al. 2006). In developed 
countries, the results from the studies vary. For example: in Denmark, potential 
pathogens were found in 54% of patients and 22% of controls (Olesen et al. 2005). In 
Switzerland, isolation of enteric pathogens from specimens of children with and 
without diarrhoea were found in 50.3% of patients and 18% of controls 
(Pabst et al. 2003). 
5.4.1 Bacteria 
Bacteria were the most common micro-organisms detected in the first study and 
rotavirus in the second. The high prevalence of bacterial isolation in the first study 
compared to the second, may be due to the former being performed 
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over a short period and excluding the winter season where rotavirus had peak 
incidence. Another explanation could be that API was not adopted for confirmation 
tests in the first study, as the number of bacteria was isolated by cultures and identified 
by Gram stain and morphological characteristics whilst some bacteria were excluded 
as they were not identified by API test in the second study. Escherichia coli was the 
most common agent isolated in 22.9% of patients and 4.2% of controls in the first 
study and 16.5% of patients and 2.7% of controls in the second study. The over- 
detection of E. coli in the first study may include non- pathogenic E. coli living in 
normal flora because it is not confirmed by serotyping or API 20E tests or other 
confirmation tests due to a lack of adequate diagnostic laboratory tools in Tripoli 
Central Laboratory at the time of the first study being performed. 
The results are similar to other studies conducted in developing countries. In Northern 
Jordan, E. coli was the most common bacterial infection leading to acute diarrhoea in 
children (28.7%; Youssef et al. 2000). In Brazil E. coli was also the most common 
bacterial isolated from stool specimens of children with acute diarrhoea (18.2%; 
Orlandi et al. 2006). In developed countries, the prevalence of bacteria was lower than 
in developing nations. In Denmark, among all sampling tested, a bacterial pathogen 
was found in 17% of cases and 4% of controls. E. coli was 6.7% (Olesen et al. 2005). 
In Libya, the prevalence of bacterial infection was similar to prevalence in developing 
nations and higher than that of developed countries. 
Campylobacter was detected from the stools of Libyan children with acute 
diarrhoea. This was 9/118 (7.6%) patients, 1/118 (0.8%) of controls of the first study 
and 24/405 (6.0%) and 4/405 (1.0%) of the second. There was great disparity between 
the two studies despite using API Campy in the second. The 
incidence of Campylobacter in Libyan children in these studies is similar to a previous 
study carried out between September 1992 and August 1993 in which Campylobacter 
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prevalence was similar to the results obtained here for patients but different in 
controls (6% of patients, 3% of controls; Ghenghesh et al. 1997). Campylobacter 
isolation rates in developing countries range from 5 to 20% (Oberhelman and Taylor 
2000). In Uruguay, the prevalence was 7.4% of patients (Torres et al. 2001). 
In Egypt, Campylobacters isolation rate was 9.0% from stool specimens taken from < 
5-years-olds with acute diarrhoea (Rao et al. 2001). In Jordan, Campylobacter was 
detected in 8.4% of children with diarrhoea and 0% of controls (Nimri et al. 2004). In 
England, the prevalence of Campylobacter spp. was 12.2% (Tompkins et al. 1999). In 
Switzerland, the prevalence was 3.3% of children with diarrhoea and 0% of children 
without it (Pabst et al. 2003). In Denmark, prevalence was 3.8% of patients and 0.5% 
of controls (Olesen et al. 2005). The studies conducted in developing countries 
demonstrated frequent human-animal contact. The presence of animals and poor 
hygiene conditions within a house are risk factors (Rao et al. 2001). In Libya, animal 
contact was very little and raw chicken was unlikely to play a role in infection by 
Campylobacter because traditional Libyan food requires meat to be well-cooked. The 
possible factors for infection may be via contaminated water or by consumption of un- 
pasteurized milk. 
Proteus was discovered in stool specimens of patients in 7.6% and 1.7% of controls of 
the first study and 2.2% of patients and 0.7 of controls of the second study. The 
prevalence of the first study was very high when compared with the second. The 
explanation for this is that detection of Proteus in the first study depended upon 
morphological features of colonies on solid media where the colonies were non- 
lactose fen-nents, had a fish-like smell and were very motile, and by Gram stain 
showed gram-negative rods and were not confirmed by other tests while the second 
study API 20E confirmed the detection. 
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Klebsiella was detected in stool specimens in 4.2% of patients and 0.8% of controls in 
the first study and 3% of patients and 0.7% of controls in the second. Again Klebsiella 
was identified by morphological features on solid media where the colonies were large, 
raised, moist and viscid. On the MacConkey medium, colonies were pink in colour, 
produced gas from fermented lactose and were non-motile. By Gram stain, gram- 
negative bacilli. Klebsiella was not confirmed by other confirmation tests in the first 
study and had higher prevalence than the second study. The API 20E was confirmed 
and two types were detected. Klebsiella pneumoniae and Klebsiella oxytoca. These 
latter both commensals of the human gastro- intestinal tract, have been reported to be 
an occasional cause of diarrhoea in humans (Arora et al. 1983). Klebsiella pneumoniae 
may induce diarrhoea through the production of an STa enterotoxin similar but not 
identical to E. coli STa (Guarino et al. 1989). However, the role of these toxins in the 
pathogenesis of klebsiella-associated diarrhoea has not been clarified (Guerin et al. 
1998). Study used the heamoagglutination method where types of fimbriae were 
identified. Above 90% in investigated klebsiella strains revealed the presence of 
fimbriae (Maczynska et al. 2003). Over 70% strains demonstrated a high level of 
adherence to cell lines. These results suggest that among Klebsiella strains in the 
gastrointestinal tract are multi- resistant strains with a high ability to adhere. These 
may represent a potential source of nosocomial infection (Maczynska et al. 2003). In 
Italy a total of 85 strains Gram-negative bacilli were screened for virulence factors, 
Proteus and Klebsiella were identified in 48/85 ((56.5%). These organisms were 
isolated in pure or dominant culture and in the absence of other intestinal pathogens 
from children with acute diarrhoea. On the other hand the production of cytotoxic 
factor was identified for 14 strains examined; in particular the frequency of cytotoxic 
strains among Proteus (Caprioli et al. 1985). Proteus and Klebsiella are free-living 
saprophytes and are not usually thought of as causing diarrhoea. They can be isolated 
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from soil, water, sewage and may be found in the intestine in many healthy individuals. 
The possible pathogenic role of these bacteria in causing diarrhoea should be 
investigated. When comparing between results of bacterial isolated by ordinary 
cultures and API 20E in the second study, there was 76.5% of bacterial isolated by 
cultures confirmed by API 20E. This difference may be due to the identification of 
bacterial isolation by morphology of colonies and Gram stain being insufficient to 
confirm that bacterial isolated is not precisely the type of bacteria, but there is a need 
to confirm this by conducting other tests e. g. serotyping or phenotyping. These were 
not available due to a lack of proper diagnostic tools in Tripoli central laboratory. The 
comparison between Campylobacter spp. were isolated by selective medium and 
identified by API Campy in the second study, 88.9% of Campylobacter spp. were 
isolated by selective medium. The difference between the other bacteria isolated by 
ordinary medium and Campylobacter spp. isolated by selective medium (CCDA) was 
very distinct because the selective medium is specific and growth of other bacteria not 
usually occur. The variation between API 20E (detected at 76.5%) of other bacteria 
isolated by ordinary medium and API Campy (detected at 88.9%) of Campylobacter 
spp isolated by selective medium may be due to difficulty in obtaining pure subculture 
on ordinary medium especially for cases of multiple infection where many bacteria 
were unconfirmed by API technique in the first study. 
The reason for the Salmonella spp. not being discovered in our studies was because of 
a dearth of diagnostic tools in Tripoli central laboratory e. g. selenite broth to enrich 
growth before culture on Salmonella-Shigella medium and also lack of serotyping or 
phenotyping. In a study carried out in Libya in (Ali et al. 2005) Salmonella spp. was 
detected. The protocol for that study differs from our studies, especially the age of 
the children involved. In that study children were aged from a few days to 12 years. 
The children participating were older than in our studies where the children attended 
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primary school and might contract food poisoning from eating contaminated food 
there. The children who participated in our studies were of preschool age. In a recent 
study carried out in Hanoi, Vietnam, no Salmonella spp. was isolated, even when 
conventional methods were used in combination with ELISA, immunoseparation and 
PCR (Vu Nguyen et al 2006). 
Despite the identification of several risk factors associated with Campylobacter 
infection by numerous case-control studies, the sources of the majority of human cases 
of Campylobacteriosis remain unknown (Cowden 1992). Rapid, sensitive and specific 
methods for detecting enteropathogenic Campylobacters are essential to detect and 
confirm Campylobacter spp. It is appropriate to utilise other methods to detect cultures. 
PCR provides a molecular approach for detecting micro-organisms by specific 
amplification of nucleic acids. Assays using this technology have been developed 
for a range of pathogenic and environmental micro-organisms, including 
Campylobacter (Giesendorf et al. 1992, Wang et al. 1992 and Hazeleger et al. 1994). 
The majority of Campylobacter PCR assays utilize primers designed from sequence 
data for the 16S RNA or flagellin genes of Campylobacter jejuni (Giesendrof et al. 
1992 and Oyofo et al. 1992). Despite the wide distribution of homologous genes 
throughout prokaryotes, such assays appear specific for Campylobacter jejuni or its 
closest relatives. This specificity appears to be due to the large phylogenetic distance 
between campylobacter and other bacterial taxa, with functionally identical genes 
having quite dissimilar DNA sequence identities (Oyofo et al. 1992). Primers used in 
this assay have been designed from previously uncharacterized Campylobacterjejuni 
two-component regulator gene (Jackson 1995). 
Several Campylobacter PCR methods cannot differentiate Campylobacterjejuni from 
Campylobacter coli (Giesendrof et al. 1992 and Oyofo et al. 1992), and specification 
of amplified strains by restriction enzyme analysis is a novel feature of the assay 
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adopted for this study. The characteristic digestion patterns appear highly stable and 
reproducible for the two most common pathogens, Campylobacter jejuni and 
Campylobacter coli (Jackson et al. 1996). 
Restriction analysis was not employed in this study. Digestion of this amplimer with 
restriction enzymes produced simple restriction fragment length polymorphism (RFLP) 
within the amplification products which are characteristic of the species of 
Campylobacter jejuni and Campylobacter coli. Simple restriction fragment length 
polymorphism of the digested PCR products can be used to differentiate the amplified 
species, without the requirement for species-specific DNA probing (Jackson et al. 
1996). When commencing work, the amount of hyperLadder V marker) 25 [d was 
taken and the marker spaced bands were joined together, especially the lower bands 
due to the large amount used (25 ýtl). After adjustment of the amount of HyperLadder 
V to 5 [fl, the banding on the gel was move district and identification of the 
appropriately sized restriction fragment was possible at between 250 and 300 bp 
(theoretically 256 bp). The large bends in figure 6 was due to overloading with DNA. 
HyperLadder V produces 12 regularly spaced bands, ranging from 25 to 500 bp. 
The use of selective media for isolation of Campylobacter followed by phenotypic 
tests is the standard method of Campylobacter detection in diagnostic laboratories. 
The results of some studies using PCR for detection of Campylobacter spp. in clinical 
specimens illustrated that PCR detected twice as many positives as culture and, further 
more, the results from this study indicated that PCR was a sensitive and specific 
method for detection of Campylobacter in human faecal specimens (Vanniasinkarn et 
al. 1999). Other studies have demonstrated that filtration techniques may be more 
sensitive than culture techniques (Kaijser and Megraud. 1992). 
The PCR technique is still unfamiliar to Libyan laboratories where they have only 
recently started to use a diagnostic procedure in Tripoli central laboratory for 
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confirmation of HIV diagnosis. Thus this is the first time where Campylobacter have 
been isolated from stool specimens collected from Libyan children by culture and 
identity confirmed by PCR. 
This study demonstrated that Campylobacter isolated by selective culture when 
identified using API Campy, the number reduced from 27 to 24, and all of 
Campylobacter (24) which were identified by API Campy. and confirmed by PCR. 
The incidence of Campylobacter in diarrhoeal disease may not be accurate because 
culture is considered to be insensitive for detection of sub-lethally damaged, un- 
culturable but viable cells, and low numbers of organisms which may be present in 
some stool specimens (Jones et al. 199 1). 
For determination of the true incidence of Campylobacter in diarrhoeal disease in 
Libya, more studies are required using culture on selective media, phenotypic tests, 
filtration technique, API Campy and PCR. 
5.4.2 Rotavirus 
Rotavirus is the second major cause of acute diarrhoea in children after bacteria in 
developing nations, whereas in developed countries rotavirus is the major 
cause and bacteria are the second most frequent cause. The incidence of 
rotavirus in Libyan children was higher in the second study at approximately 30%, 
whilst in the first study this was 15.3%. The difference of prevalence of rotavirus 
between two studies was obvious, because the first study was conducted for 3 months 
at the end of summer and beginning of autumn when rotavirus infection was very low 
while the second study was conducted during the course of a full year and rotavirus 
infection was very high during the winter season. Another recent study in Zliten, a 
small urban city in Libya showed that the prevalence of rotavirus represented 26.6% of 
patients with diarrhoea among children aged from a few days up to 12 years (Ali et al. 
2005). The difference was probably because the age of the children involved in that 
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study being older than those of our studies (from I month to 12 years). Similar results 
were obtained from studies which were conducted in developing countries. In Jordan, 
rotavirus was the most common enteropathogen (32.5% of patients; Youssef et al. 
2000). In England, the prevalence of rotavirus infection was 39% (Crowley et al. 
1997). In Argentina rotavirus infection of hospitalised children was 35.3% of patients 
(Giordano et al. 2001). On the Colombian Northern Coast, rotavirus was discovered in 
36.6% of diarrhoeal children (Urbina et al. 2003). In Tunisia, rotavirus was found in 
20% of children (Fodha et al. 2006). Among Egyptian children, clinic-based 
surveillance of two physicians, clinics rotavirus was detected among 36% in the first 
clinic and 46% in the second (Wierzba et al. 2006). By contrast, in Denmark, the 
prevalence of rotavirus was 14% (Olesen et al. 2005). In the United States, rotavirus 
was the most common pathogen recorded for 18% and 19% of diarrhoea-associated 
hospitalisation in 1997 and 2000 (Malek et al. 2006). In Switzerland, the prevalence of 
rotavirus was 18.7% of diarrhoeal children (Pabst et al. 2003). The incidence of 
rotavirus disease was observed to be similar in both developed and developing 
countries, suggesting that adequate control may not be achieved by improvements in 
water supply, hygiene and sanitation (Parashar et al. 2003a). Rotavirus in the second 
study was the most common aetiological agent detected in hospitalized Libyan 
children (30.4%). The strategy for DDC should be to introduce a rotavirus vaccine into 
the immunisation programme to prevent severe or fatal rotavirus infection, by 
lowering the rate of infection, decreasing morbidity and mortality caused by diarrhoea 
and also decreasing of hospitalisation of children due to diarrhoea. 
5.4.3 Parasites 
The prevalence of Parasite infection is higher in the second study (19.5%) and 
(8.4%) in the first study. The occurrence of Entamoeba histolytica was very much 
higher in the second. Ent. histolytica was the most common parasite cause of acute 
170 
diarrhoea in Libyan children and represented 64.6% of parasite infections. In Egypt, 
among patients with intestinal protozoa, 16.2% had Ent. histolyticaldispar by stool 
examination of stained smears (El-kadi et al. 2006). Other studies have revealed 
similar results in developing countries. In the Colombian Northern Coast, Ent. 
histolytica infection was detected in 10% (Urbina et al. 2003). In Jordan, Ent. 
histolytica was detected in 10.5% (Youssef et al. 2000). In Bangladesh, the isolation 
rate of Ent. histolytica was 10% (Haque et al. 2003a). 
The classic stool ova and parasite examination by light microscopy is insensitive and 
cannot differentiate Ent. histolytica from the non-pathogenic Ent. dispar. 
In the present study, Ent. histolytica was detected by light microscopy and other tests 
eg. ELIZA or PCR were not used. In Egypt, a recent survey using antigen detection 
tests displayed a higher isolation rate of Ent. histolytica (Abd-Alla et al. 2002). The 
detection rates of Ent. histolytica and other parasites by advanced techniques is 
required to determine accurate prevalence, especially differentiation of pathogenic 
from non-pathogenic species and treatment should only be prescribed for patients who 
have pathogenic parasite infections. 
Giardia lamblia showed a similar increase in the second study being 3.7% higher than 
the first study (1.7%). G. lamblia was detected in another recent study in Libya among 
1.2% of children (Ali et al. 2005). Similar results were obtained in other countries. In 
Uruguay, the prevalence rate was 3.6% (Torres et al. 2001). In contrast, other studies 
illustrated higher prevalence rates. In Tanzania this was 14.5% (Vargas et al. 2004), 
and 11% in India (Haque et al. 2003b), and then in Colombia 12.4% (Manrique-Abril 
et al. 2006). G. lamblia is the second parasitic infection after Ent. histolytica among 
Libyan children. 
Cryptosporidium was identified in 2.5% of patients and 0.8% of controls in the first 
study and 3.2% of patients and 0.7% of controls in the second. The incidence of 
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Cryptosporidium in these studies was for lower than that of a previous study in Libya 
which reported a high incidence at 29.5% in patients and 23.1% of controls 
(Ghenghesh et al. 1997). The variation between our studies and the latter may be due 
to the different techniques used to detect Cryptosporidium. The study yielding such a 
high incidence rate adopted the modified Ziel-Neelson acid-fast stain. With this 
method, faecal debris and some yeasts occasionally occupy the primary stain 
providing false positive results (Baxby and Blundell 1983). The method adopted in my 
study was more selective (Nicols and Thom 1984). A recent study in Libya gave the 
prevalence of Cryptosporidium as 13% (Ali et al. 2005). The technique utilised for 
detection of Cryptosporidium was the same as that used in a previous study. Other 
studies performed in developing countries revealed the incidence of Cryptosporidium 
as similar to our study. In Jordan this was 1.5% (Youssef et al. 2000), and in 
Bangladesh 8.4% (Haque et aL 2003b). In Egypt, the prevalence vas higher than our 
studies and detected was 15% (EI-Mohamady et aL 2006). In contrast, for studies in 
other developing countries, the rates were much higher. In Uganda prevalence was 
25.0% (Turnwine et al. 2003). In developed countries, the incidence proves to be very 
low 1.7% in Denmark (Olesen et al. 2005) and 6% in UK (Crowley et al. 1997). 
The detection of parasite infections using advanced techniques e. g. ELIZA, PCR will 
allow accurate determination of parasite infection rates. 
5.5 Seasonal distribution 
The first study was conducted over a relatively short period (3 months) and no 
seasonal variation could be determined. The second study was performed during a 
whole year and seasonal variation could, in this instance be determined. The highest 
frequency of isolation of enterobacteriae was in the summer season and parasites were 
detected more frequently in the summer and autumn, whereas the incidence of 
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infection with rotavirus infection was higher in the winter. Other studies in many 
countries have demonstrated the same seasonal variation. In a study in Bangladesh, the 
incidence of diarrhoea showed a greater rate in the months of March-August than was 
the case in September-February (Haque et al. 2003a). In Nepal, the prevalence of 
diarrhoea was common in the summer season at 61% of diarrhoeal cases (Ono et al. 
2001). In Tanzania, the prevalence of diarrhoea was higher in the dry season of July- 
September than any other season (Vargas et al. 2004). In Egypt, rotavirus-associated 
diarrhoea peaked in late summer to early winter, while bacterial agents were prevalent 
during summer (Wierzba et al. 2006). 
Bacteria were more frequently isolated in the summer because Libya is located in a 
temperate region, where the temperature is much higher in the summer. Many factors 
may contribute to bacteria being the leading cause of diarrhoea in the summer months, 
probably because hot weather encourages the growth of most pathogenic organisms 
(bacteria and parasites) on food and drink, which easily contaminated, especially if not 
placed in the refrigerator or left uncovered. During the summer period there is an 
increase in outdoor cooking, and picnics, where food on many occasions remains 
slightly raw which can lead to many health problems. In addition summer is also the 
breeding season for flies that act as mechanical vectors of enteropathogens to 
contaminate food and water. Various other studies supply similar results to our studies, 
regarding seasons of bacteria. In Denmark, bacterial infections tended to occur during 
summer and autumn (Olesen et al. 2005). In this study, Campylobacter isolations were 
higher in July-August and occurred later than in Egypt, where the incidence was 
higher in the warmer months between May and August (Rao et al. 200 1). 
The seasonal variation in frequency of rotavirus infections differed markedly from that 
of bacterial and parasite infections. Rotavirus was most frequently detected in the 
winter season (62/123; 50.4%). Reasons for this may stem from the high degree of 
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contact children have with other children or adults, especially in enclosed and 
overcrowded areas. Rotavirus is disseminated and transmitted through the community 
in the winter faster than is the case in the summer season. The growth of rotavirus in 
the winter is faster than the summer because the low temperature and dry air are 
suitable for optimum growth of rotavirus. The seasonal variation of rotavirus in some 
countries was similar. For instance, in Bangladesh (Albert et al. 1999), Nepal, (Ono et 
al. 2001), Denmark, (Fischer 2001), Argentina, (Giordano et al. 2001), Venezuela, 
(Salinas et al. 2004) and the United States (Malek et al. 2006). Other countries 
contrasted with this e. g. in Brazil children were hospitalised with severe rotavirus- 
associated gastroenteritis with 72% of the cases occurring in June and July (Cameirio 
et al. 2005). Again, in Brazil, rotavirus- associated diarrhoea also occurred in June and 
July (Nadya et al. 2005). In Egypt, the incidence rates of rotavirus diarrhoea was 
greater during late summer and early winter (Wierzba et al. 2006). Most countries had 
rotavirus admissions all year round, and rotavirus generally reached a seasonal winter 
peak in both temperate and tropical climates (Kane et al. 2004). 
The seasonal variation of parasite infection was similar to that for bacteria where the 
highest numbers were detected in the hot months. In studies in various nations, the 
incidence was similar to our study. In Uruguay, Cryptosporidium has a seasonal 
presentation at the end of summer and autumn (Torres et aL 200 1). In Tanzania, a high 
proportion of G. lamblia was isolated during the rainy season, while Ent. histolytica 
isolation was higher in the dry season (Vargas et al. 2004). 
In Bangladesh, Ent. histolytica-associated diarrhoeal incidence did not demonstrate a 
seasonal relationship (Haque et al. 2003a). 
5.6 Descriptive statistics 
Libyan children under one year of age were the most susceptible to acute diarrhoea 
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requiring admission to hospital. A difference between the two studies (78.8% in the 
first study and 70.1 % in the second) was noted which may have been due to increased 
breast feeding in the second study. Similar results have been reported in many 
countries. In most developing nations the incidence of diarrhoeal diseases are greatest 
among children younger than I year of age, and thereafter rates decline (Kosek et al. 
2003). In Jordan, the prevalence of acute diarrhoea was higher in children under one 
year at 69.1 % (Youssef et al. 2000). There is a difference between the present study 
and one performed in Denmark where only 27% of children with diarrhoea were aged 
under one year and incidence was highest in the age group <2 years old (68% of 
children; Olesen et al. 2005). In analysis of a 2-year study of 1249 admissions with 
GE in Tripoli Children's hospital, infants comprised 92% of patients below I year and 
59% were aged 6 months or younger (Ben Halim. 1991). A further study also 
conducted in Libya showed that the prevalence of diarrhoea was 85% of children aged 
below one year (Ghenghesh et al. 1997). These results were in contrast to many 
studies, especially those done in developed countries, where diarrhoeal incidence was 
at its highest among the age group of two-year olds. In developed countries, children 
receive good care from child health care programmes, and enjoy good environmental 
and socioeconomic conditions. In the age group of <6 months and under one year old 
Libyan children, the incidence of acute diarrhoea was still very high when compared 
with other countries and this may be due to failure of breast feeding and control. 
diarrhoeal disease programmes. 
The incidence of acute diarrhoea in both studies was slightly higher in males than 
in females. The ratio of male: female was (1.3: 1) in the first study and (1.2: 1) in the 
second. Similar results were noted in a previous study in Libya where the male : 
female ratio was 1.2: 1 (Ghenghesh et aL 1997). Gender did not bear a significant role 
in causing diarrhoea in Libyan children. In many countries the sex distribution is not 
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much different. In Jordan, the sex distribution of children demonstrated a male: female 
ratio of 1.3: 1 (Youssef et al. 2000). In Bangladesh this was 1: 0.7 (Albert et al. 1999). 
In Nepal, the male to female ratio was 1.7: 1 (Ono et al. 2001). In Australia, the male 
to female ratio was 1.2: 1 (Tenkate and Stafford 2001). The slight variance may be due 
to the natural distribution of males and females in those countries or that parents tend 
to show greater care for males than they do for females, as is the case in the majority 
of developing countries. 
Breast feeding of Libyan children had a very low percentage. Only 4.2% of patients 
and 15.3% of controls were exclusively breast fed. The total number of mothers who 
breast fed their children was 23/236 mothers (9.7%) in the first study and 11.4% of 
patients and 24% of controls i. e. 143/810 mothers (17.7%) in the second. In the second 
study the total number of mothers who breast fed their children was greater. The 
difference between the two studies regarding breast feeding was approximately 8%. 
Another study in Libya demonstrated that 97% of patients admitted to the children's 
hospital for GE were wholly artificially fed (Ben Halim. 1991). Early artificial feeding 
may be responsible for the high incidence of acute diarrhoea in Libyan infancy 
especially among the age group 7 to 12 months which represented 43-46% of patients. 
Children who were breast fed were substantially less likely to suffer diarrhoea 
compared with their non-breast fed counterparts (p <0.05). The above suggest that 
breast feeding will protect younger children from contracting diarrhoea. Many studies 
have established a relationship between breast feeding and protection from diarrhoea. 
In Brazil, the chance of presenting with diarrhoea was 64% higher in children younger 
than six months who were not breast fed. When compared to children who were 
exclusively breast fed, the chance of presenting with diarrhoea increased to 82% in 
those who were not breast fed. Breast feeding and exclusive breast feeding was found 
to be a protective factor against diarrhoea in the first six months of life (Vieira et al. 
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2003). In England, in a case-control study of diarrhoeal disease, after adjustment for 
confounders, breast feeding was associated with significantly less diarrhoeal disease. 
Associations were striking even in infants aged > or =6 months (Quigley et al. 2006). 
A study in Egypt illustrated that exclusive breast feeding was protective by reducing 
asymptornatic infections, symptomatic infections, and clinical severity of diarrhoeal 
episodes (Mahmud et al. 2001). 
In Libya, the CDD programme, where necessary, should be activated by health 
education especially breast feeding for protection of infants particularly younger 
infants from birth to 6 months old, where the majority of this age group were found to 
suffer from acute diarrhoea in both studies. In Denmark, formula milk or ready made 
food containing milk powder was associated with diarrhoea, whereas being breastfed 
was associated with decreased risk of diarrhoea (Ethelberg et al. 2006). In Turkey, 
more children in the hospitalised group had high frequency of stool of diarrhoea, 
frequency of vomiting, malnutrition, dehydration and fever, and were not breastfed on 
admission compared to the control group (Yalcin et al. 2005). 
By excluding the percentage of patients and controls who were exclusively breast fed 
and did not drink water, there was little difference between patients and controls with 
the type of water supply in either study. Thus the type of water supply was found not 
to play a significant role in causing diarrhoea among Libyan children. When 
comparing between the first and second studies, we noted the water supply of tap and 
bottle water were used more for children attending hospital in the second study than 
the first, with the difference being approximately 23%. One explanation is that water 
prior to 2000 was stored as most residents in Tripoli city had personal wells or 
collected and stored water in their homes because bottled water was very expensive. 
Subsequent to 2000, most houses in Tripoli were connected to the general network of 
water sources, when water of the Great Man- Made River reached Tripoli city and also 
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bottled water became less expensive. In the first study. usage of well and storage water 
was not significantly different between patients and controls because water of the 
Great Man-Made River did not supply Tripoli city at the time when the first study was 
carried out while in the second study, there was a statistically significant difference 
(p<0.05). Accordingly, families must be encouraged to cease use of wells and storage 
water supplies especially for administering to infants. 
The patient and control groups of the second study who used a dummy reflected a 
decrease in the number of children (36.3% and 16% respectively), compared with the 
first study (57.6% and 18.6% respectively). The explanation for this may be due to the 
increased number of children in the second study who were breast fed. The patients 
group who used a dummy were substantially more likely to contract diarrhoea 
compared with the controls (P < 0.05) of the first study and (P < 0.05) of the second. 
Use of dummies may increase the risk of diarrhoea because they are easy to 
contaminate which may lead to the transmission of pathogens, especially in families 
with poor hygiene. Moreover there is a relationship between breast feeding and the use 
of dummies because when the child is breast fed, dummies are not normally used 
whereas when the child is bottle fed the child invariably also uses a dummy. 
Education in Libya is now generally satisfactory since the government has attempted 
to eradicate illiteracy within the last thirty years by opening schools everywhere, 
particularly in rural and desert communities by encouragement of adult return to 
learning within adult education centres and by legislation so that parents are 
responsible by law if their children fail to attend school until they have at least 
completed intermediate education level. In the first study, the illiteracy rate remained 
high (21.2% of mothers of patients and 17.8% of mothers of controls). In the second 
study, the illiteracy rate was slightly lower (15.8% of mothers of patients and 12.6% of 
mothers of controls). One explanation is that illiterate mothers of children involved in 
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these studies may have been older than other educated mothers because years ago 
parents tended to manifest sexual discrimination between male and female education, 
the girls being far less likely to be educated. However, a mother's education had no 
effect upon the occurrence of diarrhoea in Libyan children in either study here. 
5.7 Clinical observation 
The history and nature of stools taken from children suffering from acute diarrhoea 
is very important, because it will provide indications of whether the diarrhoea is mild, 
moderate or severe and assessment of characteristics of stool is a key feature in 
determining potential pathogens causing an acute diarrhoea episode. Liquid non- 
bloody stools are associated predominantly with a watery stool due to small intestinal 
dysfunction process, whereas bloody diarrhoea and pus (dysenteric) or bloody stools 
are associated as a rule with an inflammatory or invasive process of the colon. Most 
viral agents and bacteria that release enterotoxins do not generally cause bloody 
diarrhoea (Podewils et al. 2004). Mucous can be present in both situations and should 
be distinguished from pus. The ability to obtain an aetiological diagnosis in a child 
with diarrhoea is largely dependent on the quality of the stool sample, the experience 
and skill of the microbiologist, and resources available for stool evaluation. In these 
studies watery stools were more frequent (58.5% in the first study and 56.6% in the 
second). This would indicate that the most likely causes of diarrhoea in both studies 
were rotavirus and E. coli. Studies from other countries illustrated that watery stool 
was more common in children with acute diarrhoea. In Jordan, watery stool 
represented 91.7% of children hospitalised with acute diarrhoea with 10.9% of bloody 
stools (Yuossef et al. 2000). 
Libyan mothers were prone to seek medical assistance if the child had fever or 
vomiting. Over 70% of patients had fever reported at admission in both studies. Most 
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studies from other nations e. g. Denmark further noted that fever was the most 
frequently observed clinical feature associated with acute diarrhoea in 56% of patients 
(Olesen et al. 2005). Fever is a common occurrence and is usually associated with 
invasive pathogens and rotavirus infections. Fever was the most frequent clinica 
feature associated with acute diarrhoea in Libyan children. 
Vomiting is one of the primary reasons for admission of a child to hospital because 
he/she is unable to obtain fluids and food orally and these will need to be replaced 
intravenously. Vomiting is the consequence of disturbed motor activity of the stomach. 
Vomiting is observed more frequently in viral diarrhoea and illness caused by 
ingestion of preformed bacterial toxins (Podewils et al. 2004). In Jordan, 
vomiting was presented in 77.1% of patients and was the most frequently observed 
clinical symptom in children hospitalised by diarrhoea (Youssef et al. 2000). 
Despite these clues, detecting the causative agent of diarrhoea in an individual patient 
based on clinical manifestations alone is normally problematic. In the first study, just 
over half the patients had vomiting at admission. Vomiting was the second most 
frequently observed clinical feature associated with acute diarrhoea in both studies. 
The number of patients who had fever associated with vomiting was 32% in the first 
study and 35% in the second. Vomiting is a significant clinical factor for hospital 
admission and IVT administered to patient. If a child with mild or moderate 
dehydration is treated with TVI and assessment after that period for to take design for 
admission or not, that may result in unnecessary hospital admission. 
All children presenting acute diarrhoea should be accurately assessed for dehydration. 
Dehydration and its complications are invariably the cause of death in acute diarrhoea 
cases especially among infants. The fundamental aim of treatment of dehydration is to 
administer fluids to correct this situation. Estimation of the type and degree of 
dehydration at admission is crucial in order to commence proper treatment according 
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to current WHO guidelines and additional practice guidelines for treatment of acute 
gastrointestinal illness in children (American Academy of Pediatrics. 1997). Because 
the most frequent type of dehydration is isotonic, measurement of serum electrolytes is 
required in only those children who have either moderate dehydration with a typical 
clinical history or findings, or in children with severe dehydration. The type of 
dehydration according to the serum sodium value at admission in both studies were 
comparable to studies conducted previously and studies performed in other countries. 
In the first study, isotonic dehydration was 76.3%, hypotonic dehydration was 13.5%, 
and hypertonic dehydration was 10.2% and 79.2%, 11.5 and 9.3% respectively in the 
second study. In Tunisia, hypertonic dehydration was 11.5 1% of children with acute 
diarrhoea (Chouchane et al. 2005). The percentage of cases of hypertonic dehydration 
declined by 2.5% in the second study, but there was still a marked difference between 
the two studies. The explanation for this is that in 1997 Tripoli city water supplies 
were extremely salty, whereas in 2000 the Great Man-Made River water supply was 
established endowing the city with low salt water (Anon. 1994). The degree of 
dehydration in the first study was 32.2% for mild, 51.7% for moderate and 16.1% for 
severe and 33.1%, 55.5% and 11.4% respectively in the second study. The variation 
between both studies was obvious in the degree of severe dehydration which decreased 
in the second study, perhaps as a result of mothers who brought their child to the 
doctor early before the dehydration became much worse. No patient who was 
deteriorated or shocked participated in either study, because such cases will be 
admitted directly to the ICU. In developing countries, where severe dehydration is 
more prevalent because there are many factors which contribute to severe dehydration: 
the mother stops breast feeding, there is no use of ORS especially for infants, there is 
cessation of administering any fluids or solid or semi-solid food, delay to bring the 
child to the medical centre or hospital, profuse watery stool and high frequency. The 
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level of serum electrolytes (sodium, potassium and chloride) during acute diarrhoea 
especially in severe dehydration cases, will be disturbed but, when the dehydration is 
corrected, the electrolytes will return to normal levels. It is critical to determine the 
serum sodium, potassium and chloride level as soon as possible after admission of the 
patient, because hypocalaernia (potassium below normal level) or hypercalaernia 
(potassium above normal levels) and hyponatraemia (sodium below normal level) or 
hypernatraernia (sodium above normal level) will require different intravenous drips to 
correct dehydration to prevent any associated complications. 
In both studies, the serum electrolytes of patients in 75.8 to 78.8 % were within normal 
ranges and residual percentage was corrected properly. No patient suffered 
complications due to electrolytes disturbance because most patients were rehydrated 
by IVT (86.2%) and others by ORT. Normally mothers had brought 
their children to hospital early before the child developed severe dehydration or 
electrolyte disturbance. 
The protocol of treatment of acute diarrhoea in recent years has altered according to 
WHO recommendations, where mild and moderate dehydration are treated by using 
ORT, a part from patients with vomiting where IVT is used. This is also adopted when 
severe dehydration is present. The effective use of ORT has saved millions of lives 
around the world. In the first study, the percentage of patients treated for dehydration 
by ORS was only 8.5% and 91.5% of patients received IVT. In the second study, the 
percentage of patients treated for dehydration by ORT was 13.8% and 86.2% of 
patients received IVT. There was a slight increase in the use of ORT in the second 
study but, generally, in Libya ORS is still not extensively used. In both studies, 
approximately I I% of patients were treated by ORT and the percentage of patients 
where moderate dehydration was diagnosed was approximately 32.5%. This is in 
contrast with WHO recommendations. Many factors may be responsible for excessive 
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use of IVT. Firstly, mothers provide an incorrect history especially of vomiting and 
frequency of diarrhoea. This may be because they consider the treatment is superior if 
their child is admitted and IVT is administered. Secondly, many authorities suggest 
that children who are assessed as being moderately dehydrated should be given IVT 
when they could be rehydrated orally according to WHO recommendations. Thirdly, 
there was an over- estimate of dehydration by junior doctors at admission which may 
lead to unnecessary hospital admission and over-treatment with IVF. This result is 
similar to a study done in Thailand (Gusbi 1991). In many other countries a high 
percentage of ORT was utilised. In Jordan, ORS was administered much more 
regularly than in Libya and rehydration of patients during hospitalisation was 58.1% 
(Youssef et al. 2000). In Saudi Arabia, mothers used ORS in greater than 40% of cases 
(Bani et al. 2002). 
5.8 Age distribution and clinical features in patients with different enteric 
pathogens 
In both studies, prevalence of acute diarrhoea in Libyan children was greatest 
among of patients were aged <6 months (48.6% and 45.6%), and previous studies 
from other countries yielded similar results. For example, Libyan children <6 rn were 
more susceptible to bacterial infections because the breast-feeding percentage was 
very low particularly for infants aged <4m, whereas bottle feeding was normally 
adopted. These may not have been prepared under hygienic conditions e. g: hand 
washing, cleaning of bottles, use of sterilising tablets, or heating of water when mixing 
it with milk powder. In this age most of the infants receiving bottle feed further used 
dummies (also easily contaminated). 
Rotavirus incidence was higher in both studies compared with other pathogens in 
children aged from 6 to 12 months (45.4% and 53.1%). In Venezuela, the prevalence 
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is similar to our study for detection of rotavirus in children aged one 
year at 46.3% (Salinas et al. 2004). 
The incidence of rotavirus infection is lower in infants <6 months because the factors 
affecting spread of rotavirus infection by environmental factors is not similar to 
bacterial spread, rotavirus spread mainly occurs in communities by close contact. 
Parasite prevalence was greater in both studies compared with other pathogens in 
children aged > 12 months (57.1% and 48.4%). The prevalence of parasites in these 
studies increased with the age of the children because they had more contact with the 
community and began to eat and drink individually. The results of both studies were 
similar to studies performed in other countries. 
Fever was the most common clinical feature of acute diarrhoea associated with 
rotavirus infection of patients (81.8%) of the first study and (77.7%) of the second. 
Bacterial infection was the second pathogens where fever was associated with acute 
diarrhoeal infections in the two studies. Parasite infections were lower than rotavirus 
and bacteria associated with acute diarrhoeal infection. 
Vomiting was the second clinical feature of rotavirus infection associated with acute 
diarrhoea in both studies. In the first study, vomiting was reported in 72.7% of cases 
and 75.5% of the second. Other studies proved to be quite dissimilar to our studies. In 
Denmark, for instance vomiting was the most clinical feature associated with acute 
diarrhoea of children and was very high at 93% (Olesen et al. 2005). 
Dehydration is the most significant clinical feature needing careful examination of the 
child to detect the type and degree of dehydration prior to starting treatment. In our 
studies mild dehydration was noted in patients with parasite infections (100%) except 
Ent. histolytica at 50% among patients with acute diarrhoea. Parasite infections, loose 
mucus of stool consistency was more common than watery stool and vomiting 
additionally was lower than rotavirus and bacterial infections. Moderate dehydration 
184 
was more common in Campylobacter infection in the first study and Proteus in the 
second. Severe dehydration was more common in rotavirus infection in both studies. 
Abdominal cramps was the most common in Cryptosporidium 2/3 (66.7) of patients 
and in 3/6 (50%) of patients with Campylobacter infection in the first study. In the 
second study, abdominal cramps were again reported as a more common clinical 
feature in patients with Cryptosporidium infection in 8/13 (61.5%) and Campylobacter 
in 9/16 (56.3%) patients. Other studies reported Cryptosporidium as the leading 
clinical feature associated with acute diarrhoea in children. 
Watery stools were commonly noted in rotavirus infection associated with acute 
diarrhoea in both studies at 72.7% and 75.5% respectively. Other studies provided 
similar results. In Vietnam, watery stools was high in 8 1.1% of patients with rotavirus 
infection associated with acute diarrhoea (Vu Nguyen et al. 2004). In Jordan, watery 
stools of patients with rotavirus infection was high in 96.2% of patients with acute 
diarrhoea (Youssef et al. 2000). Mucus present in the stools of patients with acute 
diarrhoea was common in patients with Cryptosporidium and Campylobacter 
infections in almost 70% of cases in both studies. 
Stool mixed with blood was common in Campylobacter infection in our studies in 
33.3% and 31.3% of patients respectively. 
The mean frequency of motion per day was greatest in patients with rotavirus infection 
in both studies (7.3 and 7.9 respectively). Rotavirus was the most common pathogens 
causing watery diarrhoea in our studies. The episodes of stool per day will be more 
frequent. Many other studies were similar to ours. In Vietnam, patients with acute 
diarrhoea caused by rotavirus infection, watery stool was in 8 1.1% of patients and the 
mean motion per day was 7.78. (Vu Nguyen et al. 2004). 
The mean duration of diarrhoea/days was longest in patients with Cryptosporidium 
infection which caused acute diarrhoea in both studies (7.2 and 7.4 respectively). 
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Cryptosporidium was the most likely cause of prolonged duration of acute diarrhoea 
and was responsible for alteration to chronic diarrhoea e. g. in Bangladesh the mean 
duration of Cryptosporidium infection was 9 days. This study involved 48 patients 
with acute diarrhoea, 6 Cryptosporidium-infected cases who presented with diarrhoea 
and continued to suffer from it during the follow-up period after 14 days when it 
became persistent diarrhoea (Khan et al. 2004). My study protocols did not involve 
follow-up of cases of diarrhoea and patients with persistent diarrhoea were not 
examined further. 
5.9 CONCLUSIONS 
From the results of both studies and from discussions we can conclude: 
Aetiological agents were detected in 66/118 (55.9%) of diarrhoeal patients in the first 
study and in 276/405 (68.1 %) of the second. Bacteria were the most common agents 
detected in 43.3% of patients in the first study, whereas rotavirus was the most 
common agent identified in 30.4% of patients in the second study. Parasites were 
detected in 8.4% of patients and 3.4% of controls in the first study and this increased 
to 19.3% of patients and 4.7% of controls in the second. These findings indicate that 
rotavirus GE remains a common disease in hospitalized Libyan children and causes a 
substantial burden of disease. 
API 20E and API Campy were utilised to identify bacterial isolates in the second study 
and concluded that here and the number of confirmed bacterial causes decreased from 
142 (3 5.1 %) to 112 (27.7%). 
Rotavirus peaked during the winter season (cold months) while bacteria and 
parasites peaked during the summer and at the beginning of the autumn (hot months). 
PCR technique was utilised for the first time in identification of Campylobacter in 
Libya, where Campylobacter spp. were identified (Campylobacter jejuni and 
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Campylobacter coli) as the same as detected by API Campy technique and the number 
of cases involved 24. 
Libyan children below six months of age were the most susceptible to acute diarrhoea 
requiring admission to hospital. This was observed in 55 (46.6%) children of the first 
study and 175 (43.2%) of the second. The highest prevalence of acute diarrhoea was in 
children aged one year where the number was 94 (78.8%) of the first study and 284 
(70.1 %) of the second. 
Exclusive breast feeding among Libyan children was of a very low percentage, only 
4.2% of patients and 15.3% of controls in the first study and 11.4% of patients and 
24.0% of controls in the second. Both studies illustrated that most children who 
received breast feeding were older than 6 months. Bottle feeding represented a high 
percentage of patients fed in the two studies. In the first study, there were 62.7% and 
in the second there were 53.8%. 
The use of dummies among Libyan infants was quite considerable. In the first study 
this was 57.6% of patients and in the second study 36.3%. However breast feeding 
slightly increased and bottle feeding and dummy usage decreased in the second study. 
Nevertheless Libyan infants remained susceptible to acute diarrhoea. The risk of 
contracting diarrhoea in Libyan children using dummies was about 3 times greater 
than among non-users in the first study and about 2 times greater in the second study. 
This means that when the number of children who used dummies in the second study 
decreased the risk also decreased. 
Watery stool was the most common stool consistency of diarrhoeal patients in both 
studies. This involved 58.5% of the first study and 56.6% of the second. 
Fever was the most clinical feature associated with acute diarrhoea in either study. 
In the first study, the number of patients who had fever was 86 (72.9%) and 290 
(71.6%) of the second study. 
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Moderate dehydration was the most common degree of dehydration. The number 
of patients who had this level at admission was 61 (51.7%) in the first study and 225 
(55.5%) in the second. Isotonic dehydration was the most common type of dehydration 
across the two studies. The number of patients was 90 (76.3%) for the 
first study and 307 (75.8%) for the second. 
In Libya, oral rehydration therapy is still not extensively used. From the history and 
medical records of patients, ORT was adopted for their rehydration and was at a very 
low percentage. In the first study this was 8.5% and 13.8% in the second. 
Breast feeding, use of dummies and bottle feeding are the most common factors 
associated with the occurrence of diarrhoea in Libyan children (especially infants). 
5.10 Recommendation and future studies 
From the results of both studies and discussion, recommendations will be classified to 
three levels: 
First level: health authority: 
1. Support and activate Child Health Care programmes, especially Control 
Diarrhoeal Disease (CDD) programme. 
2. Health education via mass media e. g. Radio, TV and directly to high school 
students, particularly girls, colleges. 
3. Short courses for health personnel: health workers, maternity and child health 
care and health visitors for training in CDD programme, where children first seek 
medical assistance in health centers. 
4. Promotion of National Surveillance Programme not solely for diarrhoeal diseases 
but additionally for other children's diseases. 
5. Support doctors and microbiologist to perform studies and researches for 
diarrhoeal diseases by modern diagnostic laboratories and budget to allow 
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continuation of further studies and research. 
6. Enhancing the availability and accessibility of ORS with greater health education 
regarding its use. 
7. Observation and of sources of water supply by periodical analysis both chemical 
and bacteriological to prevent contamination of water that can lead to diarrhoea and 
other diseases. 
8. Introduce rotavirus vaccine through expanding vaccination programme after 
performing epidemiological studies on rotaviruses by serological and genetic 
surveys to detect rotavirus strains within Libya. 
Second level: health personnel 
1. Promotion by health education of mothers by messages to be undertaken to correct 
faulty maternal practices during diarrhoeal episodes in their children, especially for 
feeding of children and to encourage and promote breast feeding. 
2. To use ORT for treatment of dehydration according to WHO recommendations and 
IVT to be restricted to cases of severe dehydration or vomiting alone. 
3. Hospital admission restricted solely to severe cases or for a child who has serious 
vomiting to prevent unnecessary hospitalisation and to decrease cross-infections. 
4. Restriction of overuse of antibiotics and their use only in selected cases (Shigella) 
or other bacterial or parasite causing bloody diarrhoea following stool culture or 
stool analysis to avoid antibiotic resistance. 
Third level: mothers 
1. Advice to mothers to breast feed younger babies, especially infants for at least 6 
months. There are numerous studies demonstrating that exclusively breast feeding will 
protect children from diarrhoea when compared to children who were received only 
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bottle fed. Mothers need to be advised to continue breast feeding and to delay weaning 
until two years which is better for the child s health. 
2. Early referral for medical attention if the child has frequent diarrhoea (more than 
8/day) or suffers bloody diarrhoea or severe vomiting. 
3. Women who have children must have ORS sockets in their homes and should know 
how to mix and administer them to prevent dehydration. 
4. Infants should not be in contact with any person who has diarrhoea because the 
most acute diarrhoea is caused by enterovirouses and transmission from person to 
person by contact. 
5. If there is contraindication (medical reason) for breast feeding, the bottle feeding 
must be prepared under general health precautions with the use of a safe water supply, 
very clean or sterilised bottle, hand washing by soap prior to preparing the feed to 
minimise infection. 
Further diarrhea studies are required 
In Libya, study and research on diarrhoea is still scant and faces many problems. 
1. No cooperation occurs between clinician and microbiologist to work to gather data 
for performing studies and researches not just for diarrhoeal disease but for all 
diseases. 
2. There is no budget for study and research and much of the available budget is spent 
upon treatment for diseases. 
3. Many laboratories in Libya do not function well because there is a lack of adequate 
diagnostic laboratory tools (aquipments and materials) and professional technicians 
are required for repair and maintenance of equipment and quality controls. 
4. Training of microbiologists and technicians in the proper use of modern diagnostic 
techniques and use of highly advanced equipment is required. 
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5. A Communicable Disease Surveillance Centre needs to be established. 
Future studies 
1. Wide studies in the community and a clinical base for detection of incidence and 
prevalence rates for the pathogens causing this need to be implemented. Acute 
diarrhoea in Libyan children especially the pathogens are not detected by the sensitive 
and modem diagnostic techniques obtain accurate results. 
2. Performing studies for rotavirus to detect serotype and genotype before intrducing 
rotavirus vaccine. 
3. New studies to detect morbidity and mortality related to acute diarrhoea in children 
because the current figures pertain to 1988. 
4. Performing studies to detect the accuracy of incidence of hypertonic dehydration. 
5. To detect complications of acute diarrhoea by the follow-up of children who have 
acute diarrhoea, especially those with serious complications e. g.; Guillan-Barre 
Syndrome, Haemolytic Uraemic Syndrome, and Disseminated Intravascular 
Coagulopathy. 
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Appendix 1 
Case sheet 
Case number ................ 
Date of admission ........... 
Name of patient ................................ 
Address .......................................... 
Age ............................. Sex ............. 
Mother education ........................ Family size ............ 
Type of feeding: Breast ............. Bottle ............ Mixed ........... Solid 
Use of teat .......... Type of water supply ................ Animal contact ............. 
No. of loose motion/day . ............ Duration ................ 
Stool appearance: Loose ........... Watery ........... Mucous ......... Bloody ............ 
Fever ......... Grade ........... pattern ............ duration .............. 
Vomiting ......... Frequency ............ Duration ............. 
Abdominal pain or crumb ...................... 
Dehydration ............... Type: Isotonic ......... Hypotonic ......... Hypertonic .......... 
Degree dehydration ....... Mild .......... Moderate ............ Severe ....................... 
Associated infection ................ Chest. 
infection ......... Meningitis ........ Urinary tract 
infection 
.......... Other infection ............... 
Investigation: Urea ............ Na ......... K ........ 
Hb ............. 
Treatment: Oral rehydration therapy ......... IV 
drip Therapy....... ... Both 
Body weight: On admission .......... On 
discharge .......... 
Date of discharge ................. 
Duration of stay ................... 
Comments ................... 
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Appendix 2 
Laboratory results 
Case number .......... 
Name .......................... 
Age ............................ 
Sex ............................. 
Department (Unit) ...................... 
Microscopic examination of stool: 
WBC ....... RBC ....... Others .......... 
Ova ............ Cyst ............. parasite .......... 
Type of bacterial isolation ...................... 
Date .................. 
Rotavirus Assay .............. Result of test ........................... 
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Appendix 4 
Univariate analysis of first study 
Fever and Stool Duration 
1 day 
Stool Duration 
2-3 4-6 >=7 days Total 
Fever No Count 17 22 8 6 53 
% 53.1% 39.3% 34.8% 85.7% 44.9% 
Yes Count 15 34 15 1 65 
% 46.9% 60.7% 65.2% 14.3% 55.1% 
Total Count 32 56 23 7 118 
% 100% 100% 100% 100.0% 100% 
Fever and Pathogen 
Bacteria 
Pathogen 
Rotavirus Parasite Total 
Fever No Count 17 6 3 26 
% 45.9% 54.5% 60.0% 49.1% 
Yes Count 20 5 2 27 
% 54.1% 45.5% 40.0% 50.9% 
Total Count 37 11 5 53 
% 100.0% 100.0% 100.0% 100% 
Fever and Feeding type 
Breast 
Feeding type 
Bottle Mixed solid Total 
Fever No Count 2 35 12 4 53 
% 40.0% 47.9% 42.9% 33.3% 44.9% 
Yes Count 3 38 16 8 65 
% 60.0% 52.1% 57.1% 66.7% 55.1% 
Total Count 5 73 28 12 118 
% 100.0% 100% 100% 100% 100% 
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Fever and Vomiting 
Vomiting 
No Yes Total 
Fever No Count 29 
50.9% 
24 
39.3% 
53 
44.9% 
Yes Count 28 37 65 
% 49.1% 60.7% 55.1% 
Total Count 57 61 118 
% 100% 100% 100% 
Fever and age 
Age 
Patients Patients Patients 
alged <6m aged 6-2m aged > 12 m Total 
Fever No Count 21 20 12 53 
% 44.7% 46.5% 42.9% 44.9% 
Yes Count 26 23 16 65 
% 55.3% 53.5% 57.1% 55.1% 
Total Count 47 43 28 118 
% 100.0% 100.0% 100.0% 100% 
Fever and Dummies 
Dummies 
No Yes Total 
Fever No Count 22 31 53 
% 44.0% 45.6% 44.9% 
Yes Count 28 37 65 
% 56.0% 54.4% 55.1% 
Total Count 50 68 118 
% 100% 100% 100% 
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Fever and Number of motion motion/day 
Number of motion/day 
4-6 7-9 >=10 Total 
Fever No Count 31 17 5 53 
% 50.8% 41.5% 33.3% 45.3% 
Yes Count 30 24 10 64 
% 49.2% 58.5% 66.7% 54.7% 
Total Count 61 41 15 117 
% 100.0% 100.0% 100.0% 100% 
Multivariate analysis of first study 
Logistic regression summary 
Odds 
p-value 
95.0% C. I. for OR 
ratio 
Lower Upper 
Age 1.104 0.068 0.993 1.228 
1 day (baseline) I I I 
Stool 
duration 2-3 7.195 0.116 0.614 84.343 
4-6 12.693 0.041 1.115 144.503 
>=7 days 14.757 0.035 1.206 180.496 
I I 
Vomit No (baseline) 
Vomiting vomit Yes 1.502 0.325 0.669 3.373 
4-6 (baseline) 1.00 1.00 1.00 
Motion/ 
day 7-9 0.623 0.475 0.170 2.284 
>=10 0.850 0.814 0.219 3.297 
Breast (baseline) I I I 
Type of 
feeding Bottle 6.579 0.282 0.213 203.463 
mixed 5.269 0.230 0.349 
79.582 
solid 3.232 0.306 0.341 
30.604 
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Univariate analysis of Second study 
Fever and Stool Duration 
1 day 
Stool Duration 
2-3 4-6 >=7 days Total 
Fever No Count 63 62 20 15 16F 
% 55.3% 32.6% 27.0% 55.6% 39.5% 
Yes Count 51 128 54 12 245 
% 44.7% 67.4% 73.0% 44.4% 60.5% 
Total Count 114 190 74 27 405 
% 100% 100% 100% 100.0% 100% 
Fever and Number of motion/day 
Number of motion 
motion/day 
4-6 7-9 >=10 Total 
Fever No Count 81 67 12 160 
% 40.1% 42.1% 29.3% 39.8% 
Yes Count 121 92 29 242 
% 59.9% 57.9% 70.7% 60.2% 
Total Count 202 159 41 402 
% 100% 100% 100% 100% 
Fever and Pathogen 
Bacteria 
Pathogen 
Rotavirus Parasite Total 
Fever No Count 51 19 7 77 
% 39.8% 48.7% 63.6% 43.3% 
Yes Count 77 20 4 101 
% 60.2% 51.3% 36.4% 56.7% 
Total Count 128 39 11 178 
% 100.0% 100.0% 100.0% 100% 
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Fever and feeding type 
Breast 
Feeding type 
Bottle Mixed Solid Total 
Fever No Count 6 100 32 22 160 
% 42.9% 45.5% 36.4% 26.5% 39.5% 
Yes Count 8 120 56 61 245 
% 57.1% 54.5% 63.6% 73.5% 60.5% 
Total Count 14 220 88 83 405 
% 100.0% 100% 100% 100% 100% 
Fever and Vomiting 
Vomiting 
No Yes Total 
Fever No Count 85 75 160 
% 43.1% 36.1% 39.5% 
Yes Count 112 133 245 
% 56.9% 63.9% 60.5% 
Total Count 197 208 405 
% 100% 100% 100% 
Feverand age 
Age 
Patients Patients aged Patients aged 
aged <6m 6-2m > 12 m Total 
Fever No Count 68 56 36 160 
% 43.0% 45.5% 29.0% 39.5% 
Yes Count 90 67 88 245 
% 57.0% 54.5% 71.0% 60.5% 
Total Count 158 123 124 405 
% 100.0% 100.0% 100.0% 100% 
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Fever * Dummies Crosstabulation 
Dummies 
No Yes Total 
Fever No Count 69 91 160 
% 35.8% 42.9% 39.5% 
Yes Count 124 121 245 
% 64.2% 57.1% 60.5% 
Total Count 193 212 405 
% 100% 100% 100% 
Multivariate analysis of second study 
Logistic regression summary 
Odds 
ratio 
p-value 
95.0% C. I. for OR 
Lower Upper 
Age 1.137 0.000 1.076 1.201 
1 day (baseline) I I I 
Stool 
duration 2-3 2.485 0.105 0.827 7.466 
4-6 7.039 0.000 2.373 20.881 
>=7 days 8.877 0.000 2.790 28.251 
I I 
Vomit No (baseline) 
Vomiting vomit Yes 1.657 0.038 1.028 2.672 
4-6 (baseline) I I I 
Motion/ 
day 7-9 1.083 0.849 0.477 2.458 
>=10 0.873 0.746 0.385 1.980 
Breast (baseline) I I I 
Type of 
feeding Bottle 11.129 0.013 1.677 73.864 
Mixed 10.095 0.002 2.399 42.486 
Solid 6.409 0.002 1.939 21.181 
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Univariate analysis of first study 
Vomiting and Stool Duration 
Stool Duration 
1 day 2-3 4-6 >=7 days Total 
Vomiting No Count 16 28 8 5 57 
% 50.0% 50.0% 34.8% 71.4% 48.3% 
Yes Count 16 28 15 2 61 
% 50.0% 50.0% 65.2% 28.6% 51.7% 
Total Count 32 56 23 7 118 
% 100% 100% 100% 100.0% 100% 
Vomiting and Number of motion motion/day 
Number of 
motion/day 
4-6 7-9 >=10 Total 
Vomiting No Count 31 20 6 57 
% 50.8% 48.8% 40.0% 48.7% 
Yes Count 30 21 9 60 
% 49.2% 51.2% 60.0% 51.3% 
Total Count 61 41 15 117 
% 100% 100% 100% 100% 
Vomiting and Pathogen 
Pathogen 
Bacteria Rotavirus Parasite Total 
Vomiting No Count 19 33 25 
% 51.4% 27.3% 60.0% 47.2% 
Yes Count 18 82 28 
% 48.6% 72.7% 40.0% 52.8% 
Total Count 37 11 5 53 
% 100.0% 100.0% 100.0% 100% 
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Multivariate analysis of first study 
Logistic regression summary 
Odds 
ratio p-value 
95.0% C. I. for OR 
Lower Upper 
Age 0.942 0.160 0.868 1.024 
1 day (baseline) I I I 
Stool 
duration 2-3 1.905 0.501 0.292 12.446 
4-6 1.786 0.541 0.278 11.463 
>=7 days 3.499 0.208 0.497 24.606 
No (baseline) I I I 
Fever Yes 1.438 0.368 0.652 3.173 
4-6 (baseline) I I I 
Motion/ 
day 7-9 0.527 0.308 0.153 1.808 
>=10 0.549 0.362 0.151 1.992 
Breast (baseline) I I I 
Type of 
feeding Bottle 0.048 0.075 0.002 1.357 
mixed 0.088 0.072 0.006 1.247 
solid 0.158 0.115 0.016 1.567 
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Univariate analysis of second study 
Vomiting and Number of motion/day 
Number of motion 
motion/day 
4-6 7-9 >=10 Total 
Vomiting No Count 102 82 13 197 
% 50.5% 51.6% 31.7% 49.0% 
Yes Count 100 77 28 205 
% 49.5% 48.4% 68.3% 51.0% 
Total Count 202 159 41 402 
% 100% 100% 100% 100% 
Vomiting and Pathogen 
Pathogen 
Bacteria Rotavirus Parasite Total 
Vomiting No Count 65 9 10 84 
% 50.8% 23.1% 90.9% 47.2% 
Yes Count 63 30 1 94 
% 49.2% 76.9% 9.1% 52.8% 
Total Count 128 39 11 178 
% 100.0% 100.0% 100.0% 100% 
Vomiting and Feeding type 
Breast 
Feeding type 
Bottle Mixed Solid Total 
Vomiting No Count 9 110 40 38 197 
% 64.3% 50.0% 45.5% 45.8% 48.6% 
Yes Count 5 110 48 45 208 
% 35.7% 50.0% 54.5% 54.2% 51.4% 
Total Count 14 220 88 83 405 
% 100.0% 100% 100% 100% 100% 
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Vomiting and age 
age 
Patients 
aged <6m 
Patients 
aged 6-2m 
Patients aged 
> 12 m Total 
Vomiting No Count 
% 
70 
44.3% 
69 
56.1% 
58 
46.8% 
197 
48.6% 
Yes Count 
% 
88 
55.7% 
54 
43.9% 
66 
53.2% 
208 
51.4% 
Total Count 
% 
158 
100.0% 
123 
100.0% 
124 
100.0% 
405 
100% 
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Multivariate analisis of second study 
Logistic regression summary 
Odds ratio 
p-value 
95.0% C. I. for OR 
Lower Upper 
Age . 838 . 000 . 764 . 921 
1 day 
(baseline) 
I II 
Stool 2-3 5.204 . 038 1.091 24.819 
duration 4-6 . 910 . 906 . 191 4.341 
>=7 days 1.744 . 512 . 330 9.207 
No 
(baseline) 
Fever . 854 . 703 . 379 1.921 
Yes 
4-6 
Motion (baseline) 
1 1 1 
7-9 . 290 . 068 . 
077 1.096 
>=10 . 261 . 
036 . 075 . 915 
Bacteria I I I (baseline) 
Pathogens 
Rotavirus 2.679 . 
390 . 284 
25.313 
Parasite 10.913 . 
055 . 948 
125.610 
Breast I I I 
(baseline) 
Bottle . 002 . 
000 . 000 . 
042 
Feeding type 
Mixed . 004 . 
000 . 000 . 
054 
Solid . 009 . 
000 . 001 . 
086 
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